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Abstract
Osteoporosis is an age-associated bone disease characterised by low bone mass.
The consequent fragility fractures with increased follow-up mortality and mor-
bidity underlie the clinical significance of osteoporosis in public health. How-
ever, current diagnostic criteria using bone mineral density (BMD) at the
femoral neck at most can identify half of the fragility fractures, and thereby
the ability to provide new metrics capturing the bone strength beyond neck
BMD remains of interest in osteoporosis research.
This study aims to, first, quantify pixel BMD at anatomically correspond-
ing locations in the femur; second, model the evolution of spatial BMD patterns
with ageing; and third, characterise how trabecular and cortical bone arrange-
ments change at different stages of osteoporosis progression.
To construct the atlas, a novel cross-calibration procedure is proposed to
integrate data from different DXA manufacturers into an amalgamated large-
scale dataset (n > 13000). A new technique, termed region free analysis
(RFA), is proposed to eliminate morphological variation between scans by
warping each image into a reference template. This image warping establishes
a correspondence between pixel coordinates that allows modelling pixel BMD
evolution with ageing using smooth quantile curves. Given access to large-
scale datasets, automatic quality control of DXA scans has been identified
as an emerging challenge to the community for which an unsupervised, non-
distortion-specific, opinion-free framework was proposed.
The developed atlas usefully added to our understanding of spatial BMD
patterns and their relationship with osteoporosis. The concept of osteoporo-
sis progression is introduced by proposing bone age as the age at which an
individual bone map best fits the constructed atlas. Normalising BMD maps
for bone age, local fracture-specific patterns were identified. The proposed
framework in this thesis constitutes a first step toward modelling osteoporosis
progression to identify better bone-based risk factors for prediction of fragility
fractures.
Key Words: Dual-energy X-ray Absorptiometry (DXA), Region Free Anal-
ysis (RFA), Osteoporosis, Disease Progression Estimation, Atlas Development
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1.1 Bone strength determinants and fragility fracture risk factors.
Several non-BMD clinical risk factors are identified for fragility
fractures [17]. Bone strength has an important influence on the
chance of developing a new fracture, but could be targeted as
the important outcome by itself. Bone strength is the result
of an inextricable relationship between both architectural and
material properties [20, 21]. . . . . . . . . . . . . . . . . . . . . 3
1.2 A schematic stress-strain curve of bone in tension. The initial
part of the curve is almost linear where the slope of the line de-
fines the Young’s modulus (stiffness). The area under the curve
equals the amount of energy used to deform the bone. The blue
dashed area defines toughness (the amount of energy absorbed
before fracture) and the orange shaded area defines resilience
(the amount of energy absorbed before the yield point). The
height of the curve at the fracture point defines strength (the
maximum stress bone sustains before fracture). . . . . . . . . . 4
1.3 Geometrical hip indices. (A-C) Hip axis length is the linear dis-
tance from the inner acetabulum surface to the lateral margin of
the femoral shaft below the greater trochanter drawn through
a midpoint in the femoral neck parallel to the cortices of the
femoral neck. (B-C) Femoral neck axis length is the linear dis-
tance from the apex of the femoral head to the base of the
greater trochanter. This index is similar to the hip axis length
but does not include the acetabular portion. (θ) Neck-shaft an-
gle is the angle between the shaft axis and the femoral neck
axis. (E-F) Femoral neck diameter is measured as the length of
the line perpendicular to the femoral neck axis passing through
the centre of the femoral neck. (F-G) Diaphysis diameter is the
width of the femoral shaft below the lesser trochanter. . . . . . . 10
ix
1.4 DXA region free analysis (DXA RFA) pipeline [36]. Bone maps
are restored semi-automatically from the raw files (with .p and
.r extensions) using a Matlab script. Sixty three control points
are automatically selected on the bone contour. A mean shape
is generated using generalised Procrustes analysis to serve as the
reference template. Each bone map is then individually warped
into this template to remove the morphological variation be-
tween scans. This image warping establishes a correspondence
between pixel BMD values across the population. . . . . . . . . 14
1.5 Seven Gruen zones commonly used as ROIs for analysis of peripros-
thetic BMD after total hip arthroplasty. . . . . . . . . . . . . . 15
2.1 (a) A typical Z-map of size 100 × 100 with FWHM = 20. (b)
The family-wise error rate is plotted as a function of the height
threshold tα. To control FWE rate at 0.05, a height thresh-
old of 3.38 should be chosen, which is smaller than 4.42 in the
Bonferroni correction. . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2 The Euler characteristic (EC) for two arbitrary excursion sets.
Panel (a) shows an excursion set with 4 blobs without any hole,
and so EC = 4 - 0 = 4. Panel (b) shows an excursion set with
4 blobs and 1 hole, and so the EC = 4 – 1 = 3. . . . . . . . . . 27
2.3 For a three-dimensional search volume, the Euler characteristic
is computed by summing the contributions from all cubes in
the region. An arbitrary cube with eight voxels is plotted to
illustrate this calculation. Each solid circle represents one voxel
inside the excursion set, while each hollow circle represents a
voxel outside the set. For this example, V = 5, E = 5, F = 1,
and C = 0 (see Eq. 2.12). Hence, χ = −1
8
. . . . . . . . . . . . . 28
2.4 The expected Euler characteristic E(χ) is plotted against the
height threshold t for an SPM of square shape (100 × 100 pix-
els) with FWHM = 6. At large threshold values, E(χ) would
approximate FWE rate. . . . . . . . . . . . . . . . . . . . . . . 28
x
2.5 Theoretical versus experimental computation of family-wise er-
ror rate. The blue solid line represents the estimated FWE rate
using Eq. 2.7 versus the experimental value (red dashed line)
computed based on 10,000 SPMs with a normal distribution.
FWHM = 6 and the search region is assumed to be an square
of size 100 × 100 pixels. Note that the expected EC gives an
upper bound on the actual FWE rate. . . . . . . . . . . . . . . 29
2.6 P-P plot for the FDR analysis. (a) The P-P plot for the set of
29 repositioned pairs of scans. As shown, the blue line almost
perfectly follows the diagonal line of identity indicating that
the null hypothesis of no change is valid in all pixels. (b) The
P-P plot for Charnley prosthesis after 24 months. The blue
line deviates below the line of identity, indicating the rejection
of the null hypothesis. (c) All pixels below the slope-α line
corresponding with the p-value less than 0.012 are statistically
significant at α = 0.05. . . . . . . . . . . . . . . . . . . . . . . . 34
2.7 Mean pixel BMD distribution. The mean distribution of pixel
BMD values at baseline measurement is shown for (a) composite-
beam (Charnley), (b) double-taper (Exeter), (c) triple-taper (C-
stem), (d) Bi- Metric total hip replacement, and (e) ASR hip
resurfacing prosthesis designs, respectively. . . . . . . . . . . . . 35
2.8 Longitudinal pixel BMD change over 24 months for the ce-
mented stem designs . . . . . . . . . . . . . . . . . . . . . . . . 36
2.9 FDR q-value maps after 24 months for the cemented stem designs 36
2.10 Cemented composite beam (Charnley). The first row shows the
pixel-level percentage change in BMD with respect to baseline
at 3, 6, 12, and 24 months after the surgery. The second row
shows the FDR q-values for longitudinal BMD change versus
baseline. Local p-values correspondent to the q-values are also
shown on the colour-bar. . . . . . . . . . . . . . . . . . . . . . . 37
2.11 Cemented double-taper slip (Exeter). The first row shows the
pixel-level percentage change in BMD with respect to baseline
at 3, 6, 12, and 24 months after the surgery. The second row
shows the FDR q-values for longitudinal BMD change versus
baseline. Local p-values correspondent to the q-values are also
shown on the colour-bar. . . . . . . . . . . . . . . . . . . . . . . 38
xi
2.12 Cemented triple-taper slip (C-Stem). The first row shows the
pixel-level percentage change in BMD with respect to baseline
at 3, 6, 12, and 24 months after the surgery. The second row
shows the FDR q-values for longitudinal BMD change versus
baseline. Local p-values correspondent to the q-values are also
shown on the colour-bar. . . . . . . . . . . . . . . . . . . . . . . 38
2.13 Longitudinal mean pixel BMD change and the corresponding
FDR q-value maps after 24 months are shown for Bi-Metric to-
tal hip replacement and ASR hip resurfacing prosthesis designs.
BMD change is expressed as a percentage of the baseline mea-
surement. All pixels with q ≤ 0.05 are declared as significant
events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.14 Cementless hip replacement (Bi-Metric). The first row shows
the pixel-level percentage change in BMD with respect to base-
line at 2, 12, and 24 months after the surgery. The second row
shows the FDR q-values for longitudinal BMD change versus
baseline. Local p-values correspondent to the q-values are also
shown on the colour-bar. . . . . . . . . . . . . . . . . . . . . . . 40
2.15 Cemented hip resurfacing (Articular Surface Replacement). The
first row shows the pixel-level percentage change in BMD with
respect to baseline at 2, 12, and 24 months after the surgery.
The second row shows the FDR q-values for longitudinal BMD
change versus baseline. Local p-values correspondent to the q-
values are also shown on the colour-bar. . . . . . . . . . . . . . 40
3.1 Femoral regions of interest (ROIs). The neck, trochanteric, and
intertrochanteric regions are shown in red, blue, and green, re-
spectively. The aggregation of these three regions comprises the
total hip. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
xii
3.2 Bone ageing analysis pipeline. Scans are automatically organ-
ised into sub-folders according to the study ID, geographic lo-
cation, subject ID, anatomic site, and follow-up time points.
Each scan is then warped into a reference domain to elimi-
nate morphological variations. Pixel BMD values are calibrated
across different centres such that the probability density func-
tions match one another for a subset of samples matched for gen-
der, age, body mass index, ethnicity, scan side, and geographic
location. Finally, a set of smooth quantile curves is fitted to the
standardised pixel BMD values for each pixel coordinate. . . . . 46
3.3 Median pixel-wise SNR for the Hologic QDR4500A versus the
Lunar iDXA systems. The x-axis shows the standard deviation
for the smoothing Gaussian kernel (σ) deployed to reduce the
noise level. The y-axis shows the variation in the signal-to-
noise ratio (SNR). For the Hologic system, pixel-level SNR was
computed using a set of 25 scan pairs, each pair collected on
the same day from the same subject with repositioning between
scans (section 3.3.2). For the Lunar system, pixel-level SNR was
computed using a random selection of 100 bilateral hip scans.
Deming regression analysis was deployed to compute SNR for
both systems (see section 3.2.3.(B)). . . . . . . . . . . . . . . . . 48
3.4 Conceptual illustration of region free analysis. Sixty-five land-
mark points are automatically selected around the bone contour.
A reference shape is learned by averaging over all the scans after
being aligned to a common position, scale, and orientation. A
thin plate spline (TPS) deformation function is fitted for each
individual scan such that the controlling landmark points are
mapped to the corresponding reference landmark points in the
template. Given the warp in the space, pixel intensities are
estimated using a linear interpolation technique. . . . . . . . . . 50
3.5 The first mode of shape variation in the proximal femur. . . . . 51
3.6 The check function for quantile regression with u = 0.5 and
u = 0.9. To compute the uth quantile of the random variable
Y , QY (u), the expected loss E(ρu(Y − ξ)) is minimised with
respect to ξ. Observe that u = 0.5 is equivalent to the median. . 62
xiii
3.7 DXA RFA precision analysis. (a) The pixel level CV (%) is vi-
sualised using a heat-map. Precision is worse around the bone
contour. This may be due to the inaccuracy in placing control-
ling landmark points at the bone surface. (b) The distribution
of pixel-level CV values in the femur. The median is 7.96% and
the interquartile range is 6.69%− 10.05%. . . . . . . . . . . . . 69
3.8 Estimated cross-calibration parameters between the Lunar iDXA
and the Hologic QDR 4500A systems. The quantile matching
regression technique was applied using the Hologic system as
the reference, i.e. [Lunar] = a [Hologic] + b. The average
and standard deviation of the estimated parameters over all the
pixel coordinates within the femur were 1.019 (SD, 0.140) for
the slope a and 0.170 (SD, 0.130) for the intercept b. . . . . . . 69
3.9 Bilateral hip comparison. (a) The left and the right hips are
highly correlated inside the femur, but the correlation is worse
at the boundary. (b) Average right-left differences in pixel BMD
values normalised to the population mean for the left side. (c)
Localised regions with a statistically significant difference in
BMD were observed between the bilateral sides using FDR anal-
ysis. (d) The pp-plot deviated from the identity line (dashed red
line) demonstrating a significant difference between the bilateral
sides. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.10 Estimated cross-calibration parameters between the left and the
right hips. The Deming regression technique with δ = 1 was
applied taking the right hip as the reference, i.e. [left] = a
[right] + b. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.11 The ability of the deployed calibration procedure to cancel the
observed difference between the right and the left hips. Here,
the right hip is mapped to the left side. Panel (a) shows the
average differences in BMD between the left and the calibrated
right hips normalised to the population mean for the left side.
(b, c) No statistically significant difference in BMD was observed
between the two sides following the bilateral calibration using
FDR analysis at q ≤ 0.05. . . . . . . . . . . . . . . . . . . . . . 72
xiv
3.12 The Bone ageing atlas. The median together with the first and
the third quartiles at each pixel coordinate is visualised using
heat-maps for 20, 35, 50, 65, 80, and 95 years of age. The atlas
is shown for the Lunar system at the left hip. . . . . . . . . . . 73
3.13 Quantile curves fitted at the femoral neck. The solid, dashed,
and dotted lines show the median, the 50% and the 90% quan-
tile ranges, respectively. The green shadow shows the 95% con-
fidence interval. The curves are shown for the Lunar system at
the left hip. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.14 Quantile curves fitted at the intertrochanteric region. The solid,
dashed, and dotted lines show the median, the 50% and the 90%
quantile ranges, respectively. The green shadow shows the 95%
confidence interval. The curves are shown for the Lunar system
at the left hip. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.15 The graphical user interface (GUI) developed in Matlab to fa-
cilitate manual segmentation of femoral scans. The user would
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1.1 Importance of Osteoporosis in Clinical Prac-
tice
The human skeletal is composed of two types of bone structure, termed corti-
cal (80%) and trabecular (20%) [1]. Trabecular bone, also known as cancellous
bone, has a spongy architecture forming a scaffolding network. Cortical bone
forms the hard exterior cortex giving the smooth white appearance to the
bones. Bone is a living tissue composed of two main components: an organic
collagen matrix and an inorganic phase composed of mostly calcium phosphate
crystallised as an apatite [2]. To maintain homoeostasis, bone undergoes a life-
time process of resorption and formation called bone remodelling [1]. Following
bone resorption by osteoclasts, osteoblasts first synthesise the collagen matrix
laid down at specific sites. Next, the new matrix starts a primary minerali-
sation step after about 5-10 days. After completion of this step, a secondary
mineralisation step begins. This step is slower than the primary step and
gradually increases both the amount and the size of mineralised crystals in
bone. Imbalanced regulation of bone remodelling can lead to erosion of the
arches and trusses in trabecular bone making it weaker and more prone to
fracture. Osteoporosis, which literally means porous bone, is a bone disease
characterised by low bone mass and micro-architectural deterioration leading
to an increased risk of fractures. [3, 4].
Osteoporosis is an age-associated disease caused by gradual bone loss, and
is asymptomatic unless a fracture occurs. In fact, the consequent fragility
fractures underlie the clinical significance of osteoporosis in public health [5].
The lifetime risk of suffering from a fracture in the forearm, hip, or vertebra is
1
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40% in women and 15% in men from the age of 50 onwards [6]. Osteoporotic
fractures are associated with increased mortality, morbidity, and reduced qual-
ity of life [7]. These fractures can bring a heavy burden on community and
healthcare systems. In Europe, the total number of osteoporotic fractures in
2000 was estimated at 3.79 million (1.05 million in men and 2.74 million in
women) with estimated total direct costs at £21.2 billion which is expected
to be doubled by 2050 (£51.1 billion) [8]. However, effective treatment op-
tions available for osteoporosis patients could prevent up to a quarter of all
osteoporotic-related fractures [8]. With these treatments that favourably al-
ter the natural osteoporosis progression, development of accurate quantifiable
techniques for fracture prediction and diagnosis of osteoporosis is a crucial step
so that treatments can be targeted efficiently to high-risk individuals [9].
An operational definition for osteoporosis is based on bone mineral density
(BMD) measured at the proximal femoral neck [9]. It is well established that
bone mass is inversely related to the fracture risk [10, 11, 12]. The World
Health Organisation (WHO) definition of osteoporosis is a BMD that lies 2.5
standard deviations or more below the mean for young healthy women [13, 4].
With this definition, however, a majority of individuals who will experience
fractures are not identified [14, 15, 16]. Almost half of all fragility fractures
occur in subjects with a normal BMD at the femoral neck [15, 16]. A meta-
analysis of eleven separate studies showed that methods based on BMD anal-
ysis can be used for predicting fracture trends in large populations but cannot
assess individual fracture risk accurately [10]. To address this limitation, re-
searchers have suggested deploying easily obtained clinical risk factors other
than BMD to enhance fracture prediction (Fig. 1.1). Currently, FRAX is the
leading toolbox for fracture risk assessment based on a combination of clini-
cal risk factors and BMD at the femoral neck [17]. FRAX takes into account
several clinical risk factors such as age, low body mass index (BMI), previous
fragility fractures, parental history of hip fracture, long-term use of oral gluco-
corticoids, smoking, rheumatoid arthritis, secondary osteoporosis, and alcohol
consumption [17]. The FRAX algorithm can be used with or without BMD
as a risk factor, and so prior estimation of risk can save the added expense of
bone densitometry when a DXA scan is not required.
The introduction of the FRAX algorithm has facilitated the assessment
of fracture risk but it does not capture other skeletal determinants of bone
strength beyond the femoral neck BMD. Arguing that femoral neck BMD is
not an optimal surrogate for bone strength, researchers have tried to provide
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alternative valid metrics for bone quality assessment. In the following sections,
first, an explanation of bone quality is presented (section 1.2) and then the
recent advances in bone quality assessment using DXA is reviewed (section
1.3). Several other imaging techniques also exist for quantitative bone quality
assessment, including Quantitative Ultra Sound (QUS), Quantitative Com-
puted Tomography (QCT), and Magnetic Resonance Imaging (MRI) [18]. All
techniques have advantages and disadvantages (see [18, 19] for a review) but
DXA is the most widely available method in clinical practice and will remain
so for the foreseeable future. This thesis mainly focuses on the application of
DXA and other imaging modalities are not further discussed here. Section 1.5
reviews the current limitations in the literature and presents the main objec-
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Figure 1.1: Bone strength determinants and fragility fracture risk factors. Several non-BMD
clinical risk factors are identified for fragility fractures [17]. Bone strength has an important
influence on the chance of developing a new fracture, but could be targeted as the important
outcome by itself. Bone strength is the result of an inextricable relationship between both
architectural and material properties [20, 21].
1.2 Bone Quality
When bone is loaded, it deforms in response to the force. The intensity of
the force divided by the cross-sectional area where it acts is called stress. The
proportional change in length due to the applied force is called strain. The
stress-strain curve is a useful tool to assess the mechanical properties of bone
(Fig. 1.2). Four quantities are used for this purpose: strength, toughness,
resilience, and stiffness. Strength can be defined as the maximum stress that
bone can sustain before it breaks when loaded slowly. Toughness is defined
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as the amount of energy bone can absorb before it breaks measured as the
area under the curve (the blue dashed area in Fig. 1.2). This is specifically
important during falls as bone should absorb a huge amount of energy in a
short time. Note that strength is different from toughness; for example, glass
is quite strong but brittle. Resilience is defined as the amount of elastic energy
before the yield point (the orange shaded area in Fig. 1.2). Finally, stiffness
is the ratio of stress to strain when the stress-strain curve is still linear. This
















Figure 1.2: A schematic stress-strain curve of bone in tension. The initial part of the curve
is almost linear where the slope of the line defines the Young’s modulus (stiffness). The area
under the curve equals the amount of energy used to deform the bone. The blue dashed area
defines toughness (the amount of energy absorbed before fracture) and the orange shaded
area defines resilience (the amount of energy absorbed before the yield point). The height
of the curve at the fracture point defines strength (the maximum stress bone sustains before
fracture).
Bone strength can be measured destructively in a laboratory by gradually
increasing the loading until the bone breaks [22]. For in vivo measurements
of bone deformation in response to various loading conditions, two types of
engineering models are broadly deployed: finite element (FE) and beam models
[23]. The latter assumes the femur as a supporting beam and stresses are
computed at three different cross-sections across the neck, intertrochanter, and
the shaft [22]. A software called hip strength analysis (HSA) was developed by
Beck and colleagues [22] to measure the bending strength reported as the cross-
sectional moment of inertia (CSMI). HSA combines the BMD measurements
and the hip geometry to predict bone strength but its precision is sensitive
to femur positioning [22]. Scaling for body size is also critically important
in this technique [22]. FE modelling provides a means for more sophisticated
simulation of the load behaviour in the femur by breaking it up into small
elements [24]. For an accurate model it is necessary to have information on
the specific loading conditions, bone geometry, and the material properties
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distributed in the femur. Despite the frequent application of these techniques
in research, their usage in clinical practice is not established [18].
Fragility fractures are indeed the result of decreased bone strength, but
interpreting sufficiently strong may be different, depending on the specific
event leading up to the fracture [21]. For example, a stress applied repeatedly
may break the bone while a similar impact applied only once may not break the
bone. Each of the mechanical properties described above could potentially have
a different impact on the overall bone competence and the relative importance
of each of these properties needs to be better understood [25]. Therefore, the
ability to measure a biomechanical parameter like strength may not provide a
comprehensive picture of bone competence. Here, I use the term bone quality
to emphasise the difference between bone strength as the maximum sustainable
stress and the soundness of bone in general. However, whenever clear from the
context, bone quality and bone strength are used interchangeably in this thesis.
Bone quality is known to be the result of an inextricable relationship be-
tween the bone architecture including bone geometry, trabecular microarchi-
tecture, and cortical thickness and its material properties including the degree
of mineralisation of bone, crystal size, the mineral-to-matrix ratio, and micro-
damage (Fig. 1.1) [18, 20, 21]. The ability to derive a single ideal measure
for bone quality is still unmet [21]; however, any tools that can reflect one
or more determinants of bone quality independent of femoral neck BMD can
potentially have an added value in the prediction of fractures. In the next
section, I review the recent advances in bone quality assessment using DXA.
1.3 DXA in Clinical Practice
DXA is the WHO gold standard tool used to measure areal BMD, and is de-
fined as the amount of bone mass per unit area ( g/cm2). Femoral neck BMD is
a simple metric that has been shown to be predictive of approximately 60-70%
of the variance in the bone mechanical properties and has been used widely as
a surrogate for bone strength in clinical practice [18, 26, 22]. Several studies
have shown a robust relationship between BMD and fracture risk [10, 11, 12].
However, given that DXA provides a 2D projection map of the BMD distri-
bution in the whole femur (see section 1.3.1), it can be postulated that DXA
scans contain much more information beyond which femoral neck BMD could
represent. A typical DXA scan can reflect the femoral shape and geometry
[27] as well as trabecular microarchitectural [28]. This extra information, if
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manipulated effectively, can potentially improve our understanding of bone
quality in the femur.
Recent advances in image processing and statistical analysis techniques
have opened new opportunities for the development of novel frameworks for
DXA analysis providing a more comprehensive picture of bone quality in the
femur [29, 30]. The central question of data mining in DXA has been ap-
proached from different angles: section 1.3.2 reviews attempts to restore 3D
spatial distribution of BMD values from 2D DXA scans; section 1.3.3 reviews
the literature on extracting new geometrical indices for enhanced fracture risk
assessment; and finally section 1.3.4 reviews techniques to represent spatial
texture patterns of BMD distribution extracted from DXA scans.
1.3.1 Principles of DXA
The fundamental principle underlying DXA systems is based on the amount
of attenuation for two X-rays with different energy levels traversing through
the body. When an X-ray beam passes through a tissue with mass attenuation
coefficient µ (cm2/g) and areal densityM ( g/cm2), the incident radiation in-
tensity I0 is attenuated due to photoelectric and Compton effects [31, 32]. The
pattern of attenuation for a homogeneous material can be described according
to the formula:
I = I0 exp [−µM] , (1.1)
where I is the transmitted intensity. In practice, the tissue that the X-
ray beams are transmitted through it is not homogeneous. However, for
BMD computation, it is sufficient to assume the traversing medium as a two-
compartment model of bone mineral and soft tissue. Then, Eq. 1.1 can be
rewritten as:
I = I0 exp [−(µsMs + µbMb)] , (1.2)
where the subscripts s and b stand for soft tissue and bone mineral, respec-
tively. Taking the natural logarithm of Eq. 1.2 gives:
− ln( I
I0
) = µsMs + µbMb. (1.3)
To differentiate between soft tissue and bone mineral, two X-rays one with
high-energy and the other with low-energy are required. Tow different ways are
deployed for generating the required spectrum with an X-ray tube: the energy
switching technique or the rare-earth K-edge filtering approach. In Hologic
Section 1.3. DXA in Clinical Practice 7
DXA scanners (Hologic In, Waltham, MA), the X-ray tube potential is rapidly
switching between 100 and 140 kVp [31]. Alternatively, Lunar DXA scanners
(GE Healthcare, Madison, WI) use an X-ray generator with a highly stable
constant potential (100 kVp). The X-ray beam is then passed through a K-edge
filter that divides the spectrum into the high- and low- energy components.
The high- and low- energy X-rays provide two independent equations
J = µsMs + µbMb, (1.4)
J ′ = µ′sMs + µ′bMb, (1.5)
where the primed variables are associated with the low-energy radiation. For
ease of notation, − ln( I
I0
) in Eq. 1.3 is replaced with J in Eqs. 1.4 and 1.5.
Given the value of the four attenuation coefficients, areal densities for both
bone mineral and soft tissue can be computed as:
Mb =




J ′ − (µ′b/µb)J
µ′s − (µ′b/µb)µs
(1.7)
Eq. 1.6 can be used for BMD computation only if the attenuation coeffi-
cients for soft tissue and bone are known. In practice, attenuation coefficients
are not known a priori given the variation in the composition of soft tissues
and bones. For an accurate assessment of bone density, Hologic scanners pass
the generated high- and low- energy X-ray beams through a proprietary au-
tomatic internal reference system [33, 31]. In this system, patient’s bone is
continuously compared against a known value contained in the internal ref-
erence standard. Let Mcs and Mcb denote the areal densities of the known
calibration filters for soft tissue and bone, respectively. Therefore, Hologic
scanners provide six transmission measurements through the air (no filter),
bone, and soft tissue filters at both high and low energies. Let J , Jb, and
Js denote the received logarithmic transmission factors for air, bone, and soft
tissue, respectively. The increments in attenuation when the calibration filters
are interposed can be computed for bone and soft tissue.
∆Jcb = Jb − J and ∆J ′cb = J ′b − J ′, (1.8)
∆Jcs = Js − J and ∆J ′cs = J ′s − J ′. (1.9)
Given these values, the effective values of attenuation coefficients can be com-
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puted as follows:
µb = ∆Jcb/Mcb and µ′b = ∆J ′cb/Mcb, (1.10)
µs = ∆Jcs/Mcs and µ′s = ∆J ′cs/Mcs. (1.11)
Substituting the estimated attenuation coefficients in Eq. 1.6, the areal density
for bone mineral can be computed.
The bone density is computed per each pixel of the area being scanned.
This results in a bone map consisting of many thousands of pixel BMD values.
In conventional analysis, these pixel values are averaged in a priori identified
regions of interest (ROIs) including the femoral neck. This data pooling has
been established as the standard protocol for DXA in clinical practice. How-
ever, pixel BMD information was deployed for research purposes in several
previous studies [34, 35, 36].
1.3.2 Volumetric BMD with DXA
DXA is a 2D modality that can provide projected BMD measurements on a
plane perpendicular to the X-ray beams. This can raise three limitations: first,
slight variation in the angle of the scan could potentially lead to a significant
change in the measured BMD values [37]. For example, ten degrees of internal
rotation from the customary position decreased the average BMD by 0.009,
0.005, and 0.006 g/cm2 in the femoral neck, trochanter, and Ward’s area
(p-value: <0.001, 0.008, and <0.001), respectively [37]. Second, areal BMD
cannot account for the variation in bone size; given the same volumetric BMD,
larger bones tend to have a higher areal BMD value [18]. Third, 3D spatial
BMD information is lost in DXA.
To address these limitations, several techniques have been proposed in the
literature for 3D reconstruction of shape and volumetric BMD information
using one or more DXA scans collected at different angels [38, 39]. These
techniques, albeit different in implementation details, conceptually follow three
main steps: first, construction of a 3D statistical atlas from a subset of QCT
scans. Second, construction of a digitally reconstructed radiograph (DRR)
by projecting an instance from the atlas to the plane where DXA scan was
collected. Various parameters including shape modes, scale, rotation, and
translation are modified iteratively so that the constructed DRR resembles
the actual DXA scan. Third, calibration of the volumetric BMD values using
areal BMD measurements from DXA scans collected at the anteroposterior
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position. For each pixel areal BMD, all voxels in the 3D reconstructed image
contributing to that projected pixel are linearly scaled.
Accurate 3D reconstructed scans can potentially improve the diagnosis of
osteoporosis and fracture risk estimation. For example, Whitmarsh et al. [40]
reported an enhancement in the area under the receiver operator character-
istic (ROC) curve for discrimination between a group of 80 patients with a
contra-lateral femur fracture and a control group of the same size. A two-fold
cross-validation technique was applied in this study. The average area under
the ROC curve was increased from 0.60 using only the femoral neck BMD
as the feature to 0.68 when adding the first mode of variation and the scal-
ing parameter as new features. Despite this marginal improvement, 2D-3D
techniques have other limitations as well. The 3D atlases are often trained
based on a small set with a few hundred QCT images. Therefore, this atlas
may not account for the full population variation including the effects of age-
ing. Further research is required to demonstrate the added value of 3D spatial
BMD information in comparison to 2D planar BMD measurements [41]. For
example, Goodyear et al. [42] also reported similar enhancement in discrim-
ination between fracture and non-fracture groups using statistical shape and
appearance models directly applied to DXA scans. The second limitation with
bone size does not seem to be addressed with 2D-3D techniques as the final
calibration is still based on planar BMD values from DXA.
1.3.3 Shape and Geometry
The geometric structure of the femur is known to be an important risk factor for
hip fracture. However, characterising the shape of the femur and its association
with fracture is a non-trivial task. Several hand-crafted geometrical indices
have been suggested in the literature. For example, Michelotti el at. [43]
investigated 15 different indices to identify their contribution to hip fracture
risk using logistic regression analysis. Table 1.1 shows the mean (SD) for five
different indices frequently reported in the literature: the hip axis length, the
femoral neck axis length, the neck-shaft angle, the femoral neck diameter, and
the diaphysis diameter. Fig. 1.3 demonstrates the definition for each term.
The literature does not present a clear consensus (Table 1.1); Faulkner et
al. [27] suggested that the hip axis length could be predictive of hip fractures
independent of age and femoral neck BMD where one standard deviation in-
crease in the hip axis length almost doubled the hip fracture risk (odds ratio =
1.8; 95% confidence interval = 1.3-2.5). While several studies confirmed sim-








Figure 1.3: Geometrical hip indices. (A-C) Hip axis length is the linear distance from the inner
acetabulum surface to the lateral margin of the femoral shaft below the greater trochanter
drawn through a midpoint in the femoral neck parallel to the cortices of the femoral neck.
(B-C) Femoral neck axis length is the linear distance from the apex of the femoral head to
the base of the greater trochanter. This index is similar to the hip axis length but does not
include the acetabular portion. (θ) Neck-shaft angle is the angle between the shaft axis and
the femoral neck axis. (E-F) Femoral neck diameter is measured as the length of the line
perpendicular to the femoral neck axis passing through the centre of the femoral neck. (F-G)
Diaphysis diameter is the width of the femoral shaft below the lesser trochanter.
ilar findings [44, 45, 46], others do not show a significant difference between
fracture and control groups for the hip axis length or the femoral neck axis
length [47, 43, 48, 49]. Despite this discrepancy in results, all studies reported
a higher length for the fracture group in comparison to the control group. The
neck-shaft angle was the second most frequently measured geometrical index.
The neck-shaft angle was consistently larger for the fracture group. Again,
the significance of this larger neck-shaft angle was confirmed in some studies
[45, 47, 46] and rejected in others [27, 44, 43].
Evaluation of the published data is complicated for three reasons. First, the
measurements are not standardised. For example, the hip axis length varies
from 3.71 cm in [45] to 12.96 cm in [44]. Second, the effect of patient positioning
on the geometrical indices has not been addressed. For example, the reported
3.4% increase in the hip axis length by Faulkner et al. [27] could be created by
about 5◦ of hip abduction [43]. Third, the measurement error using manual or
automatic techniques should be taken into account for each study. Given the
discrepancies in the published studies, Michelotti et al. [43] suggested that the
common belief that the femoral neck length is an independent risk factor for
the hip fractures remains unproven.
































































































































































































































































































































































































































































































































































































































































































































































































































































12 Chapter 1. Introduction
With developments in statistical shape models, rather than manually craft-
ing discriminant geometrical features, Gregory et al. [48] deployed active shape
models to quantify the morphological variation in the proximal femur. Al-
though the sample size was small (n = 26 fracture cases and 24 control sub-
jects), the results look promising. While active shape models have the potential
to correct for image magnification and poor patient positioning, these issues
have not been addressed in [48]. Further research is required to investigate
this technique in a larger population.
1.3.4 Trabecular Bone Microarchitecture
Trabecular bone microarchitecture is a key determinant of bone strength [1].
DXA cannot measure bone microarchitecture directly but has the potential
to provide reliable information on the overall status of bone microarchitec-
ture in patients [50]. Each DXA scan typically yields over 10,000 pixel BMD
measurements depending on the scan site and resolution. This information,
if quantified properly, can reflect on both material and architectural proper-
ties concerning the bone strength [2, 28]. However, BMD values extracted
from DXA scans are manipulated inefficiently by pooling pixels into a priori
identified ROIs.
Since the introduction of DXA in the late 1960s, little effort has been made
to quantify BMD deficit patterns using DXA scans. The earliest attempt to
deploy BMD information to quantify spatial texture patterns was likely in
1996 by Berry et al. [34]. Motivated by the Singh index [51], Berry et al.
[34] proposed a semi-automatic grading system to classify observed spatial
patterns into 5 groups. In another study, Boehm et al. [52] introduced a
new index called MF2D based on the Minkowski functions as follows: the
bone map is binarised using various threshold values. For each supra-threshold
map, the area, perimeter, and Euler characteristic (EC) number are computed.
The EC number is defined as the number of connected components in the
supra-threshold map minus the number of holes (see section 2.2.2.(C)). This
procedure gives three different functionals representing the texture pattern
in bone. The final MF2D score is proportional to the integral sum of these
profiles such that the area under the ROC curve is maximised for classification
between fracture and control groups.
More recently, trabecular bone score (TBS) was developed to provide in-
sight into the overall status of trabecular microarchitecture [28]. TBS is a
manually-handcrafted feature of bone texture representing the variation in the
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bone density distribution in the femur. TBS can be explained using the vari-
ogram [28]. For a given Bone map M(x), the variogram V (k) is defined as the
half of the expected squared differences of BMD between any two points with





where uθ is the unit vector in the θ direction. The variogram can be computed
experimentally by averaging over a large number of random initialisation for
the location x and direction θ. Given the experimental variogram with a log-
log representation, TBS is then defined as the slope of the variogram at the
origin. The conceptual interpretation for TBS is as follows: the greater the
TBS, the greater the degree of variation between adjacent pixels in the bone
map, and so the more dense the trabecular architecture in the 3D volume.
Therefore, an elevated TBS would be associated with a better bone quality
resistant to fractures whereas a low TBS would be associated with a more
fragile bone.
The importance of TBS in clinical practice has been reviewed previously
[53, 50]. TBS has been shown to be correlated with microarchitectural param-
eters including trabecular number (r = −0.84), trabecular spacing (r = 0.73),
and connectivity (r = −0.85) but not with the trabecular thickness (r = 0.23)
[28]. Several studies suggest that TBS can enhance fracture risk estimation
independent of BMD [54, 55, 53].
TBS, despite its prospective advantages, has also a number of limitations.
First, the physical meaning of TBS is not clear as grey-level values rather than
actual pixel BMD measurements are deployed in the computation algorithm.
Doge et al. [35] addressed this issue by using actual BMD measurements.
Dong et al. [35], arguing that TBS does not capture the global trend of the
variogram, suggested to fit an exponential function to the variogram:
V (k) = c0 + c[1− exp(−k/L)], (1.13)
where c, sill variance, c0, nugget variance, and L, correlation length, are the
model parameters. Dong et al. [35] showed that using the three parameters
together with the BMD can increase the area under the receiver-operating char-
acteristic (ROC) curve for classification between fracture and control groups
from 0.625 (when only neck BMD is deployed) to 0.748 (p-value = 0.001).
TBS or other similar scores presented in the literature provide a means of
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global texture characterisation in bone with limited ability to analyse localised
BMD deficits. To address this limitation, Morris et al. [36] presented a frame-
work called region free analysis (RFA) to allow localised statistical inference
in the proximal femur.
1.3.5 DXA Region Free Analysis
DXA RFA is an innovative toolkit developed for periprosthetic BMD varia-
tion analysis in a longitudinal study (Fig.1.4) [36]. To render pixel-wise bone
maps, a Matlab script was developed by the authors based on the proprietary
algorithm Apex v3.2 (Hologic Inc, Waltham, MA) as follows: the raw scan
files (with .p and .r extensions) were read to restore 6 image maps associ-
ated with the X-ray transmitted intensities through the air (no filter), bone,
and soft tissue density measurements at both high and low energies. The
maps were used to semi-automatically segment the prosthesis, bone, and soft
tissue using thresholding and morphological operations. Finally, the BMD
map was computed as discussed in section 1.3.1. Given the segmented bone
maps, sixty-three controlling landmark points were selected automatically on
the bone contour. Next, a reference template was generated as the mean of se-
lected control points after being corrected for translation, rotation, and scaling
using Generalised Procrustes analysis [56, 57]. Finally, each scan was warped
to the mean shape using a deformable thin plate spline (TPS) registration










Figure 1.4: DXA region free analysis (DXA RFA) pipeline [36]. Bone maps are restored semi-
automatically from the raw files (with .p and .r extensions) using a Matlab script. Sixty three
control points are automatically selected on the bone contour. A mean shape is generated
using generalised Procrustes analysis to serve as the reference template. Each bone map is
then individually warped into this template to remove the morphological variation between
scans. This image warping establishes a correspondence between pixel BMD values across the
population.
Morris et al. [36] applied DXA RFA for longitudinal analysis of peripros-
thetic BMD changes in the femur after total hip arthroplasty (THA). In con-
ventional DXA analysis, seven Gruen zones ROIs are usually selected (Fig. 1.5)
[59]. Use of predefined ROIs imposes a potential bias on the BMD analysis and
may lead to a masking of the true BMD changes [60]. Moreover, due to the
pooling of pixel values, global analysis of BMD maps within the whole imaging
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site is not possible. DXA RFA allows global pixel-level inferences by removing
the morphological variation between scans. A two-tailed paired t-test was de-
ployed in [36] to test the significance of BMD change after 12 months at each
pixel coordinate. The derived pixel p-values were visualised using a heat-map.
Though the heat-map is a useful tool to visualise the p-values within the femur,
making a sound global statistical inference requires p-value corrections for a
large number of tests. This problem known as multiple comparisons problem
is not addressed in [36].
Figure 1.5: Seven Gruen zones commonly used as ROIs for analysis of periprosthetic BMD
after total hip arthroplasty.
1.4 Rationale and Motivation
DXA is an inexpensive, widely available clinical tool with excellent precision
and extremely low radiation exposure. Conventional DXA analysis by means of
averaging pixel BMD information in a priori identified ROIs is long-established
in clinical practice as the standard tool for osteoporosis management and frac-
ture risk prediction. However, advances in medical image analysis have pro-
moted the extraction of additional information from DXA scans in clinical
research. TBS is a recently-developed tool for representing texture patterns in
DXA scans, and thereby provide insight on trabecular microarchitecture. Low
TBS is consistently associated with an increase in the prevalence of fragility
fractures. Moreover, TBS has been shown to be predictive of fracture indepen-
dent of FRAX scores. These findings suggest that exploring spatial texture
variation in BMD maps can potentially have an independent role from neck
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BMD and other clinical risk factors to enhance fracture prediction. TBS, how-
ever, cannot capture localised BMD variation. More specifically, to generate
the variogram, local grey-level variation is averaged over the whole femur, and
so TBS provides an insight on the overall texture patterns rather than local
BMD deficits.
To capture localised BMD variation in bone, Morris et al. [36] proposed
a technique called DXA RFA. DXA RFA allows pixel-level BMD analysis by
removing morphological variation between scans. However, it does not address
multiple comparisons problem over a large number of pixels. To address this
limitation, I integrated the False Discovery Rate (FDR) analysis into DXA
RFA. This integration would allow global inference over the whole femur, lo-
calising significant BMD variations in the femur (chapter 2).
To date, little research has been done to explore site-specific BMD varia-
tion patterns in the native femur. Bone turnover events may lead to areas of
both high and low mineral density with complex spatial patterns [20]. Under-
standing which spatial distribution pattern has a detrimental effect on bone
strength is an important consideration in the management of osteoporosis.
More specifically, it is of interest to know what changes osteoporosis produces
in the trabecular arrangement of the proximal femur at different stages of the
disease. Given the close relationship between involutional bone loss and the
underlying mechanism of osteoporosis, one can postulate that age-related bone
loss patterns, if quantified properly, may help explain why bones get weaker
with ageing.
1.5 Objectives of This Thesis
The overall aims of this study are, firstly, to extend the RFA framework into
a fully automatic pipeline in the setting of the native femur, and, secondly, to
apply this technique to a large cohort of Caucasian women to examine site-
specific patterns of involutional bone loss in the femur and its relationship
with osteoporosis. To this end, a spatio-temporal atlas of ageing bone in the
femur is developed, and some initial clinical observations made exploring its
potential future clinical utility.
In summary, the objectives of this thesis are as follows:
1. Integrate False Discovery Rate analysis into DXA RFA to localise pixels
with significant BMD variation.
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2. Extend the DXA RFA technique into a fully automatic pipeline applica-
ble to large-scale population analysis.
3. Construct a reference spatio-temporal atlas of ageing bone in the femur.
4. Examine site-specific patterns of involutional bone loss in the femur and
its relationship with osteoporosis.
5. Explore the feasibility of 6-year bone loss prediction based on the baseline
scans in the cohorts from the OPUS study
6. Develop an automatic quality control framework of femoral DXA scans.
1.6 Thesis Structure
The remainder of this thesis is organised as follows:
Chapter 2 demonstrates the integration of FDR analysis into DXA RFA
framework to address the multiple comparisons problem over a large num-
ber of pixels. I applied the technique to quantitate the magnitude and areal
size of periprosthetic BMD changes using scans acquired during two previous
randomised clinical trials (2004 to 2009); one comparing three cemented pros-
thesis design geometries [61], and the other comparing a hip resurfacing versus
a conventional cementless prosthesis [62]. DXA RFA resolved subtle differ-
ences in magnitude and area of bone remodelling between prosthesis designs
not previously identified in conventional DXA analyses.
Chapter 3 presents the development of a reference spatio-temporal atlas
of ageing bone in the native femur using a large cohort of North Western
European Caucasian women (n=13,338). To this end, the RFA framework,
initially developed for periprosthetic BMD analysis, is extended to the native
femur. The extended RFA framework is fully automatic applicable to large-
scale datasets with thousands of images. To integrate data from different
densitometer manufacturer technologies, a novel cross-calibration procedure
termed quantile matching regression technique is proposed.
Chapter 4 presents four potential applications of the developed atlas in os-
teoporosis management. First, the delineation between trabecular and cortical
bone architecture in the femur and how these patterns evolve with ageing is
presented, for which conventional region-based analysis would be insensitive.
Second, a new index called bone age is introduced to reflect the overall evo-
lution of spatial BMD variation with ageing. Bone age aims to estimate the
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actual progression, rather than the chronological age, of each subject along
the median bone ageing trajectory with potential to serve as an alternative
for progression estimation in osteoporosis. Third, a new index called f-score
is introduced to reflect the localised fracture-specific patterns in the femur.
Integration of bone age (the global metric) and f-score (the local metric) to
improve hip fracture prediction is discussed here. Finally, the potential to
extend the proposed bone ageing analysis framework for other explanatory
variables including body mass index (BMI) is presented.
Chapter 5 presents an emerging challenge for retrospective quality con-
trol of large-scale DXA scans. Subjective quality assessment would require
a considerable amount of time and expertise, making it unfeasible for use in
population imaging studies with thousands of scans. This chapter presents
the first automatic quality control framework for use in femoral DXA scans.
The proposed framework would be fully unsupervised; it does not require any
prior information on the anticipated artefact types or the subjective ground
truth labels for each scan. This framework, despite its limitations, is the first
attempt toward automatic quality control of DXA images.
Finally, chapter 6 concludes this thesis by summarising the key contri-
butions this work makes to the field. Current limitations are discussed and
suggestions are provided for future work on this tool.
Chapter 2
False Discovery Rate Integration
with Region Free Analysis
DXA region free analysis (DXA RFA) allows pixel-level quantitation of BMD
change within a longitudinal study where a paired t-test could be deployed
between the baseline and the follow-up at each pixel coordinate to determine
a statistically significant difference in BMD. However, to make a global statis-
tical inference, determining regions with a significant BMD change, the false
positive rate should be controlled over the whole femoral area rather than a
single pixel. This chapter demonstrates the integration of False Discovery Rate
(FDR) analysis with DXA RFA to address the multiple comparisons problem
over the group of pixel p-values. Here, I applied the technique to quantitate the
magnitude and areal size of periprosthetic BMD changes using scans acquired
during two previous randomised clinical trials (2004 to 2009); one comparing
three cemented prosthesis design geometries, and the other comparing a hip
resurfacing versus a conventional cementless prosthesis. DXA RFA resolved
subtle differences in magnitude and area of bone remodelling between prosthe-
sis designs not previously identified in conventional DXA analyses.
The content of this chapter is adapted from the following publication:
Mohsen Farzi, Richard M. Morris, Jeannette Penny, Lang Yang, Jose M. Pozo, Soren Overgaard,
Alejandro F. Frangi, and J. Mark Wilkinson, “Quantitating the effect of prosthesis design on femoral
remodelling using high-resolution region-free densitometric analysis (DXA-RFA),” Journal of Orthopaedic
Research, vol. 35, no. 10, pp. 2203–2210, 2017.
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2.1 Introduction
In conventional DXA analysis, BMD values are averaged in pre-defined regions
of interest. This data averaging aims to account for morphological variation
due to differences in patient anatomy and positioning during scan acquisition,
but limits our understanding of more focal BMD deficits. Recently, Morris et
al. [36] reported a high-resolution computational method for DXA analysis,
termed DXA region free analysis (RFA). DXA RFA maps each scan into a stan-
dardised coordinate space to account for the morphological variation between
scans [36]. This image warping establishes a correspondence between pixel
coordinates across the subjects. This correspondence allows the deployment
of appropriate statistical tests per each pixel coordinate to compare pixel-level
BMD values between different groups. The objective of a statistical test is to
evaluate the probability that the observed effect (or a more extreme one) has
occurred by chance given the null hypothesis is true. This probability is called
the p-value. Morris et al.[36] rendered the computed p-values per each pixel
as a heat-map to visualise the statistical significance of the observed BMD
change patterns in the femur.
In statistical hypothesis testing, it is often of interest to declare a non-zero
effect or equivalently reject the null hypothesis. To draw such an inference, the
computed p-value is compared against a cut-off level known as the significance
level or the alpha level (α). If the p-value is below α, the observed effect is
declared as statistically significant. Note that declaring an effect as significant
is based on an arbitrary selection of the α-level as part of the study design. If
the null hypothesis is true and a significant effect is declared, it is said to be a
false positive. In a single hypothesis test, the probability of committing a false
positive, known as type one error, would be less than α. However, increasing
the number of performed tests will increase the chance of committing a false
positive given the same α-level used in a single hypothesis test. This increased
false positive rate hampers sound statistical inference over a group of p-values
known as the multiple comparisons problem.
The multiple comparisons problem is not addressed in the proposed DXA
RFA framework by Morris et al. [36]. In this chapter, I extend the DXA RFA
method to allow global statistical inference within the femur by integrating
the false discovery rate (FDR) analysis into the toolkit. This extension en-
ables quantitation of the areal size and the anatomic position of regions with
statistically significant BMD change without imposing any a priori assump-
tions on the analysis region of interest. The results are usable in a wide range
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of applications, including localising fracture-specific patterns (see section 4.4),
but are discussed with particular reference to periprosthetic BMD change in
this chapter. More specifically, I analyse scans collected during two previous
randomised clinical trials conducted between 2004 and 2009; one comparing
three cemented prosthesis design geometries [61], and the other comparing a
hip resurfacing versus a conventional cementless prosthesis [62].
The remainder of this chapter is organised as follows. Section 2.2 reviews
different techniques to address the multiple comparisons problem. Section
2.3 presents the motivation, the study population, and the study design for
analysing periprosthetic BMD change after total hip arthroplasty (THA). Re-
sults and discussion are presented in sections 2.4 and 2.5. Section 2.6 concludes
this chapter.
2.2 Multiple Comparison Problem
Notation: Consider the problem of testing N hypotheses H1, · · · , HN , of
which N0 are true and N1 = N − N0 are false. Table 2.1 summarises the
required notations as follows: N0n, N0p, N1n, and N1p are representing the
number of true negatives, false positives, false negatives, and true positives,
respectively. Np = N0p +N1p is the total number of tests that are declared as
positive, i.e. an effect exists and the null hypothesis is rejected. Nn = N0n+N1n
is the total number of tests that are declared negative, i.e. the null hypothesis
cannot be rejected.
Table 2.1: Possible outcomes when testing N hypotheses.
Declared non-significant Declared significant Total
True null hypothesis N0n N0p N0
False null hypothesis N1n N1p N1
Nn Np N
In a single hypothesis testing procedure, a test statistic, i.e. a numerical
value derived from a sample data-set, is selected such that it measures the
distance between the data and the predictions under the null hypothesis, for
example, t-statistic and χ2-statistic. Each test statistic is a random variable
itself and so is denoted by a capital letter. For example, T denotes a t-statistic
and the scalar t denotes the computed statistic on the sample data-set. The
p-value is then defined as the probability of observing an effect at least as
large as the one computed on the sample data-set when the null hypothesis
is true, i.e. p = P(T > t|H = 1). Conclusions based on the statistical
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tests are uncertain and, in general, an acceptable maximum probability of
committing a false positive, known as the alpha level, is selected. The null
hypothesis is rejected if p < α. It is important to note that the computed
p-value is itself a random variable with uniform distribution under the null
hypothesis, i.e. P |H = 1 ∼ U(0, 1). Therefore, rejecting a test with a p-
value less than α ensures controlling the false positive rate at the level α, i.e.
P(reject H|H = 1) = P(P ≤ α|H = 1) = α.
Multiple comparisons refer to the testing of more than one hypothesis at a
time. In multiple hypothesis testing, a variety of generalisations are possible
to control the false positive rate. Per-comparison error (PCE) rate is defined
for each test as the probability of the type one error. The average PCE rate
can be defined as the expected value of the number of false positives divided
by the total number of tests.
PCE = αn = P(reject Hn|Hn = 1) for n = 1, · · · , N (2.1)









Family-wise error (FWE) rate is defined as the probability of committing at
least one false positive in the family.
FWE = P(N0p ≥ 1) (2.3)






In Eq. 2.4, the ratio N0p
Np
is defined zero when Np = 0.
When controlling the PCE rate in a multiple hypotheses testing problem,
the FWE rate increases, often sharply, with the number of tests. This may
pose serious consequences if the set of tests must be considered as a whole.
Numerous techniques have been proposed to address this issue. Below, two
common approaches based on the Bonferroni method (section 2.2.1) and the
random field theory (section 2.2.2) are presented to control the FWE rate.
Section 2.2.3 reviews the Benjamini and Hochberg technique [63] to control
the FDR. For explanation purposes, I assumed a z-test wherever a test statis-
tic should be considered. However, the discussion is valid for any other test
statistics.
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2.2.1 Bonferroni Correction
Calculation of the exact FWE rate is not trivial. The Bonferroni inequality
provides a conservative upper bound on the FWE rate. Assume {zi}Ni=1 are
the corresponding Z-statistics per each hypothesis test Hn. Then, the FWE
rate is bounded by Nα where α is the PCE rate per each test;




P(Zn ≥ zn) ≤ Nα.
(2.5)
(A) The Simple Bonferroni Method




will control the FWE rate at the α-level. When all αn are chosen to
be equal, the method is called the unweighted Bonferroni method. However,
as long as the sum of αn equals α, the method still controls the FWE rate at
the desired α-level.
This simple method is an example of a single-stage testing procedure. One
drawback with this technique is the low average power for testing the individ-
ual hypotheses; the larger the number of hypotheses, the smaller the average
power. To partially overcome this limitation, multi-stage testing procedures
based on sorted p-values are deployed in the literature [64].
(B) Holm’s Sequential Procedure
This method is deployed in multiple stages as follows [65]: sort the p-values
increasingly so that p(1) ≤ p(2) ≤ · · · ≤ p(N) with arbitrary ordering in case
of ties. At the first stage, reject H(1) if p(1) ≤ αN ; otherwise, all hypotheses
are accepted and the method terminates. If H(1) is rejected, continue the
procedure with the remaining hypotheses; at any stage n, reject H(n) if all
previous hypotheses H(n′) with n
′ < n are rejected and pn ≤ αN−n+1 .
(C) Hochberg’s Sequential Procedure
This method is based on the Simes equality [66]; if all hypotheses are true
and independent, then with probability 1− α, p(n) ≥ nαN . p(n) are increasingly
sorted p-values. Hochberg [67] utilised the Simes equality to modify the Holm’s
procedure as follows: at the first stage, check if p(N) ≤ α, then reject all
hypotheses; otherwise, continue the procedure with the remaining hypotheses.
At any stage n = 1, · · · , N , if p(n) ≤ αN−n+1 , then reject all hypotheses H(n′)
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with n′ ≤ n and terminate the procedure. If no n exists such that p(n) ≤ αN−n+1 ,
all hypotheses are accepted.
(D) Hommel’s Sequential Procedure
Hommel [68] utilised the results of the Simes equality [66] to modify the
Bonferroni method. This procedure is more powerful than the Hochberg’s




n′ = 1, · · · , n. If no such n exists, reject all hypotheses; otherwise, reject all
H(n′′) with p(n′′) ≤ αn .
2.2.2 Random Field Theory
In medical imaging applications, it is of interest to make an inference over a
search volume where the set of test statistics for each voxel are rendered as
a statistical parametric map (SPM) [69]. For example, detection of activated
regions in the brain in response to a certain condition [70] or identifying regions
with thinner femoral cortex in a fracture group in comparison to a non-fracture
group [71]. To address the multiple comparisons problem over the search
volume, the conventional Bonferroni-based correction methods are often too
conservative for use in the imaging data; the average power in localising an
effect at each individual voxel is too small. This can be explained by the
fact that the number of independent tests is much fewer than the number of
voxels in the image due to the spatial correlation between voxels [69]. In fact,
attributing any effect to the voxels is ill-posed as the number of voxels is more
or less arbitrary in an image. Therefore, instead of controlling false positive
voxels, a statistical map can be seen as a random field where inferences are
made based on the topological features of an SPM [69].
A random field can be simply defined as a stochastic process over a pa-
rameter space of dimensionality D ≥ 1 [72, 73]. Random field theory (RFT)
allows analysing SPMs to identify local extremes that are unlikely to happen
under the null hypothesis. Assume X(s) denotes an SPM where s ∈ RD char-
acterises the parameter space. The FWE rate defined in Eq. 2.3 can be then
interpreted as the probability of observing a local maximum in the SPM;




where i indexes the pixels in the image and tα is the height threshold cor-
responding to the significance level α. Given the spatial correlation between
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pixels in an SPM, when one pixel passes the threshold tα , adjacent pixels that
are close enough to this pixel will pass the threshold as well. Thus, deriving
an expression for P(maxiX(si) ≥ tα) is equivalent to the probability that a
local maximum appears on the map. Since the number of peaks is less than
the number of voxels, RFT yields a less conservative threshold for smoothed
maps in comparison with the Bonferroni-based methods.
To localise significant regions in a statistical map X, a suitable height
threshold tα is calculated and pixels above this threshold are selected as sig-
nificant events. This method is called height thresholding in the literature [69].
How RFT selects this threshold is discussed in section 2.2.2.(A). Other topo-
logical features including the area of local peaks or the number of local peaks
are also suggested in the literature [74].
(A) Peak level analysis
Deriving an expression for the probability of local peaks is not trivial from the
statistical point of view [73]. The way RFT solves this problem is by using
results that give the expected Euler Characteristic for a smooth SPM that
has been thresholded. The EC is discussed in details in section 2.2.2.(C), but
for now, it is important to note that the expected EC leads to the expected
number of local peaks, and so it can be used to approximate the FWE rate
[70].




In Eq. 2.7, D is the dimension of the statistic map. For example, for 2D maps
D = 2. Rd is the number of d-dimensional resolution elements or concisely
resels, which is explained in section 2.2.2.(B). The Rd would be a constant
number in Eq. 2.7 that is dependent on the shape and smoothness of the map.
ρd(t) is the EC density function which is only dependent on the distribution
function of the statistic map. For example, the EC density functions for the
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where Γ(.) is the gamma function.
The application of RFT proceeds in the following stages: first, the smooth-
ness, i.e. the number of resels, of the SPM is estimated. Second, FWE rate is
computed for each threshold value t using Eq. 2.7. Finally, the corresponding
threshold tα is calculated and all supra-threshold pixels are marked as sig-
nificant events. For example, Fig. 2.1(a) shows a smoothed Z-map of size
100× 100 with Full Width at Half Maximum (FWHM) 20. FWHM is a met-
ric to express the smoothness level of a smoothing kernel g(x) defined as the
difference between the two data points x1 and x2 at which the kernel function
is equal to half of its maximum value. Fig. 2.1(b) shows the experimental
estimation of the FWE rate. RFT gives the height threshold of 3.38 that is






























(b) Selection of suitable height threshold
Figure 2.1: (a) A typical Z-map of size 100× 100 with FWHM = 20. (b) The family-wise error
rate is plotted as a function of the height threshold tα. To control FWE rate at 0.05, a height
threshold of 3.38 should be chosen, which is smaller than 4.42 in the Bonferroni correction.
(B) Resolution Elements
Worsley et al. [75] introduced the term resolution element or briefly resel to
capture the concept of smoothness in an SPM. The number of resels can be
thought as an analogy to the number of independent observations in an SPM,
but it is not the same as the height threshold tα also depends on the EC
density functions (Eq. 2.7). Note that the number of resels is only dependent
on the smoothness level and the geometry of the search volume. For a Gaussian
random field of dimension D with the covariance matrix of partial derivatives




where W = (2Λ)−1.
(2.11)
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Following estimation of the FWHM at each voxel, transferring to the resel
space is simply achieved by division of voxel dimensions dx × dy × dz with
FWHMx, FWHMy, and FWHMz, respectively. The number of resels Rd is
defined as follows [75]:
• R3: It is defined as the volume of the search region in the resel space.
• R2: It is defined as half of the surface area of the search region in the
resel space. If the map is 2D, then R2 is simply the area of the search
region.
• R1: It is defined as twice the average width of all bounding boxes of the
search region in the resel space. If the map is 2D, then R1 is half of the
perimeter length of the search region in the resel space. If the map is
1D, then R1 is simply the length of the search region in the resel space.
• R0: It is the same as the Euler characteristic (EC) of the search region
(see section 2.2.2.(C)).
(C) Euler Characteristic
For an SPM X, the excursion set is defined as the supra-threshold voxels where
X(s) > tα. It is clear that for any arbitrary height threshold tα, a unique
excursion set can be defined. In the special case of 2D maps, any excursion
set would be comprised of some blobs and holes (Fig. 2.2). Then, EC can
be defined over an excursion set as the number of connected blobs above the
threshold value tα minus the number of holes.
(a) EC = 4 (b) EC = 3
Figure 2.2: The Euler characteristic (EC) for two arbitrary excursion sets. Panel (a) shows
an excursion set with 4 blobs without any hole, and so EC = 4 - 0 = 4. Panel (b) shows an
excursion set with 4 blobs and 1 hole, and so the EC = 4 – 1 = 3.
Worsley et al. [75] provided an exact mathematical definition for the EC
likewise the classical definition for the polyhedrons, i.e. χ = V −E+F . Here,
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V , E, and F denote respectively the number of vertices, edges, and faces. The
formulation proposed by Worsley et al. [75] is as follows. Assume a cube of
2× 2× 2 with 8 adjacent vertices (Fig. 2.3). Let V be the number of vertices
above threshold tα, E be the number of edges connecting the vertices inside
the excursion set, and F be the number of faces that all 4 vertices belong to
the excursion set. In this way, EC is defined as:
χ = V/8− E/4 + F/2− C, (2.12)
where C is a binary variable indicating whether all vertices of the cube lie
inside the excursion set or not. For a specific search volume, EC is defined as
the sum of χ in Eq. 2.12 for all the cubes in the region.
Figure 2.3: For a three-dimensional search volume, the Euler characteristic is computed by
summing the contributions from all cubes in the region. An arbitrary cube with eight voxels is
plotted to illustrate this calculation. Each solid circle represents one voxel inside the excursion
set, while each hollow circle represents a voxel outside the set. For this example, V = 5, E = 5,
F = 1, and C = 0 (see Eq. 2.12). Hence, χ = −1
8
.
Since EC is defined based on the excursion set of a random field, it is a ran-
dom variable itself with a specific probability density function ρ(t). In [70], it
is calculated for Gaussian, Student-t, and Fisher random fields for dimensions
d = 0, 1, 2, 3. Eq. 2.8-2.10 present density functions for t-distribution with ν
degrees of freedom. The expected EC can be computed using Eq. 2.7. Fig.
2.4 shows the expected EC for an SPM of square shape (100×100 pixels) with
FWHM = 6.
threshold














Figure 2.4: The expected Euler characteristic E(χ) is plotted against the height threshold t
for an SPM of square shape (100 × 100 pixels) with FWHM = 6. At large threshold values,
E(χ) would approximate FWE rate.
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For high thresholds tα, a blob may appear or not; thus, the EC would
be one or zero. With this intuition, the expected value of EC, E(χ), can be




X(si) ≥ tα) ≈ P(χ ≥ 1) ≈ E(χ) as P(χ > 1)→ 0 for tα →∞
(2.13)
This explanation justifies the estimation of the FWE rate in Eq. 2.7. Fig. 2.5
shows the FWE rate for different thresholds based on the random field theory
(blue solid line) and the experimental simulations (red dashed line). Please
note that the expected EC gives an upper bound on the actual FWE rate.
threshold







Family Wise Error Probability
Experimental
Theory
Figure 2.5: Theoretical versus experimental computation of family-wise error rate. The blue
solid line represents the estimated FWE rate using Eq. 2.7 versus the experimental value (red
dashed line) computed based on 10,000 SPMs with a normal distribution. FWHM = 6 and
the search region is assumed to be an square of size 100× 100 pixels. Note that the expected
EC gives an upper bound on the actual FWE rate.
2.2.3 False Discovery Rate Analysis
In some scenarios, it is of interest to control the number of erroneous rejections
of null hypothesis rather than whether any error was made at all. In this
case, Benjamini and Hochberg [63] introduced FDR as an alternative to the
FWE rate to address the multiple comparisons problem. FDR is the expected
proportion of false positives among all detected pixels (Eq. 2.4).
FDR can be interpreted as a weak controller of the FWE rate [69]; given
that all null hypotheses are true (N1 = 0), FDR controls the false positives
exactly in the same manner as the FWE rate. In case of an arbitrary mixture
of null hypotheses (N1 > 0), it can be shown that the FDR is always less than
or equal to the FWE rate; if a procedure controls the FWE rate at the level
α, it also controls the FDR at the level α. However, the reverse is not true.
Benjamini and Hochberg [63] introduced a simple procedure to control the
FDR at a predefined level α. The BH-FDR procedure is as follows: sort the
p-values increasingly so that p(1) ≤ p(2) ≤ · · · ≤ p(N) with arbitrary ordering
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in case of ties. Let k be the largest n for which p(n) ≤ nN α. Then, reject all
hypotheses H(n) for n = 1, · · · , k. This procedure guarantees control of the
FDR at the level α [63].
FDR does not provide any corrected p-values. However, q-value, as an
analogy to the p-value, can be defined as the minimum FDR level α for which
the test hypothesis H(n) would be rejected. The mapping from p-values to q-
values is obtained as follows. First, sort the p-values increasingly as mentioned




With this interpretation, to control the FDR at the level α, all tests with
qn ≤ α are rejected.
Although FDR does not explicitly use the notion of smoothness in SPMs
deployed in RFT, it is still independent of the number of pixels in the map.
Since FDR controls the expected proportion of false positives among all de-
tected pixels, doubling the number of pixels, for example, would double both
the number of detected pixels as well as the number of false positive pixels,
and so the ratio would remain unchanged.
The primary BH-FDR algorithm requires the independence of the test
statistics corresponding to the true null hypotheses. However, Benjamini and
Yekutieli [77] showed that the method is still valid to be used on correlated
tests under the Positive Regression Dependency on Subset (PRDS) condition.
PRDS seems a reasonable condition for many medical imaging applications.
For example, Li et al. [78] used BH-FDR analysis to identify fracture-critical
regions inside the proximal femur. Glickman et al. [79] also suggested the
BH-FDR method as an alternative to Bonferroni corrections in medical appli-
cations.
2.3 Periprosthetic BMD Analysis
2.3.1 Motivation
Prosthesis design influences the local mechanical environment of the proximal
femur after THA, resulting in strain-adaptive bone remodelling [80, 81, 82].
Several factors influence the extent of bone loss that occurs around different
prosthesis types; including prosthesis geometry, material stiffness, method of
fixation, and surface coating [83, 84, 85, 86, 87, 88, 89]. Periprosthetic bone
loss is a risk factor for fracture and causes reconstruction challenges at revision
surgery [90, 91].
There is a need for high-resolution, low-radiation exposure technologies for
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evaluating the bone architectural changes associated with different biomate-
rial designs and implant geometries [92]. Such technologies would facilitate
the non-invasive clinical assessment of novel prostheses that aim to better
mimic the natural loading environment, or have surface coatings that aim to
modulate the biology of the local bone environment [93]. Here, I applied the
DXA RFA integrated with FDR analysis to examine the impact of prosthesis
design on strain-adaptive bone remodelling in the setting of two previously
reported clinical trials using substantially different femoral prosthesis designs
[61, 62]. In one trial, I compared three different geometries of cemented femoral
prosthesis, the Charnley (DePuy International, Leeds, UK), Exeter (Stryker,
Newbury, UK), and the C-Stem (DePuy International, Leeds, UK). These
prostheses may be classified as shape-closed or force-closed designs [94, 95].
Shape-closed designs, like the Charnley, use a bonded prosthesis-cement inter-
face to fix the stem within the cement mantle, acting as a composite-beam,
and transfer the load to the femur mainly at the level of femoral diaphysis.
Force-closed designs, such as the double-tapered (Exeter) and triple-tapered
(C-Stem) prostheses, have a non-bonded prosthesis-cement interface, where
the stem acts as a mobile wedge within the cement mantle [94, 96]. This
allows initial distal migration to set up hoop stresses in the proximal cement
mantle resulting in more proximal load transfer between the femoral prosthesis
and the host bone [97]. In the other trial, I compared bone remodelling around
a hip resurfacing prosthesis versus a conventional cementless total hip replace-
ment. The load transfer pattern in hip resurfacing occurs directly from the
femoral head to the metaphysis, and is thought to be more representative of
that found in the native proximal femur than that for a conventional stemmed
prosthesis [98, 99, 100, 101, 102].
2.3.2 Study Populations and Scan Acquisitions
Anonymised DXA scans from two previous ethically approved clinical trials,
for which written, informed consent was provided, were examined using DXA
RFA [61, 62]. All subjects underwent surgery for idiopathic or secondary
osteoarthritis, and were free from use of drugs known to affect BMD. All scans
were acquired using a Hologic QDR 4500A fan-beam densitometer (Hologic
Inc., Waltham, MA), using the metal removal hip scanning mode with a point
resolution of 0.6 mm and a line spacing of 1.1 mm. Scans were performed with
the subject in the supine position with the legs in neutral rotation and full
extension. Scan acquisition was started approximately 2.5 cm distal to the
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tip of the femoral prosthesis, with the longitudinal axis of the prosthesis shaft
vertical and occupying the centre of the scan field. The scan was continued
proximally until 2 cm above the tip of the greater trochanter [103].
2.3.3 Study Design
(A) FDR Validation
To investigate the reliability of FDR algorithm incorporation into the DXA
RFA framework, I examined sequential DXA scans taken on the same day
after repositioning in 17 men (mean age 50 years, range 33–67) and 12 women
(mean age 53 years, range 35–61). Scans were acquired a mean of 6 months
(SD 3) after THA [103]. The hypothesis tested here was that no significant
differences are expected in measured pixel-level BMD between the individual
scan pairs at FDR level of 0.05.
(B) The Effect of Cemented Stem Design on Bone Remodelling
The subjects in this study were randomised at a ratio of 1:1:1 to receive ei-
ther a cemented composite-beam prosthesis (Charnley, DePuy Synthes Ltd,
n = 35), a double-tapered prosthesis (Exeter, Stryker UK Ltd, n = 38), or
a triple-tapered prosthesis (C-stem, DePuy Synthes Ltd, n = 38) [61]. All
patients were mobilised with unrestricted weight bearing on the first or second
postoperative days. BMD was measured at postoperative baseline within 1
week of surgery, and at 3, 6, 12, and 24 months later using the same Hologic
densitometer.
(C) Effect of Hip Resurfacing Versus Cementless THA on Bone
Remodelling
The subjects in this study were randomised at a ratio of 1:1 to receive ei-
ther a hip resurfacing prosthesis (Articular Surface Replacement (ASR) total
femoral prosthesis, DePuy Synthes Ltd, n = 13) or THA using a cementless,
proximally plasma-coated, titanium femoral component (Bi-metric, Biomet,
Bridgend, UK, n = 17) [62]. All patients were mobilised full weight bearing on
the first or second postoperative days. BMD was measured at postoperative
baseline within 1 week of surgery, and at 2, 12, and 24 months later using the
same Hologic densitometer.
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(D) Baseline Analysis
The baseline demographic characteristics of the subjects between each of the
prosthesis groups were compared using the χ2 test, Fisher’s exact test, the
Mann–Whitney U test, or Student’s t-test, as appropriate. The mean dis-
tribution of pixel BMD values among the post-operative baseline scans was
computed for each prosthesis.
(E) Follow-up analysis
For each Hologic prosthetic hip scan, the pixel-level BMD map was extracted
from the two archived Hologic scan files (.p and .r files) using DXA RFA
based upon a proprietary DXA bone map extraction algorithm APEX 3.2
(Hologic Inc, Waltham, MA) [36]. DXA RFA rendered a bone map with
approximately 14,000 pixels per scan where the pixel size was 0.56×0.56 mm2.
Next, a reference template was learned per each prosthesis design and scans
were warped into their corresponding template to remove shape variability
between scans as described previously (see section 1.3.5) [36]. The pixel-level
BMD change with respect to the baseline measurement was examined using a
paired t-test at each time-point. To address the multiple comparisons problem,
I deployed the Bonferroni correction, RFT, and FDR techniques. However,
the statistical power was limited with the Bonferroni and RFT techniques
and so here I only report results for the FDR approach [63]. All pixels with
q ≤ 0.05 were selected as statistically significant. The areal size of regions with
significant BMD change was quantitated as the fraction of the periprosthetic
bone area, i.e. the number of pixels with q ≤ 0.05 divided by the number of
all pixels in the template. The pixel-level FDR q-values were also rendered as




Figure 2.6(a) shows the P-P plots for the repositioned scans examined here.
A P-P plot is a diagram of increasingly sorted observed p-values against the
i/(N + 1) quantile of the uniform distribution, where N is the total number of
observed p-values. Under the null hypothesis, the expected curve in the P-P
plot is the diagonal line of identity. Large deviations from this diagonal have
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(a) (b) (c)
Figure 2.6: P-P plot for the FDR analysis. (a) The P-P plot for the set of 29 repositioned pairs
of scans. As shown, the blue line almost perfectly follows the diagonal line of identity indicating
that the null hypothesis of no change is valid in all pixels. (b) The P-P plot for Charnley
prosthesis after 24 months. The blue line deviates below the line of identity, indicating the
rejection of the null hypothesis. (c) All pixels below the slope-α line corresponding with the
p-value less than 0.012 are statistically significant at α = 0.05.
lower probability given the null hypothesis is true. As shown in Fig. 2.6(a), the
P-P plot follows the line of identity. This means that no pixels with significant
BMD change were identified across all pixels in the bone as expected. In
comparison, Fig. 2.6(b) shows the P-P plot for the Charnley prosthesis after
24 months as an example where the null hypothesis is rejected, since the P-P
plot deviates below the slope-α line (Fig. 2.6(c)).
2.4.2 Clinical Trial Subject Characteristics
The participants within each clinical trial were of similar age, sex distribution,
and body mass index (Table 2.2). The subjects participating in the cemented
stem geometry trial were older than those participating in the conventional
cementless femoral prosthesis versus hip resurfacing trial (71±6 vs. 57±6, p <
0.001), and a greater proportion were female (53:58 vs. 22:8, p = 0.013). The
BMI of participants in each study was 29.2±4.4 versus 28.3±4.4, respectively
(p = 0.397).
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Table 2.2: Characteristics of the patient populations participating in the DXA RFA analyses.




(n = 35) (n = 38) (n = 38)
Age at surgery (years) 70± 6 71± 7 71± 6 a0.929
Sex (M:F) 14:21 19:19 20:18 c0.527
BMI (kg/m
2
) 28.9± 4.6 29.2± 4.8 29.3± 3.9 a0.914
Cementless Stemmed Versus Hip Resurfacing Study
Characteristic
Hip Resurfacing Cementless Stem
p-value
(n = 13) (n = 17)
Age at surgery (years) 57± 6 56± 6 b0.320
Sex (M:F) 8:5 14:3 d0.201
BMI (kg/m
2
) 28.0± 5.9 28.6± 3.0 b0.680
Continuous data are presented as mean±standard deviation, and analysis is between groups within
each study using aANOVA or bMann–Whitney test. Categorical data were analysed using the cchi-
squared or dFisher’s exact test.
2.4.3 Post-Operative Baseline Mean BMD Distribution
Baseline scans for all prosthesis groups showed a pattern of mean BMD dis-
tribution consistent with proximal femoral architecture with differentiation of
cancellous versus cortical bone (Fig. 2.7). Areas of lowest BMD (approxi-
mately, 0.5–1 g/cm2) were observed in the cancellous bone within the greater
and lesser trochanter. BMD was highest (2–3 g/cm2) in the cortical bone of
the femoral diaphysis. Subjects with cemented prostheses showed the high-
est bone mass in the region of cementation, with a measured BMD of up to
4 g/cm2.
(a) (b) (c) (d) (e)
Figure 2.7: Mean pixel BMD distribution. The mean distribution of pixel BMD values at
baseline measurement is shown for (a) composite-beam (Charnley), (b) double-taper (Exeter),
(c) triple-taper (C-stem), (d) Bi- Metric total hip replacement, and (e) ASR hip resurfacing
prosthesis designs, respectively.
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2.4.4 Effect of Cemented Stem Design on Bone Remod-
elling
The areal size of regions with significant BMD change and the correspond-
ing BMD change in that regions are reported in Table 2.3. Fig. 2.8 shows
the magnitude of pixel BMD change (%) at 24 months. Fig. 2.9 shows the
corresponding FDR q-maps.
Table 2.3: Area size of regions with significant pixel BMD change (q ≤ 0.05) with corresponding
mean BMD change for three cemented prosthesis designs over 24 months.








Charnley 31.4 12.2 16.6 32.1 14.8 -10.3
Exeter 24.1 5.3 9.7 31.2 14.4 -12.1
C-stem 12.7 12.1 6.5 34.5 6.2 -11.1
The area sizes are expressed as a percentage of the total area of periprosthetic bone in the template image.
The average BMD change values are also expressed as a percentage of the baseline BMD value.
(a) (b) (c)
Figure 2.8: Longitudinal mean pixel BMD change over 24 months expressed as a percentage
of the baseline measurement for (a) composite-beam (Charnley), (b) double-taper (Exeter),
and (c) triple-taper (C-stem), respectively.
(a) (b) (c)
Figure 2.9: FDR q-value maps after 24 months are shown for (a) composite-beam (Charnley),
(b) double-taper (Exeter), and (c) triple-taper (C-stem), respectively. All pixels with q ≤ 0.05
are declared as significant events.
Section 2.4. Results 37
BMD change events occurred in discrete focal areas. An increase in bone
mass was observed consistently in the greater trochanter area, a site of multiple
tendinous attachments. Here, an average BMD increase of 32.1% within 16.6%
of the periprosthetic bone area was observed for the cemented composite beam
(Charnley) prosthesis, 31.2% within 9.7% of the area for the cemented sliding
double-taper (Exeter) prosthesis, and 34.5% within 6.5% of the area for the
cemented sliding triple-taper (C-stem) prosthesis was observed at 24 months
(q ≤ 0.05 for all comparisons).
An average bone loss of 10.3%, 12.1%, and 11.1% within an area of size
14.8%, 14.4%, and 6.2% was observed for the Charnley, Exeter, and C-stem
prostheses, respectively (q ≤ 0.05), mostly at the lesser trochanter. The great-
est BMD changes occurred in the metaphyseal region for all cemented pros-
thesis designs, with relatively less change at the femoral diaphysis.
Bone remodelling patterns were both rate and location specific to each
prosthesis design (Fig. 2.10–2.12). No significant BMD change was observed
at any pixel at 3 months for the Charnley prosthesis. However, an average
BMD increase of 12.7% was observed within a small fraction (0.7%) of the
periprosthetic bone area for the C-stem prosthesis at this time-point (q ≤
0.05), and bone loss of 6.8% over 7% of the bone area medial to the Exeter
prosthesis (q ≤ 0.05).
Figure 2.10: Cemented composite beam (Charnley). The first row shows the pixel-level
percentage change in BMD with respect to baseline at 3, 6, 12, and 24 months after the surgery.
The second row shows the FDR q-values for longitudinal BMD change versus baseline. Local
p-values correspondent to the q-values are also shown on the colour-bar.
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Figure 2.11: Cemented double-taper slip (Exeter). The first row shows the pixel-level per-
centage change in BMD with respect to baseline at 3, 6, 12, and 24 months after the surgery.
The second row shows the FDR q-values for longitudinal BMD change versus baseline. Local
p-values correspondent to the q-values are also shown on the colour-bar.
Figure 2.12: Cemented triple-taper slip (C-Stem). The first row shows the pixel-level per-
centage change in BMD with respect to baseline at 3, 6, 12, and 24 months after the surgery.
The second row shows the FDR q-values for longitudinal BMD change versus baseline. Local
p-values correspondent to the q-values are also shown on the colour-bar.
2.4.5 Effect of Hip Resurfacing Versus Cementless THA
on Bone Remodelling
The areal size of regions with significant BMD change and the average BMD
change in that regions are reported in Table 2.4. Fig. 2.13 shows the magnitude
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of pixel BMD change (%) and the corresponding FDR q-maps at 24 months.
An average BMD increase of 35.9% over an area of 22.3% was observed lo-
cally at the greater trochanter for the Bi-metric prosthesis (Figs. 2.13(a) and
2.13(b)). A diffuse pattern of bone loss (14.3%) was also observed at the
femoral shaft for the Bi-metric prosthesis at 24 months over a small fraction of
the periprosthetic bone area (0.6%). No periprosthetic bone loss was observed
around the hip resurfacing prosthesis at 24 months (Figs. 2.13(c) and 2.13(d)).
However, an average BMD increase of 34.3% was observed over 30.7% of the
proximal femoral metaphysis (q ≤ 0.005).
Table 2.4: Area size of regions with significant pixel BMD change (q ≤ 0.05) with corresponding
mean BMD change for a conventional cementless femoral prosthesis (Bi-Metric) versus a hip
resurfacing femoral prosthesis (ASR) over 24 Months.








Cementless stem 22.9 34.6 22.3 35.9 0.6 -14.3
Hip resurfacing 30.7 34.3 30.7 34.3 0.0 0.0
The area sizes are expressed as a percentage of the total area of periprosthetic bone in the template image.
The average BMD change values are also expressed as a percentage of the baseline BMD value.
(a) BMD change (b) FDR q-value
Bi-Metric total hip replacement
(c) BMD change (d) FDR q-value
ASR hip resurfacing
Figure 2.13: Longitudinal mean pixel BMD change and the corresponding FDR q-value maps
after 24 months are shown for Bi-Metric total hip replacement and ASR hip resurfacing
prosthesis designs. BMD change is expressed as a percentage of the baseline measurement.
All pixels with q ≤ 0.05 are declared as significant events.
The contrasting patterns of focal trochanteric versus a widespread meta-
physeal increase in BMD for the Bi-Metric versus ASR prostheses was apparent
by 12 months, and persisted at 24 months (Figs. 2.14 and 2.15). The increase
in bone mass around the ASR prosthesis was observed over the whole proximal
femoral metaphysis, but was most densely concentrated in the bone adjacent
to the lateral border of the prosthesis and the greater trochanter.
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Figure 2.14: Cementless hip replacement (Bi-Metric). The first row shows the pixel-level
percentage change in BMD with respect to baseline at 2, 12, and 24 months after the surgery.
The second row shows the FDR q-values for longitudinal BMD change versus baseline. Local
p-values correspondent to the q-values are also shown on the colour-bar.
Figure 2.15: Cemented hip resurfacing (Articular Surface Replacement). The first row shows
the pixel-level percentage change in BMD with respect to baseline at 2, 12, and 24 months
after the surgery. The second row shows the FDR q-values for longitudinal BMD change versus
baseline. Local p-values correspondent to the q-values are also shown on the colour-bar.
2.5 Discussion
I analysed BMD changes around five different prosthesis designs using DXA
RFA with FDR to demonstrate in high-resolution the effect that different pros-
thesis designs have on proximal femoral strain-adaptive remodelling. This ap-
proach is widely clinically applicable, non-invasive, and associated with low-
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radiation exposure. Some remodelling features are observed that were common
to all prostheses, and others that were design-specific. Our finding that remod-
elling events occurred in small but spatially discrete quanta is consistent with
the concept that post-operative bone remodelling occurs in discrete multicel-
lular units [104, 105]. The observation that periprosthetic bone remodelling
events are spatially complex, heterogeneous, and vary in density distribution
with prosthesis design supports finite element analysis predictions [106]. It is
also consistent with the view that the conventional ROI-based approach results
in substantial data loss that impacts interpretation [103].
Consistently across all prosthesis designs, a gain in bone mass was found
in the region of the greater trochanter, albeit this increase in bone mass was
most widely distributed for the hip resurfacing group. Hip resurfacing was also
the only prosthesis design around which increased bone mass occurred within
the cortical bone of the proximal medial femur. This aligns with finite element
predictions of the stress-redistribution at the femoral neck induced by this
prosthesis class [107, 108]. Penny et al [62] have previously identified a similar
BMD trend using conventional DXA, however, analysis using DXA RFA en-
abled precise localisation of the magnitude and area of these events. Although
these data support the concept that head resurfacing prosthesis induce load
transfer at the metaphyseal level, the approach does not quantitate over the
studied time-frame the possible influence of adverse responses to metal debris
on the local tissue microenvironment.
Previous conventional analysis using the seven Gruen zones showed that
the greatest bone loss occurred in R7 and R6 over 2 years for the three ce-
mented designs [61]. While DXA RFA analysis also showed significant bone
loss adjacent to the prosthesis at lesser trochanter (Fig. 2.9), this was more
precisely resolved using the RFA technique. Small areas of bone gain at the
tendon-bone interface of the lesser trochanter were also observed (Fig. 2.8). In
conventional DXA analysis, this spatial information is lost due to the averag-
ing pixels into regions of interest. Moreover, this averaging may cancel out the
bone loss with the bone gain in a region. For the hip resurfacing prosthesis,
the conventional analysis showed a bone gain in all the Gruen zones [62]. This
is compatible with spatial BMD change patterns in Fig. 2.13(c), where these
changes are anatomically observed in the femoral shaft.
The incorporation of FDR into the DXA RFA framework enabled quanti-
tation of the architectural details of femoral bone mass distribution and robust
statistical analysis of BMD change events. These changes were also rendered
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as heat-maps for visual assessment. The FDR algorithm was applied to limit
the proportion of false positives among statistically significant results. This
primary concern is not directly addressed with Bonferroni-type adjustments
[79, 63]. Moreover, the FDR approach gives increased statistical power in
comparison with the methods that control the FWE rate [79, 63]. The valida-
tion of the FDR correction on the set of 29 repositioned scans confirmed the
reliability of the method when applied in the DXA RFA framework.
2.6 Conclusion
This chapter presents the importance of deploying appropriate multiple hy-
pothesis testing procedures in the setting of DXA RFA. More specifically, I
demonstrated the integration of the FDR analysis with DXA RFA to anal-
yse periprosthetic BMD changes around 5 different prosthesis designs. This
integration allows quantification of the areal size of regions with a significant
BMD change, which was not possible using the original RFA framework. In
the next chapter, I extend the RFA framework to the native femur to analyses




Ageing Bone in the Native
Proximal Femur
Ageing is associated with a gradual and progressive bone loss, which pre-
disposes to osteoporosis. Given the close relationship between involutional
bone loss and the underlying mechanism of osteoporosis, improving the un-
derstanding of the bone ageing process could lead to enhanced preventive and
therapeutic strategies for osteoporosis. To facilitate this understanding, this
chapter presents a method to develop a spatio-temporal atlas of ageing bone in
the native proximal femur with a cohort of ∼13,000 Caucasian women. To the
best of our knowledge, this is the first spatio-temporal atlas of ageing bone.
To this end, the region free analysis (RFA) framework is extended to the na-
tive femur and a fully automatic formulation applicable to large-scale datasets
is presented. Furthermore, a novel cross-calibration technique is proposed to
homogenise data from different vendors (Hologic and Lunar GE) into a unified
multi-centre large-scale dataset.
The content of this chapter is adapted from the following publication:
Mohsen Farzi, Jose M. Pozo, Eugene McCloskey, Richard Eastell, J. Mark Wilkinson, and Alejandro F.
Frangi, “Spatio-Temporal Atlas of Bone Mineral Density Ageing,” in International Conference on Medical
Image Computing and Computer-Assisted Intervention (MICCAI2018). Springer, pp. 720–728, 2018.
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3.1 Introduction
Ageing is associated with a gradual and progressive bone loss, which predis-
poses to osteoporosis. Osteoporosis, which literally means porous bone, is a
bone disease characterised by low bone mass and micro-architectural deteri-
oration. Given the close relationship between involutional bone loss and the
underlying mechanism of osteoporosis, improving the understanding of the
bone ageing process has been of interest for the osteoporosis research commu-
nity [109, 110]. To facilitate this understanding, I propose a method to develop
a spatio-temporal atlas of ageing bone in the femur.
Spatio-temporal atlases are useful tools for visualising and accessing a
wide range of data in Medical Image Computing [111]. For example, brain
atlases demonstrated great potential for visualising age-related pathology in
Alzheimer’s disease [112]. However, to the best of our knowledge, no bone
ageing atlas has been developed in osteoporosis research so far. Developing a
comprehensive model of involutional bone loss is a challenging task. Firstly,
this requires a robust and accurate quantification technique for bone mineral
density (BMD) measurement and its spatial distribution. Dual-energy X-ray
Absorptiometry (DXA) is the reference gold standard to measure BMD in
clinical practice [18]. In conventional DXA analysis, BMD values are averaged
in a priori specified regions of interest (ROIs) to compensate for shape varia-
tion between scans (Fig. 3.1). This data averaging, however, may reduce our
insight on more focal BMD deficits.
The second challenge is the ability to homogenise BMD measurements
across different technologies, as a systematic difference exists between different
proprietary DXA manufacturers [113, 114, 115]. Two broad cross-calibration
procedures are commonly used. In one approach, each scanner is separately
calibrated by fitting bone phantom measurements to its nominal density val-
ues. Pearson et al. [116] suggested an exponential curve and explored the
technique using the European Spine Phantom (ESP) prototype. In the other
approach, different scanners are calibrated simultaneously using density values
measured on a common group of individuals [113, 114, 115].
Both DXA calibration procedures suffer from a number of key limitations.
Cross-calibration using phantom measurements is challenged by a study con-
ducted under the auspices of the International DXA Standardisation Com-
mittee (IDSC) [113]. Genant et al. [113] showed a disagreement between
regression curves fitted to the phantom measurements and those fitted to the
human measurements. On the other hand, the second approach requires re-
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Figure 3.1: Femoral regions of interest (ROIs). The neck, trochanteric, and intertrochanteric
regions are shown in red, blue, and green, respectively. The aggregation of these three regions
comprises the total hip.
peated measurements of each subject across all machines [113, 114, 115]. This
can be a serious limiting constraint in large multi-centre studies, where the
first approach may be preferred in practice [117].
I address these challenges as follows: To maintain fidelity to high-resolution
pixel BMD values, I have extended the region free analysis (RFA) technique,
previously applied to quantitate periprosthetic bone loss [36], to the native
femur (section 3.2.2). DXA RFA aligns each individual scan to a reference
template and so eliminates the morphological variation between scans. This
deformable image alignment establishes a virtual correspondence between pixel
coordinates enabling statistical inference at a pixel level. To control the corre-
spondence between scans, the initial RFA technique [36] used a set of anatom-
ical landmark points selected semi-automatically around a prosthesis and the
bone contour. Here, I automate the selection of landmark points using con-
strained linear models (CLM) [118]. This allows application of the toolkit to
large-scale datasets with thousands of images.
To amalgamate data from different scanner technologies, I propose a novel
cross-calibration technique based on human measurements where the require-
ment for scanning the same group of subjects on all the machines is moderated.
In this method, the patient groups scanned on each machine are assumed to
be independent and identically distributed samples of the same population, as
all are white North European females from similar geographic latitudes. The
proposed method minimises the mutual difference between the probability dis-
tributions of BMD values measured by each proprietary DXA scanner (section
3.2.3).
This chapter describes the development of the first spatio-temporal atlas of
ageing bone in the femur generated using DXA data from over 13,000 subjects.
To this end, I propose a fully automatic bone ageing analysis pipeline to ensure
high-throughput computing applicable to large-scale datasets (Fig. 3.2). I also
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Figure 3.2: Bone ageing analysis pipeline. Scans are automatically organised into sub-folders
according to the study ID, geographic location, subject ID, anatomic site, and follow-up
time points. Each scan is then warped into a reference domain to eliminate morphological
variations. Pixel BMD values are calibrated across different centres such that the probability
density functions match one another for a subset of samples matched for gender, age, body
mass index, ethnicity, scan side, and geographic location. Finally, a set of smooth quantile
curves is fitted to the standardised pixel BMD values for each pixel coordinate.
derive a set of reference quantile curves per each pixel coordinate to model the
temporal BMD evolution as a function of age. I will show that ageing not
only affects the amount of bone loss but also the anatomical distribution of
bone within the femur. The developed atlas provides new insights into the
spatial pattern of bone loss in the femur, for which conventional DXA analysis
is insensitive.
3.2 Bone Ageing Analysis Pipeline
I propose an automated image analysis pipeline to construct a spatio-temporal
atlas of ageing BMD in the native femur. The generated atlas models the
distribution of BMD over the population as a function of age within the femur.
Fig. 3.2 shows the conceptual outline of the proposed method. Below, different
steps of the proposed framework are explained in detail: pre-processing and
data organisation, region free analysis, comparative calibration, and quantile
regression.
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3.2.1 Pre-Processing and Data Organisation
(A) Pixel BMD Map Extraction
The raw data from the DXA scanner is not immediately usable for analysing
BMD maps. To export BMD maps, the raw data requires processing using
a proprietary algorithm integrated into a computer software package specific
to its vendor. I have used Hologic Apex v3.2 (Hologic Inc, Waltham, MA)
and Lunar enCORE v16 (GE Healthcare, Madison, WI) to extract pixel BMD
information for scans collected on a Hologic QDR 4500A or a Lunar iDXA
densitometer, respectively.
(B) Multi-Scale Analysis and Noise Reduction
Spatial resolution and pixel-wise noise levels vary between different DXA man-
ufacturers. For example, the spatial resolution, expressed as height×width, is
0.50× 0.90 mm2 for a Hologic QDR 4500A scanner and 0.25× 0.30 mm2 for a
Lunar iDXA scanner. To compute the signal-to-noise ratio (SNR) at the pixel
level, two sets of DXA scans were selected per each vendor. For the Hologic
system, n = 25 scan pairs were deployed where each pair was collected on
the same day from the same subject at the left hip with patient reposition-
ing between scans. For the Lunar system, n = 100 scan pairs were selected
where each pair was collected on the same day from the same subject at the
left and the right hips. All scans were warped to the template space to estab-
lish anatomical correspondence between pixel coordinates (see section 3.2.2 for
more details). Deming regression was then applied at each pixel to compute
the SNR for each system (see section 3.2.3.(B) for more details on Deming
regression). Here, the median SNR over all pixels in the template is used to
compare the two systems (Fig. 3.3).
While the Lunar system provides a better resolution by a factor of two in
height and three in width, pixel-wise SNR is approximately 10 dB higher in
the Hologic system compared to the Lunar system (Fig. 3.3); larger pixels
often result in higher SNR values. Observe that the lower SNR in the Lunar
system versus the Hologic may also be attributed to other factors such as in-
trinsic bilateral differences between the left and the right hips or the operator
proficiency to ensure consistent patient positioning between scans. Nonethe-
less, to enable pixel-wise comparison between different DXA manufacturers,
an appropriate analysis scale should be selected such that both the spatial
resolution and the pixel-wise SNR are consistent across the two systems.
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Figure 3.3: Median pixel-wise SNR for the Hologic QDR4500A versus the Lunar iDXA sys-
tems. The x-axis shows the standard deviation for the smoothing Gaussian kernel (σ) deployed
to reduce the noise level. The y-axis shows the variation in the signal-to-noise ratio (SNR).
For the Hologic system, pixel-level SNR was computed using a set of 25 scan pairs, each pair
collected on the same day from the same subject with repositioning between scans (section
3.3.2). For the Lunar system, pixel-level SNR was computed using a random selection of
100 bilateral hip scans. Deming regression analysis was deployed to compute SNR for both
systems (see section 3.2.3.(B)).
For the selection of an appropriate scale, all scans were resampled at an
isotropic spatial resolution of 0.5 × 0.5 mm2. Following the resampling, each
image was smoothed with a Gaussian kernel to enhance the SNR. Fig. 3.3
shows the median pixel-wise SNR within the whole femur for both the Lunar
and the Hologic systems at different scales. Given that the SNR is quite high
(22.4 dB) for the Hologic system without any smoothing, I selected σ = 0 for
the Hologic system and then found the σ at which the SNR is equivalent to
22.4 dB for the Lunar system, i.e. σ = 4.5.
Note that in the conventional region-based analysis where pixel BMD values
are averaged in larger ROIs with a few hundreds of pixels, the noise level would
be negligible anyway in each ROI and so the choice of the analysis scale does
not matter.
(C) Data Organisation
To enable high throughput analysis of the imaging data, a data organisation
module is crucial to address the following challenges. First, each DXA man-
ufacturer uses a different format to store the pixel BMD maps. The Apex
software uses a proprietary binary file format with a ’.b’ extension. The en-
CORE software, however, can export the bone maps in various file formats
including the Matlab with a ’.mat’ extension. Second, the naming scheme is
neither consistent between the manufacturers nor informative for image anal-
ysis purposes. Third, no meta-information such as the scanner type, the scan
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type or the pixel size is stored with the bone map. This requires passing the
corresponding meta-information as extra variables in the pipeline that would
result in an unnecessary increase in the complexity of the pipeline. Fourth,
the number of scans per subject is often different; some subjects miss a few
scans or have more images than expected.
To address these challenges, the exported bone maps are automatically
organised into sub-folders according to the study ID, the geographic location,
the anatomic site, and the follow-up ID (Fig. 3.2). A uniform naming scheme
is used for the files and directories.
3.2.2 Region Free Analysis
The objective is to find a set of coordinate transformations such that the
warped scans are aligned with each other in the template domain. There-
fore, each pixel coordinate in the template domain corresponds to the same
anatomical location in the image domains. This correspondence allows pixel
level inference of the BMD values. The proposed technique has three steps
(Fig. 3.4): automatic landmark localisation, template derivation using gen-
eralised Procrustes analysis, and pairwise registration between the reference
template and each scan.
(A) Automatic Landmark Localisation
To compute the geometrical warp between the image domain and the template
(see section 3.2.2.(C)), a set of robust landmark points is required. This section
addresses the problem of automatically locating prominent feature points in
the femur. A standard approach to this problem is to first build a model of
shape and texture variation from a manually labelled training set, and then fit
the model to an unseen image [118]. Below, statistical shape models (SSMs)
[119] and statistical appearance models (SAMs) [120] are briefly reviewed, and
later constrained local models (CLMs) [118], an elegant method of combining
both shape and appearance models, is presented to find landmark points in
the femur [121].
In SSMs, each object is represented by a set of landmark points. Let
pm = [x1,m, x2,m]
T denote the coordinates for the mth landmark point and
s =
[
pT1 , · · · ,pTM
]T
denote a shape in a 2M−dimensional space R2M . The
distribution of this vector, known as point distribution function (PDM), can





Thin Plate Spline Deformable Registration
Estimate spatial Deformation
!"($", $&) and !&($", $&)
Linear Interpolation for Intensity 
Estimation at New Coordinates
Figure 3.4: Conceptual illustration of region free analysis. Sixty-five landmark points are au-
tomatically selected around the bone contour. A reference shape is learned by averaging over
all the scans after being aligned to a common position, scale, and orientation. A thin plate
spline (TPS) deformation function is fitted for each individual scan such that the controlling
landmark points are mapped to the corresponding reference landmark points in the tem-
plate. Given the warp in the space, pixel intensities are estimated using a linear interpolation
technique.
be approximated using the principal component analysis (PCA) [119]:
s = s+ Φsbs, (3.1)
where s is the mean shape, Φs is a set of orthogonal modes of shape varia-
tion, and bs is a vector of shape parameters. Fig. 3.5 shows the first mode of
variation in the femur. To fit an instance of the model to an unseen image,
first, a set of initial landmark points are defined in the image frame. Then,
an iterative procedure is applied to improve the quality of fit as follows [119]:
for each landmark point, the local image profile perpendicular to the image
boundary is searched for an optimal match based on a similarity metric. Next,
the new positions are mapped to the model space to avoid individual false de-
tections that are inconsistent with the learned global shape configuration. The
algorithm iterates between these two steps until convergence happens. Behiels
et al. [122] applied this technique for segmenting the femur in radiographic
scans.
In SAMs, both the shape and texture variability are modelled together
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Figure 3.5: The first mode of shape variation in the proximal femur.
[120]. The shape model is learned similar to SSMs (Eq. 3.1). To build a
statistical model of grey-level appearance, each sample image is warped to the
mean shape so that the controlling landmark points in the image frame are
matched to the landmark points in the template domain. The grey-level infor-
mation is then collected over a region covering the landmark points from the
warped scans. Let g denotes the vectorised pixel-level intensity information. A
linear model of intensity variation can be learned using a PCA transformation
as follows:
g = ḡ + Φgbg, (3.2)
where g is the mean grey-level vector, Φg is a set of orthogonal modes of
intensity variation, and bg is a vector of texture parameters. The shape (bs)
and texture (bg) parameters are then concatenated into a single vector b,










c = Qc, (3.3)
where W is a diagonal weight matrix for shape parameters accounting for the
unit difference between the shape and texture models. The vector c includes
the appearance parameters. To fit an instance of the model to an unseen image,
an iterative procedure is applied to minimise the texture residual between the
model and the target image [120].
CLMs combine the flexibility of appearance models with global shape con-
straints [118]. A joint shape and texture model is learned in a similar manner
to SAMs (Eqs. 3.1, 3.2, and 3.3); however, the texture sampling method is
in the form of rectangle patches around landmark points. In the CLM frame-
work, a response image is generated per each landmark point independently.
To generate a response image for the mth landmark point, random patches at
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its local neighbourhood are selected and the correlation of each patch with a
priori trained template is computed. Then, the objective function J (bs) is
maximised to find the optimal shape parameters [118].
















T is the current estimation of landmark point m, Rm is the
response image for point m, J is the total number of shape parameters, and λj
are the corresponding eigenvalues of the shape model. The algorithm iterates
until convergence happens.
Lindner et al. [121] applied CLMs in the setting of femur segmentation.
However, instead of computing the correlation with a template, random forest
voting was deployed to generate the response images where the decision trees
voted for the required displacements. To initialise the landmark points, a
Hough-like approach was utilised to automatically detect the femur in the
scan [123]. Here, I deployed Bone Finder [124], a software implementation
provided by Lindner et al. [121], to segment the femoral scans using the CLM
approach. All parameters were set as explained in [121].
(B) Template Derivation











represents the set of M landmark point coordinates for the subject n. General
Procrustes analysis is adopted to find the reference template T [56]. First,
all scans are aligned to a common position, scale, and orientation. Next,
the reference template is updated as the average of the aligned shapes. The
algorithm iterates between these two steps until convergence as detailed below.
Let Tn(Sn) = knRnSn+cn denote the geometric transformation that aligns
the subject n to the template, where the scalar k is the scaling factor, R is the
rotation matrix, and the vector c represents the translation. The objective is




‖T − Tn(Sn)‖2F , (3.6)
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is minimised (Algorithm 1). ‖S‖F denotes the Frobenius norm of the matrix
S defined as the square root of the sum of the absolute squares of its elements.
Let Ti be the estimated template for the iteration i. Then, a closed-form
solution exists to map each shape Sn to the template Ti such that ‖Ti −
Tn(Sn)‖2F is minimised (the first step).









cn = T i − knRnSn (3.10)
Sn and T i represent the column-wise average of matrices Sn and Ti, respec-
tively. S̃n = Sn − Sn and T̃i = Ti − T i. tr(.) denotes the trace of a matrix
defined as the sum of its diagonal elements. Given the geometrical transfor-
mations Tn(Sn), the template is updated to the average of the transformed






knRnSn + cn (3.11)
It can be shown that generalised Procrustes analysis converges to a unique
solution except for a scaling, rotation, or translation factor. To cancel out
the arbitrary scaling of the template, the converged template was normalised




(k∗1 + · · ·+ k∗N)
]−1
where k∗n is the final scale factor
after convergence. To cancel out the arbitrary rotation of the template, the
template was rotated such that the bottom cross-section at the femoral shaft
is parallel to the horizontal axis. To cancel out the arbitrary translation, the
centre of gravity, i.e. the average of all landmark points on the template, is
shifted to the origin at the [0, 0]T coordinate.
(C) Image Registration
To eliminate morphological variation between scans, each individual scan is
warped to the template domain using a thin plate spline (TPS) registration
technique [58]. In this technique, a geometrical transformation is found such
that the landmark points in the source image are exactly mapped to their
corresponding landmark points in the reference template. To do this mapping,
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6: Ti ← Sn . for a random n
7: while ‖Ti−1 − Ti‖2F ≤ ε do
8: for n = 1 : N do
9: Tn ← argminT ‖Ti − T (Sn)‖2F (Eq. 3.7)






the transformation function involves two components: an affine transformation
to compensate for the global scale, translation, and rotation variation; and a
radial basis function, i.e. g(r) = r2 log r2, to compensate for the local variation
around each control point.







(x1 − x1,m)2 + (x2 − x2,m)2),
(3.12)
where d = 1, 2 represents the horizontal and vertical axes in a 2D image. Note
that [y1, y2]
T and [x1, x2]
T denote the coordinate space in the template and
image domains, respectively. yd,m and xd,m also denote the coordinates of the
mth landmark point in the template and image domains, respectively.
Given the transformation function fd(x1, x2) (Eq. 3.12), the total number
of parameters is 2(M + 3). For an exact solution, fd(x1, x2) should map each
landmark point in the image domain to the corresponding landmark point in
the template domain:







(x1,m − x1,m′)2 + (x2,m − x2,m′)2). (3.14)
Eq. 3.13 provides 2M constraints. The other 6 constraints are suggested by
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y2,mω2,m = 0 (3.17)
Using Eq. 3.13 and Eqs. 3.15-3.16, I have 2(M + 3) linear equations that
can be solved for the computation of the parameters in the model. Given the
transformation functions, the whole image space is warped to the template
domain and the intensity values are interpolated using a linear interpolation.
Note that the linear interpolation preserves the average BMD measured at
conventional ROIs after warping each scan to the template. An alternative
would be to preserve the average bone mineral content, i.e. BMD multiplied
by the area, by scaling the pixel BMD values in proportion to the areal size
of each scan with respect to the template. This property is not of interest in
this study and so no calibration for bone size is made here.
3.2.3 Comparative Calibration
Assume C systems each used to measure the same characteristics on a common
set of N subjects. Each system may not be consistent in the repeated mea-
surements of the same patient resulting in a within-patient sampling variation.
However, I assume this variation is consistent for different patients. Ignor-
ing this sampling fluctuation, I refer to the mean of repeated measurements
as true values. Note that the true underlying values are not directly observ-
able. Furthermore, I assume that a linear relationship exists between each
pair of systems given the true underlying measurements. Then, comparative
calibration refers to the problem of simultaneous estimation of the pairwise
relationships between these systems [125, 115].
Let the latent random variable X represent the underlying true value and
the random variable Y c represents the observed value measured on the machine
c. Barnett [125] proposed a linear model for comparative calibration between
the systems.
Y (c) = acX + bc + E
(c), for c = 1, · · · , C. (3.18)
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E(c) ∼ N (0, σ2c ) represents the measurement noise for each system and X ∼
N (µx, σ2x) represents the distribution of the population. Given the observed
measurements yn =
[
y1n, · · · , yCn
]T
for the subject n, the objective is to es-
timate the model parameters {ac, bc, σc}Cc=1. This model is overparametrised
and to resolve this identifiability problem, it is common to take one system,
e.g. c∗, as the reference. For this system, then, it is assumed that ac∗ = 1 and










ac = A0, (3.19)
where B0 and A0 are two constants defined based on either hypothetical as-
sumptions or phantom measurements. Barnett [125] presented the solution for
C = 3 using the second order moment estimates. Lu et al. [115] presented an
expectation maximisation (EM) approach to estimate the model parameters
for C > 3. For C = 2, the problem is known as Deming Regression problem
(section 3.2.3.(B)).
Here, I deployed this method in the settings of two calibration problems:
cross-calibration between DXA manufacturers (section 3.2.3.(C)) and calibra-
tion between the left and the right hips (section 3.2.3.(D)). In these settings, it
is common not to access multiple measurements of one subject on all different
systems. In the extreme case, only one sample measurement is available for
each subject. In these scenarios, I propose a new technique based on pairwise
quantile matching between different systems (section 3.2.3.(A)). I will show
that this technique provides a reliable alternative for parameter estimation
when multiple measurements are not accessible.
(A) Quantile Matching Technique
I propose a novel quantile matching technique for the comparative calibration
problem (Eq. 3.18) when only one single measurement is available for each
subject (cf. [115] and [125]). The new technique is developed based on two
assumptions: First, a unique distribution of the latent variable X exists in-
dependent of the measurement systems. Second, the SNR is sufficiently large
such that
QY (c)(u) ≈ acQX(u) + bc, (3.20)
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where QX(u) and QY (c)(u) denote the quantile functions. For a random vari-
able X, the quantile function u→ QX(u) is defined as
QX(u) := inf {x : u ≤ P(X ≤ x)} . (3.21)
Note that quantiles are invariant to monotone transformations; if ψ is a mono-
tone function, then
Qψ(X)(u) = ψ(QX(u)). (3.22)
Therefore, if the noise power is zero, then the approximation would be re-
placed with equality in Eq. 3.20. With this assumption, estimation of the
model parameters Θ = {ac, bc} can be decoupled from the estimation of noise
variances, i.e. {σ2c}. This technique cannot estimate the noise variances be-
cause of insufficient statistics due to missing multiple measurements. However,
this technique can provide reliable estimations for the slope ac and intercepts
bc as detailed below.
















ac = 1. (3.24)
To set the constants in Eq. 3.19, I assume that the true value X equals the





(c)|X). This results in B0 = 0 and A0 = 1 (Algorithm 2).
Optimisation: To convert the constrained optimisation problem into an
unconstrained one, I can simply express the parameters aC and bC based on
the other parameters:
aC = C −
∑
c 6=C




To estimate the parameters, an alternating minimisation technique is adopted:
Given the model parameters, the latent variable xn for each of N subjects can
be estimated as (step 1),
xn = E(X|y(cn)n ; acn , bcn) ≈
1
acn
(y(cn)n − bcn), (3.26)
where cn is the corresponding system for subject n. To update the model
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J are set to zero.
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∂ac

















QX(u)(QY (C)(u)−QY (c)(u))du = 0, (3.27)
∂
∂bc













(QY (C)(u)−QY (c)(u))du = 0. (3.28)
Computing QX(u) using the estimated latent variables, Eq. 3.27 and Eq.
3.28 are linear with respect to the model parameters. Therefore, I have 2(C−1)
linear equations with 2(C − 1) parameters for which a closed-form solution
exists (step 2). The algorithm iterates between these two steps until the root
mean square of the difference between estimated parameters at two consecutive
iterations is less than a user-defined tolerance ε.
Algorithm 2 Quantile Matching Technique for Comparative Calibration
1: Input: Y = {y(cn)n }Nn=1
2: Parameters: ε . Convergence tolerance
3: Output: Θ = {ac, bc}Cc=1
4: procedure Quantile-Matching(Y)
5: for c = 1 : C do
6: QY (c)(u)← Estimate quantile values for Yc = {y
(cn)
n : cn = c}
7: i← 1 . Number of iterations





c − a(i−1)c )2 + (b(i)c − b(i−1)c )2 ≤ ε2 do
10: i← i+ 1
11: for n = 1 : N do
12: xn ← E(X|y(cn)n ; Θi) (Eq. 3.26)













(QY (c)(u)− acQX(u)− bc)2du . (step 2)
(B) Deming Regression Problem
If C = 2, the comparative calibration formulation (Eq. 3.18) reduces to a single
regression problem. Assuming the first system as the reference, i.e. a1 = 1
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and b1 = 0, I have six parameters to be estimated: a2, b2, σ1, σ2, µ, and σx.
Maximum likelihood estimation of the parameters results in minimising the


















(y1n − xn)2 +
1
σ22
(y2n − a2xn − b2)2, (3.29)
subject to σ21 ≤ SY (1),Y (1) and σ22 ≤ SY (2),Y (2) .
Minimising the SSR (Eq. 3.29) is indefinite as the number of sufficient statistics
is 5 and one extra constraint is required. The most common constraint is to
fix the variance ratio δ =
σ22
σ21
. Then, the intercept b2 and the slope a2 can be

















































































Note that the Deming regression problem is different from the simple linear
regression. When the ratio of the standard deviation of the measurement
error to the standard deviation of the population exceeds 0.2, i.e. σ1
σx
> 0.2,
the simple linear regression results in a significant error in the estimation of
parameters and the Deming regression should be adopted instead [127].
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(C) Comparative Calibration Between DXA Manufacturers
Systematic differences in BMD measurements exist between DXA manufac-
turers [113, 114, 115]. Discussing the biological or technical reasons for this
discrepancy is not the purpose of this study, but to provide a universal stan-
dardisation of BMD values. The first attempt at cross-calibration between
DXA scanners, sponsored by IDSC, showed that measurements across differ-
ent machines are highly correlated [113]. Later, Lu et al. [115] formulated this
as a comparative calibration problem and proposed a fully statistical frame-
work for cross-calibration between DXA manufacturers. This method cannot
be used if any given subject is scanned only once on each machine. Requiring
multiple measurements of each subject across all machines is an implausible as-
sumption in large-scale multi-centre studies. Alternatively, calibration against
phantom measurements is a common pragmatic approach [117]. However, us-
ing human measurements is preferred for calibration purposes as a significant
disagreement exists between the model parameters fitted to the phantom mea-
surements and those fitted to the human measurements [113].
In this study, I used the proposed quantile matching regression technique
(section 3.2.3.(A)) to address missing multiple scans. To deploy this calibration
technique, one should ensure that the population distribution of BMD values
is identical on different machines (cf. assumption 1 in section 3.2.3.(A)). To
this end, I selected a prospective cohort from those scanned on each machine
such that they were matched for gender, age, body mass index (BMI), scan
side, ethnicity, and the geographical location.
(D) Bilateral Calibration
Scanning only one side (left or right) has become the standard procedure in
bone densitometry [128]. Good correlation between BMD of the left and the
right hip subregions and small absolute differences reported in the literature
may have reinforced unilateral hip measurements [129, 130]. However, to amal-
gamate data from both sides to construct the atlas, a calibration procedure is
still required as a statistically significant difference in BMD exists between the
bilateral hip measurements [128, 131]. Here, given access to n = 6916 bilateral
hip measurements, I applied the Deming regression to estimate the calibration
parameters.
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3.2.4 Quantile Regression
Regression analysis allows statistical modelling of the relationship between a
response variable Y and a set of explanatory covariates X [132]. The ordinary
least squares regression can capture how the mean of Y changes with X, i.e.
estimates E(Y |X); however, this method does not provide a complete picture
by considering the conditional distribution of Y given X, i.e. P(y|x). Quantile
regression is a type of regression analysis where conditional quantiles of the
response variable are estimated. These quantile curves show the distribution
of Y as it changes according to the given covariates and so no information is
lost. Here, the objective was to model the evolution of pixel BMD values as a
function of age using quantile regression.
(A) Notation and Background
Assume the real-valued random variable Y with cumulative distribution func-
tion (CDF) FY (y) = P (Y ≤ y) represents a response variable of interest, e.g.
BMD values at a single pixel coordinate, and the multivariate random vari-
able X = [X1, · · · , Xp]T represents an explanatory covariate vector, e.g. age,
BMI, etc. Then, the conditional quantile function (u,x) 7−→ QY |X=x(u,x) is
defined as
QY |X(u,x) := inf
{
y : u ≤ FY |X=x(y)
}
, (3.37)
where 0 < u < 1. The main objective is to estimate QY |X(u,x) from N
observed scattered points (yn,xn).
(B) Classical Quantile Regression
Formulating conditional quantile functions in terms of a regression problem
was introduced by Koenker and Bassett [133]. The uth quantile of the random
variable Y can be found by minimising the E(ρu(Y − ξ)) with respect to ξ,
where
ρu(x) = x(u− 1(x < 0)), (3.38)
is known as the check function. This is plotted in Fig. 3.6 for u = 0.5 and 0.9.
Therefore, given the observed samples of Y , the uth quantile can be found by
solving




ρu(yn − ξ). (3.39)








0.9x if x ≥ 0
−0.1x if x < 0
Figure 3.6: The check function for quantile regression with u = 0.5 and u = 0.9. To compute
the uth quantile of the random variable Y , QY (u), the expected loss E(ρu(Y − ξ)) is minimised
with respect to ξ. Observe that u = 0.5 is equivalent to the median.
Given the explanatory random variable X, the linear conditional quantile
function can be estimated as follows:
QY |X(u,x) = x
T β̂(u), (3.40)





ρu(yn − xTnβ). (3.41)
Eq. 3.41 is solved by linear programming as details are explained in the work
by Koenker and Bassett [133].
(C) The LMS Technique
Classical quantile regression can lead to the quantile crossing problem. One
way to avoid this problem is to enforce commonality between adjacent quan-
tile curves, i.e. the spacings between quantiles are constrained to be related to
each other [134]. To establish commonality, some forms of a probability distri-
bution are assumed for the measurements. Cole and Green [134] assumed an
underlying skewed normal distribution so that a suitable Box-Cox transforma-
tion (Eq. 3.42) would render a normal distribution. For ease of explanation












), λ(t) = 0.
(3.42)
The Box-Cox transformation has three parameters: the power λ, the mean µ,
and the coefficient of variation σ. For fitting the quantile curves, the three
parameters are first estimated as a smooth function of the covariate t, and
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then the quantile curves can be simply computed as:
QY |T (u, t) =

µ(t) [1 + λ(t)σ(t)QZ(u)]
1/λ(t) , λ(t) 6= 0;
µ(t) exp (σ(t)QZ(u)) , λ(t) = 0.
(3.43)
The initial letters of the Roman transcriptions of the Greek letters λ, µ, and
σ give the name LMS to this method. Note that a key assumption of the
LMS method is that the Box-Cox transformation with appropriate parameters
exists such that the random variable Y can be mapped to a standard normal
distribution Z ∼ N (0, 1), for which Y > 0 is required.
A penalised maximum log-likelihood is presented by Cole and Green [134]
to estimate the smooth parameter curves. Given the scattered points for N














where zn is the corresponding mapped score of yn. The curves λ(t), µ(t), and
σ(t) are estimated by maximizing the penalized likelihood:













The pseudo-code to implement this technique is detailed in [134].
(D) Vector Generalised Additive Models
Different LMS-type techniques could arise depending on the choice of the un-
derlying probability distribution. Yee [135] proposed a unified framework for
this class of techniques by formulating the regression problem using vector
generalised additive models (VGAMs). Below, the underlying concepts for
VGAMs are reviewed briefly and later the application of the R-package VGAM
for fitting quantile curves using the LMS technique is presented.
To facilitate the explanation of VGAMs, let’s start with vector generalised
linear models (VGLMs). VGLMs are defined as a framework to model the
conditional distribution of a response variable Y given the explanatory P-
vector X as:
P(y|x;β0,B) = h(y, η1, · · · , ηM), (3.46)
where h(.) is a known function, coefficients B = [β1, · · · ,βM ] ∈ RP×M and
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the intercepts β0 =
[
β(1)0, · · · , β(M)0
]T
are unknown regression coefficient, and
η = [η1, · · · , ηM ]T are linear predictors. For example, for a normal distribution,
M = 2 and η1 = µ and η2 = log σ. Note that log(.) is a link function to ensure
estimated standard deviation is always positive. The mth linear predictor is
then estimated as:




⇒ η = β0 +BTx.
(3.47)
VGAMs are an extension to VGLMs in the sense that predictors ηm are
estimated as the sum of smooth functions of the individual covariates xp rather
than being a linear function of the covariates. So, Eq. 3.47 is generalised to











f(1)p, · · · , f(M)p
]T
. Given the log-likelihood of the parameters `,
fp(xp) are estimated simultaneously using vector smoothers in a VGAM by
maximising the penalised likelihood below.













Eq. 3.49 (cf. Eq. 3.45) naturally formulates the LMS quantile regression for
M = 3.
The smoothness of the fitted parameter curves, e.g. f(t) = [λ(t), σ(t), µ(t)]T
in the LMS quantile regression, is controlled using a vector smoothing spline.
Assuming a scalar explanatory variable t and letting t1 < t2 < · · · < tn be the
given knots, each parameter curve f(m)(t) is estimated using piece-wise smooth
polynomials at each interval tn ≤ t < tn+1 as follows:
f(m)(t) = a(m)(n) + b(m)(n)(t− tn) + c(m)(n)(t− tn)2 + d(m)(n)(t− tn)3. (3.50)
Substituting the log-likelihood ` (Eq. 3.44) and smooth functions f(m)(t) (Eq.
3.50) into the cost function J given in Eq. 3.49, one should maximise J with
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respect to the parameters an(m), bn(m), cn(m), and dn(m).
In this study, I deployed the R-package VGAM (version 1.0.3) to fit the quan-
tile curves [135] using the LMS technique. I have modelled the two parameters
λ and σ as intercepts. To control the smoothness of the parameter µ, the
equivalent degree of freedom (edf) was set to 3.
(E) Numerical Stability and Range-Restriction Problems
The VGAM implementation for the LMS technique has two limitations [135]:
first, the optimisation procedure is numerically complex; the second derivatives
are approximate and the algorithm fails to converge for a fraction of pixels.
Second, 1+λ(t)σ(t)QZ(u) > 0 is required to compute the quantile values using
the Eq. 3.43. Hence, the range of the transformation depends on λ.
To address the first problem, outliers were removed and the LMS technique
was applied to the cleaned data. Algorithm 3 shows the outlier removal pro-
cedure: given the pixel BMD value yn and the age an, subjects are divided
into different sub-groups based on their ages. Next, the first and the third
quartiles, denoted by q1 and q3, are estimated at each sub-group. Subjects
with a pixel BMD value above q3 + w2(q3 − q1) or below q1 − w1(q3 − q1) are
marked as outliers.
Algorithm 3 Outlier Selection Scheme for the LMS Quantile Regression
1: Input: D = {(yn, an)}Nn=1
2: Parameters: w1 = 1.5, w2 = 2
3: Output: o = [o1, · · · , on]T . Binary vector; one indicates the outliers
4: procedure Outlier-Identification(D)
5: amin ← bminn anc
6: amax ← dmaxn ane
7: on ← 0 for n = 1, · · · , N.
8: for c = amin : amax do
9: Y ← {yn : c− 0.5 ≤ an ≤ c+ 0.5}
10: q1, q3 ← estimate the first and the third quartiles of Y
11: J ← n : [yn ∈ Y ] & [yn < q1 − w1(q3 − q1) ‖ yn > q3 + w2(q3 − q1)]
12: on ← 1 for n ∈ J .
Following outlier removal, the LMS technique converged for a majority of
pixels (> 99%) in the template. For those pixel coordinates with the range-
restriction problem, an offset was added to the pixel BMD values to shift the
original BMD range to extremely positive values. The original quantiles were
then computed by subtracting the offset term from the estimated quantiles on
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the shifted data. In this study, I used an offset value of 20 for all the pixels
where the LMS technique was crashed.
(F) Confidence Intervals
Assume Y(i) = {yn(i) : n = 1, · · · , N} represents the BMD values from N dif-
ferent subjects measured at an individual pixel i. It is of interest to compute a
confidence interval for the estimated quantile curves using the observed dataset
Y(i). Here, a bootstrapping procedure was deployed [136]: at each pixel coor-
dinate, N observations are randomly sampled with replacement from Y(i) to
obtain a bootstrap dataset denoted Y∗(i). Note that each sample from Y(i)
may contribute more than once in the set Y∗(i) as selected samples are re-
placing in the original set Y(i) during the sampling procedure. Next, quantile
curves are re-estimated using the bootstrap dataset Y∗(i). This procedure was
repeated 1000 times collecting a distribution of possible quantile curves. From
these observations, the 95% confidence intervals were estimated.
3.3 Results
3.3.1 Datasets
To generate the spatio-temporal bone ageing atlas over the adulthood age
range (20-95 years), I integrated data from three North Western European
population studies: The UK Biobank [137], the Osteoporosis and Ultrasound
Study (OPUS) [138], and the MRC-Hip study [139]. The UK Biobank covers
the middle-age range (45-80 years); The OPUS covers the younger age range
(20-39 years) and the older age range (55-79 years); and finally, the MRC-Hip
covers the elderly population (75-95 years).
(A) The UK Biobank Dataset
UK Biobank is a prospective study with over 500,000 participants recruited in
middle-age during 2006-2010 across the UK [137]. UK Biobank aims to provide
an extensive source of phenotypic and genotypic information about its partici-
pants to facilitate the investigation of a wide range of life-threatening diseases,
e.g. heart diseases, stroke, diabetes, arthritis, osteoporosis, etc. As part of
data collection within UK Biobank, a multi-organ, multi-modality imaging
study aims to acquire and store imaging data from 100,000 participants [140].
Here, I used a cohort of 6,918 white women aged 45-80 years at the time of
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scan acquisition. DXA scans are available for left and right hips, left and right
knees, spine (both lateral and anterior-posterior (AP) views), and the whole
body using a Lunar iDXA densitometer.
(B) The OPUS Dataset
The OPUS study was a multi-centre European study [138]. Five centres were
involved: Sheffield (n = 535), Aberdeen (n = 161), Berlin (n = 189), Kiel
(n = 399), and Paris (n = 468). All participants were women recruited at
two different age segments: 20-39 and 55-79 years of age. Scans were acquired
using either a Hologic QDR4500 Acclaim densitometer (Sheffield, Paris, and
Kiel) or a Lunar Prodigy scanner (Aberdeen and Berlin). In this study, only
scans (n = 1402) collected on the Hologic system were used.
(C) The MRC-Hip Dataset
The MRC-Hip study was a randomized pharmaceutical clinical trial to examine
the effect of clodronate on the incidence of hip fractures [139]. An elderly
population cohort of 5018 White women (≥ 75 years) living in the general
community in South Yorkshire and North Derbyshire was included in this
study. BMD was measured at the hip using a Hologic QDR4500 Acclaim
densitometer.
3.3.2 Precision Analysis
Precision or reproducibility of a quantitative measurement technique describes
the ability of that technique to produce consistent results when measuring
the same quantity repeatedly. In other words, precision is a description of
random errors in the system. In DXA bone densitometry, three sources of error
exist [141]: the machine (e.g., the scanner noise), the operator (e.g., patient
positioning), and the software (e.g., femur segmentation and deformable image
alignment).
To assess the overall precision of the RFA technique, 25 Caucasian women
(mean age = 70.1±6.2 years) were scanned on the same day twice with reposi-
tioning between the scans. This data had been collected as part of the OPUS
study in Sheffield. In conventional DXA analysis, precision is reported as the
coefficient of variation (CV), i.e. the root mean square standard deviation
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Here, N = 25 is the number of paired measurements; y and y′ are the measured
BMD values at the two independent positions.
Table 3.1 reports the precision of conventional region-based DXA analysis
at four common ROIs. To use RFA to recreate conventional region-based
analysis, pixel BMD values of the warped scans were averaged at each ROI
in the template domain. RFA resulted in similar precision scores to those
reported in the literature at these ROIs (Table 3.1). However, imaging at a
finer spatial resolution results in a worse precision at the pixel level in the RFA
technique. Fig. 3.7(a) shows the distribution of pixel-level CV values at the
proximal femur. Precision was worse around the bone contours. This may be
explained due to the inaccuracy in placing controlling landmark points around
the bone. Fig. 3.7(b) shows the histogram of pixel-level CV values where
the median is 7.96% and the interquartile range is 6.69% − 10.05%. Note
that the worse precision in comparison to conventional region-based analysis
is a compromise that offers a higher spatial resolution which is necessary for
characterising spatially complex bone remodelling events.
Table 3.1: Coefficient of variation (%) at four common conventional ROIs. Top row shows
scans measured using DXA RFA with pixels were aggregated to reproduce the conventional
ROIs. Lower rows show comparison with published precision data from other investigators.
method scanner subjects No.×scans No.
CV%
total hip neck trochanter intertrochanter
RFA
Hologic
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Figure 3.7: DXA RFA precision analysis. (a) The pixel level CV (%) is visualised using a
heat-map. Precision is worse around the bone contour. This may be due to the inaccuracy
in placing controlling landmark points at the bone surface. (b) The distribution of pixel-level
CV values in the femur. The median is 7.96% and the interquartile range is 6.69%− 10.05%.
3.3.3 Parameter Estimation for Comparative Calibra-
tion between DXA Systems
In this study, scans were collected either on a Hologic QDR 4500A or a Lunar
iDXA scanner. To integrate data from both scanners, the proposed quantile
matching regression technique is deployed to cross-calibrate the BMD maps
between the two systems. For each scanner, n = 406 white British women
matched for age and BMI with an scan on the left side were selected. No
significant difference in age or BMI distribution was observed between the two
groups using a two-sample Kolmogorov–Smirnov test (p-value = 0.9). Note
that this cohort selection step is a prerequisite for the quantile matching regres-
sion technique to ensure that any variation in the BMD distributions between
the two groups is only associated with the imaging systems. Fig. 3.8 shows
the estimated calibration parameters per each pixel coordinate, i.e. the slope
a and the intercept b, taking the Hologic system as the reference. Given these
parameters, the calibration parameters for mapping the Lunar system to the
Hologic system can be simply estimated as the slope 1
a















(b) The intercept b
Figure 3.8: Estimated cross-calibration parameters between the Lunar iDXA and the Hologic
QDR 4500A systems. The quantile matching regression technique was applied using the
Hologic system as the reference, i.e. [Lunar] = a [Hologic] + b. The average and standard
deviation of the estimated parameters over all the pixel coordinates within the femur were
1.019 (SD, 0.140) for the slope a and 0.170 (SD, 0.130) for the intercept b.
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3.3.4 Bilateral Calibration
A total number of 6,916 bilateral hip scans were available in the UK Biobank
dataset. Pixel level analysis of BMD values between the right and the left hips
confirmed a high correlation between the two sides (Fig. 3.9(a)). However,
regions with a statistically significant difference in BMD were observed in the
femur (Fig. 3.9(b),(c), and (d)). Given the high correlation between the two
sides, it is possible to calibrate the BMD maps for the lateral side. This
calibration would enable integration of data from both sides to generate a











































Figure 3.9: Bilateral hip comparison. (a) The left and the right hips are highly correlated
inside the femur, but the correlation is worse at the boundary. (b) Average right-left differ-
ences in pixel BMD values normalised to the population mean for the left side. (c) Localised
regions with a statistically significant difference in BMD were observed between the bilateral
sides using FDR analysis. (d) The pp-plot deviated from the identity line (dashed red line)
demonstrating a significant difference between the bilateral sides.
To test the validity of the estimated calibration parameters, I randomly
selected 2000 scans for testing and the remaining scans were used to learn
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the calibration parameters. The Deming regression technique with δ = 1 was
deployed here as both the left and the right scans were available from the same
subject. Figs. 3.10(a) and 3.10(b) show the estimated calibration parameters,












(b) The intercept b
Figure 3.10: Estimated cross-calibration parameters between the left and the right hips. The
Deming regression technique with δ = 1 was applied taking the right hip as the reference, i.e.
[left] = a [right] + b.
Inside the femur, the slope a and the intercept b are approximately one
and zero, respectively (see the shade of green in Fig. 3.10). This observation
suggests a close relationship between the bilateral sides within the femur and
away from the bone contour. At the bone boundary where the correlation
between the bilateral sides was low (see Fig. 3.9(a)), the calibration parameters
a and b deviated from one and zero, respectively.
To test the validity of the proposed calibration technique, I deployed the
estimated calibration parameters to map the pixel BMD measured at the right
side to the left side, i.e. computing the expected pixel BMD at the left side
given the measurements at the right hip. Note that the test set used in this
experiment was not deployed during the estimation of calibration parameters.
Fig. 3.11 shows the normalised difference in population mean between the two
sides, the corresponding FDR q-map, and the pp-plot for the FDR analysis
following calibration for the scan side. No statistically significant difference
in BMD was observed between the two sides confirming the validity of the
proposed calibration technique.



































Figure 3.11: The ability of the deployed calibration procedure to cancel the observed difference
between the right and the left hips. Here, the right hip is mapped to the left side. Panel (a)
shows the average differences in BMD between the left and the calibrated right hips normalised
to the population mean for the left side. (b, c) No statistically significant difference in BMD
was observed between the two sides following the bilateral calibration using FDR analysis at
q ≤ 0.05.
3.3.5 The Spatio-Temporal Atlas
Fig. 3.12 shows the constructed Atlas; visualising the median, the first and the
third quartiles of BMD values at different ages using heat-maps. An overall
decline in BMD with increasing age was observed throughout the proximal fe-
mur. However, the observed bone loss patterns were site-specific and spatially-
complex. Cortical thinning was observed consistently with ageing around the
femoral shaft from the 60th decade onwards. A widespread bone loss was also
observed in the trochanteric area.
Quantile regression curves demonstrated different rates of bone loss at dif-
ferent anatomic locations within the proximal femur (Figs. 3.13 and 3.14).
For example, the decrease in BMD at the superior femoral neck cortex was bi-
modal; the bone loss slowed down from the 70s onwards (Fig. 3.13(a)). BMD
at the mid-femoral neck showed a steady decrease throughout the whole age
range (Fig. 3.13(b)), whilst bone mass was preserved the most in the inferior
femoral neck cortex (Fig. 3.13(c)). Fig. 3.14 shows quantile regression curves
at the intertrochanteric region. Bone mass at the superior trochanteric region
was preserved until the just before 70 years, and was followed by a decline
with a similar slope to the other trochanteric regions (Fig. 3.14(a)). Bone loss
was observed at a consistent rate at the mid trochanteric region throughout
the whole age range (Fig. 3.14(b)). BMD in the inferior cortex close to the
lesser trochanter was maintained until the age of 60th years, following which
point BMD showed a steady decline (Fig. 3.14(c)).
Note that the inflection point observed at age 75 years in Fig. 3.14 is indeed
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due to ageing rather than the integration of the MRC-Hip dataset (age range:
75-97 years). Repeating the same analysis using only the UK Biobank dataset
(age range: 45-80 years) demonstrated similar ageing trends (data not shown).
Here, I present the results for the integration of all datasets together.













Figure 3.12: The Bone ageing atlas. The median together with the first and the third quartiles
at each pixel coordinate is visualised using heat-maps for 20, 35, 50, 65, 80, and 95 years of




(a) Superior Femoral Neck
(b) Mid Femoral Neck (c) Inferior Femoral Neck
Figure 3.13: Quantile curves fitted at the femoral neck. The solid, dashed, and dotted lines
show the median, the 50% and the 90% quantile ranges, respectively. The green shadow shows
the 95% confidence interval. The curves are shown for the Lunar system at the left hip.




(a) Superior Trochanteric Region
(b) Mid Trochanteric Region (c) Inferior Trochanteric Region
Figure 3.14: Quantile curves fitted at the intertrochanteric region. The solid, dashed, and
dotted lines show the median, the 50% and the 90% quantile ranges, respectively. The green
shadow shows the 95% confidence interval. The curves are shown for the Lunar system at the
left hip.
3.4 Validation of the Atlas Construction Steps
3.4.1 Segmentation Accuracy
To evaluate the segmentation accuracy, I manually annotated a subset of scans
(n = 32) randomly selected from the database; 16 scans (8 from each side)
from the Lunar iDXA system and 16 scans (8 from each side) from the Hologic
QDR 4500A system. For this purpose, an interactive toolkit was developed in
Matlab (Fig. 3.15). The user should select a number of control points around
the bone and the software computes a smooth contour passing through the
selected points. The toolkit allows the user to move the control points, delete
them, or insert new ones if required. The segmentation accuracy was evaluated
using the Dice similarity coefficient (DSC). DSC is defined as the twice the
areal size of the overlap between two binary masks divided by the sum of the





where A and M represents the automatic and the manual segmentation masks,
respectively. DSC ranges between 0 and 1 with 1 representing a perfect agree-
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ments between the two masks. The mean and the standard deviation for DSC
over the 32 selected scans were 0.9698 and 0.0048, respectively. Fig. 3.16 shows
the worst and the best segmentation results based on the DSC metric. Observe
that since the cut-off point at the femoral shaft is arbitrary, the shorter distal
cut-off point between the manual and the automated masks is used to cancel
















Instructions:                                                 
Use appropriate tools to segment the bone or select 
landmarks.
Manual Segmentation
Figure 3.15: The graphical user interface (GUI) developed in Matlab to facilitate manual
segmentation of femoral scans. The user would select a number of control points around the
bone and the software computes a smooth contour passing through the selected points. The
toolkit allows the user to move the control points, delete them, or insert new ones if required.
(a) DSC = 0.9801 (b) DSC = 0.9620
Figure 3.16: The best and the worst femoral segmentation among 32 randomly selected scans
from the database using the dice coefficient index as the evaluation metric. The green and
the red contours show the ground truth and the automatic segmentation, respectively.
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3.4.2 Point Localisation Accuracy
To evaluate the point localisation accuracy, five landmark points were selected
manually at key prominent geometrical locations: centre of the femoral head;
the centre, superior, and inferior positions at the femoral neck; and finally
the apex at the greater trochanter. To reduce the observer error in placing
landmark points, the femoral hip axis is first selected semi-automatically. Next,
the femoral head centre and the femoral neck centre are selected on this axis.
Then, the user is asked to select the upper and the lower margins on an axis
perpendicular to the femoral hip axis passing through the neck centre.
The same dataset (n = 32) used for the evaluation of segmentation accuracy
were deployed here. For each image, the landmarks are then transferred to
the template using the same TPS warping transformation computed per each
image (Fig. 3.17).






Figure 3.17: Point localisation error. Five landmark points were selected on the template at
the centre of the femoral head; the centre, superior, and inferior positions at the femoral neck;
and the apex at the greater trochanter (the red cross-marks). To assess the point localisation
error, thirty-two scans were randomly selected. For each image, five landmark points were
selected manually at anatomically correspondent locations and then mapped to the reference
domain using the estimated TPS transformations for each image (the blue dots). The average
error was 1.57 mm. The space is shown in millimetre.
Table 3.2 shows the mean and the standard deviation of the distance be-
tween each landmark point and its corresponding point on the template. The
overall error was 1.57 mm (cf. [146]). Given the space resolution of 0.5 × 0.5
mm in the template domain, the average error was 3.15 pixels.











mean (SD) 1.64 (0.67) 1.63 (1.10) 1.54 (0.94) 1.67 (1.34) 1.39 (0.82)
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3.4.3 Experimental Validation for the Quantile Match-
ing Regression Technique
The proposed quantile matching regression technique provides a means of com-
parative calibration when multiple measurements of a subject on different sys-
tems are not available. I validated this technique using synthetic numerical
values at different noise levels. Furthermore, I validated this technique in the
setting of bilateral calibration where paired measurements are available.
(A) Synthetic Data
The experimental set-up is as follows: the number of different systems was set
to 2, i.e. C = 2 in Eq. 3.18. I randomly sampled N = 5000 observations
for the latent random variable X from a skewed normal distribution; Each
observation was sampled from a standard normal distribution N (1, 0) and
then transformed using an inverse Box-Cox transformation (Eq. 3.42) with
parameters λ = 0.4, µ = 1.3, and σ = 0.5. The nominal values for the model
parameters were set to a1 = 1, b1 = 0, a2 = 0.8, and b2 = 0.1. The Gaussian
noises E(c) were selected independently from N (0, σ2c ) for c = 1, 2.. I tested
the performance of the proposed quantile matching regression technique for
various noise levels (Table 3.3). A Monte Carlo procedure with 1000 iterations
was conducted and the mean and the standard deviation of the estimated
parameters are reported.
Table 3.3: The comparison between the proposed quantile matching regression versus the
Deming regression using synthetic samples at different noise levels (σ2 = σ1).
GTa
σ1 = 0.1 (r
2 = 0.94) σ1 = 0.2 (r
2 = 0.81) σ1 = 0.4 (r
2 = 0.48)
QMRb DRc QMRb DRc QMRb DRc
a2 0.8 0.80(0.003) 0.80(0.003) 0.82(0.006) 0.80(0.005) 0.86(0.011) 0.80(0.012)
b2 0.1 0.09(0.005) 0.10(0.004) 0.08(0.009) 0.10(0.008) 0.02(0.017) 0.10(0.018)
a The Ground Truth, b the proposed Quantile Matching Regression technique, and c the Deming Regression with
δ = 1 [126]. r2 is the squared correlation value between the two systems. Estimated values for the parameters
are reported as mean (standard deviation) of 1000 Monte Carlo repetitions.
Deming regression is a reliable tool for comparative calibration when paired
measurements of each subject on both systems are available. When paired
measurements are not available, the proposed quantile matching regression
resulted in good approximations when the noise level was low (r2 = 0.94) but
as the noise power increased, the estimated parameters started to deviate from
the ground truth (Table 3.3).
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(B) Clinical Data
To validate the performance of the proposed quantile matching regression tech-
nique in a clinical setting, I applied this technique to the bilateral calibration
problem addressed previously in section 3.3.4 using the Deming regression.
Here, I did not use the fact that the left and the right hip measurements are
collected from the same subject. Figs. 3.18(a) and 3.18(b) show the slope
and the intercept, respectively. The overall pattern is similar to the results
for the Deming regression (c.f. Figs. 3.10). However, subtle differences were
observed at the bone margin near the contours where the correlation between
the left and the right hips were low (Fig. 3.18(c)). In the grey zone with
r2 ≥ 0.5 (Fig. 3.18(c)), however, the estimated parameters using quantile
matching technique perfectly matches the results from the Deming regression
with a root mean square (RMS) error of 0.013 and 0.017 for the slope a and












(b) The intercept b (c) r2 < 0.5
Figure 3.18: Estimated cross-calibration parameters between the left and the right hips. The
quantile matching regression technique was applied taking the right hip as the reference, i.e.
[left] = a [right] + b. The estimated parameters are similar to those computed using the
Deming regression (cf. Fig. 3.10). Over the region with a high correlation between the left
and the right hips (r2 ≥ 0.5), the RMS error was 0.013 for the slope a and 0.017 for the intercept
b, respectively
3.4.4 Compliance with Normality after the Box-Cox Trans-
formation
The LMS quantile regression technique assumes that a Box-Cox transforma-
tion of the response variable with appropriate parameters exists such that
the mapped values are normally distributed. Given this assumption, the pe-
nalised log-likelihood of the parameters is minimised. However, minimising
the cost function given in Eq. 3.45 does not guarantee that the transformed
BMD values using the Box-Cox function with the estimated parameters in-
deed follows a normal distribution. To test this hypothesis, I applied the Kol-
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mogorov–Smirnov test to the transformed pixel BMD values using the learned
parameters λ, µ, and σ of the constructed atlas. To account for the multiple
comparisons problem, FDR analysis is applied to the computed p-values at
each pixel coordinate (Fig. 3.19). The learned LMS models are valid in the
majority of pixels except for regions at the rim of the femoral head, and at the
bone margin next to the lesser trochanter (Fig. 3.19(a)). Otherwise, as shown
in Fig. 3.19(b), the pp-plot (the solid blue line) follows the identity (the red
dashed line) confirming the validity of the null hypothesis over a large portion































Figure 3.19: FDR analysis to identify pixels where the distribution of the transformed pixel
BMD values using the estimated LMS model significantly deviates from a normal distribution.
The learned LMS models are valid in the majority of pixels except for regions at the rim of
the femoral head, and at the bone margin next to the lesser trochanter.
3.5 Atlas Validation using Longitudinal Data
The bone ageing atlas was developed based on cross-sectional data from a
large cohort of women (n = 13, 338). To show that the cross-sectional atlas
generation fits with the actual longitudinal BMD change, a subset of scans
from the OPUS dataset (n = 400; mean age, 64.7 years; range, 55− 80 years)
is deployed here for which follow-up measurements at 6 years (mean time lapse,
70.9 months; standard deviation, 1.2 months) were available. The hypothesis
tested here is that no significant BMD change should be observed between the
expected BMD values at 6 years based on the projected BMD atlas and the
actual measurements at 6 years. To project the BMD values at six years at
each pixel coordinate, firstly the quantile value for the given pixel BMD at the
baseline age is read from the atlas. Next, the corresponding BMD value at the
follow-up age is read from the same quantile trajectory.
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For this analysis, I divided the data into 5 intervals: 55−60 years (n = 120);
60 − 65 years (n = 99); 65 − 70 years (n = 82); 70 − 75 years (n = 63); and
75 − 80 years (n = 36). In each sub-group, a paired t-test proceeded by the
FDR analysis was used once between the baseline and the actual follow-up
measurements, and another time between the projected and the actual follow-
up BMD values. No change would be expected in the latter.
Figs. 3.20-3.24 show the results for each sub-group, respectively. Significant
bone loss was observed in the trochanteric region and the medial femoral shaft
in all the groups except the last one (Fig. 3.24). This can be explained
by the small number of samples in this sub-group (n = 36). The projected
BMD values using the constructed atlas fits the actual measurements where






































































Figure 3.20: Longitudinal atlas validation (sub-group 1: 55-60 years, n = 120). The top
row compares actual baseline and follow-up measurements at 6 years while the bottom row
compares the projected BMD values at 6 years versus the actual follow-up measurements.
The first column shows the normalised BMD change between the follow-up and either the
baseline or the projected values. The second and the third columns show the FDR significance
q-map and the corresponding PP plot, respectively.





































































Figure 3.21: Longitudinal atlas validation (sub-group 2: 60-65 years, n = 99). The top row
compares actual baseline and follow-up measurements at 6 years while the bottom row com-
pares the projected BMD values at 6 years versus the actual follow-up measurements. The
first column shows the normalised BMD change between the follow-up and either the baseline
or the projected values. The second and the third columns show the FDR significance q-map





































































Figure 3.22: Longitudinal atlas validation (sub-group 3: 65-70 years, n = 82). The top row
compares actual baseline and follow-up measurements at 6 years while the bottom row com-
pares the projected BMD values at 6 years versus the actual follow-up measurements. The
first column shows the normalised BMD change between the follow-up and either the baseline
or the projected values. The second and the third columns show the FDR significance q-map
and the corresponding PP plot, respectively.





































































Figure 3.23: Longitudinal atlas validation (sub-group 4: 70-75 years, n = 63). The top row
compares actual baseline and follow-up measurements at 6 years while the bottom row com-
pares the projected BMD values at 6 years versus the actual follow-up measurements. The
first column shows the normalised BMD change between the follow-up and either the baseline
or the projected values. The second and the third columns show the FDR significance q-map





































































Figure 3.24: Longitudinal atlas validation (sub-group 5: 75-80 years, n = 36). The top row
compares actual baseline and follow-up measurements at 6 years while the bottom row com-
pares the projected BMD values at 6 years versus the actual follow-up measurements. The
first column shows the normalised BMD change between the follow-up and either the baseline
or the projected values. The second and the third columns show the FDR significance q-map
and the corresponding PP plot, respectively.
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3.6 Discussion
Osteoporosis is an age-associated disease caused by gradual deterioration of
bone tissue with ageing. While ageing is associated with significant bone loss,
its effect on bone strength still needs to be better understood [147]. Conven-
tional DXA analysis has provided important insights into the bone loss patterns
in different ROIs including the femoral neck; however, its utility is limited by
the fact that spatial BMD information is lost by pooling pixels into larger ROIs
with a few hundreds of pixels. This data averaging limits our understanding
of more focal BMD deficits. To resolve this issue, this work presents the de-
velopment of a reference spatio-temporal atlas of ageing bone in the proximal
femur using cross-sectional data from a large cohort of North Western Euro-
pean Caucasian women (n=13,338). Atlas development is a complex task with
a number of sophisticated steps including data organisation, image segmenta-
tion and alignment, inter-scanner calibration, and quantile regression analysis.
A fully automatic pipeline applicable to large-scale population analysis was
proposed to streamline the process.
I validated the methodology for the creation of the atlas using both ex-
perimental and synthetic datasets. Each module in the pipeline was evaluated
separately. To evaluate the segmentation accuracy, 32 scans were randomly se-
lected and manually annotated. The average segmentation accuracy expressed
as the Dice index was 0.97. To assess the overall registration error, five control
points were manually selected at the femoral head centre; inferior, mid, and
superior femoral neck; and the apex of the greater trochanter. The same 32
scans used for the segmentation evaluation were also deployed here. Warping
each individual image to the mean template, the landmark points were mapped
onto the template. The mean point to point distance was 1.57 mm equivalent
to 3.15 pixels.
The extended RFA framework precision was evaluated using a set of 25
scan pairs, each pair collected on the same day from the same subject with
repositioning between scans. All subjects were women (mean age = 70.1± 6.2
years) and scanned using a Hologic QDR 4500A densitometer as part of the
OPUS study [138]. RFA precision was comparable to conventional DXA anal-
ysis when measured on the same ROIs, but worse at the pixel level. However,
this compromise offers a higher spatial resolution which is necessary for char-
acterising spatially complex bone remodelling events. The median for the
pixel-level coefficient of variation within the femur was 7.96%. The precision
was worse at the bone margins (≥ 15%). This lower precision could be ex-
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plained with landmark localisation error, but this error does not affect the
bone distribution patterns within the femur since all landmarks were selected
on the bone contour (Fig. 3.7(a)).
The validity of the proposed quantile matching regression technique for
comparative calibration was tested using both synthetic and experimental
datasets. I tested the viability of the quantile matching regression for bilateral
calibration using a subset of scans from the UK Biobank study where both
hips were scanned. The estimated calibration parameters were consistent with
the results from the Deming regression analysis. However, at regions close to
the bone margin where the correlation between the left and the right hips were
low, the estimation error increased for the quantile matching regression tech-
nique. Since no paired measurements on the Hologic and the Lunar systems
were available, I could not test the viability of the proposed technique directly
for DXA cross-calibration. However, numerical experiments with synthetic
datasets supported the validity of the proposed framework in this context as
well.
The precision of the LMS quantile regression for modelling the temporal
BMD evolution was tested using a bootstrapping procedure. The overall un-
certainty was sufficiently small so the ageing effect was observable (Figs. 3.13
and 3.14). However, the uncertainty was higher for the young age group, i.e.
age < 40 years, and the elderly population, i.e. age > 90 years, due to the
small number of samples. The validity of the Box-Cox transformation for map-
ping the skewed pixel BMD distributions to a Normal distribution was tested
using a Kolmogorov-Smirnov test proceeded with the FDR analysis to correct
for multiple comparisons. Except for three small blobs at the inferior and
superior femoral head; and next to the lesser trochanter at the bone margin,
the test was not rejected in the majority of pixels in the femur confirming the
validity of the LMS technique for this application.
The new technique presented three key contributions. First, RFA allowed
high-resolution pixel level BMD analysis. The increased spatial resolution
made it possible to observe spatially-complex bone ageing patterns for which
conventional region-based bone densitometry routine is insensitive. The valid-
ity of the observed ageing patterns was tested using a subset of scans (n = 400)
with follow-up measurements at 6 years. The data were divided into five groups
based on the age at the baseline measurement. No statistically significant dif-
ference was observed between the atlas-based projected BMD values and the
actual BMD measurements at 6 years using a paired t-test except for group
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4 (age, 70-75 years, n = 63). Individual analysis of these scans suggested
the development of osteoarthritis between the baseline and the follow-up time
points for a subset of scans (n = 5). Removing these scans and repeating the
FDR analysis, no significant difference was observed. Second, the proposed
calibration technique allowed the integration of data from different DXA man-
ufacturers. The new method does not require multiple scans from the same
subject and so is applicable to large multi-centre studies where every subject
is often scanned only on one system. Third, a fully automatic bone ageing
analysis pipeline was proposed that would streamline the atlas generation pro-
cess. This automation would facilitate population-specific atlas generation
from other ethnic libraries in the same way that population-specific z scores
are computed.
This technique also had limitations. To observe the ageing effect, the vari-
ability due to RFA inaccuracy should be smaller than the BMD variation
in the population so that its impact on the estimated quantiles is negligible.
Pixel-level noise has two effects on the estimated quantile curves: increasing
the inter-quartile range, and increasing the confidence interval around each
estimated quantile curve. The latter is included in the estimated confidence
intervals shown in Figs. 3.13 and 3.14. Since the sample size was sufficiently
large, the uncertainty around each curve was sufficiently small and the ageing
effect was observable. However, the bias effect leading to an increase in the
inter-quartile range cannot be easily observed in these plots; it is difficult to
attribute the observed variability to either the population or the measurement
noise. However, since noise only affects the inter-quartile ranges and the es-
timated median curves are unbiased regardless of the noise power, the ageing
trend visualised in Fig. 3.12 is still valid in all pixel coordinates.
The areal BMD measured by DXA does not represent the true volumetric
BMD, and so the constructed atlas is a 2D projection of the actual 3D patterns.
A 2D/3D approach could address this issue [148, 39]. These techniques are
often based a 3D statistical shape/appearance model learned from a small
subset of QCT images, for example, n = 57 (all highly osteoporotic women)
[148]. Hence, the learned atlas cannot account for the full population variation
(cf. n = 13, 338 in this study). If a large QCT dataset was available, the ageing
atlas could have been directly developed from them where the principle applied
here can be readily transferred to 3D imaging.
This technique shows promise in characterising spatially-complex BMD
changes with ageing. These patterns were visualised using heat-maps. Further-
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more, quantile curves plotted at different pixel coordinates showed consistently
different rates of bone loss at different regions of the femoral neck. Our future
work aims at improving fracture risk assessment using the developed atlas to
determine whether this increased resolution enhances the fracture predictive
ability of DXA.
3.7 Conclusion
This work presented the development of a reference spatio-temporal model
of ageing bone in the femur using a large cohort of North Western European
Caucasian women (n=13,338). I have presented a technique, termed region free
analysis (RFA), to eliminate morphological variation between DXA scans by
warping each image into a reference template. This image warping establishes
a virtual correspondence between pixel coordinates enabling sound statistical
inference at the pixel level. I have also presented a novel cross-calibration
procedure, termed quantile matching regression technique, to integrate data
from different studies into an amalgamated large-scale dataset. Unlike previous
techniques, no multiple measurements of each subject on different scanners
are required. DXA RFA has the potential to transform conventional bone
densitometry routine where spatial resolution is limited due to pooling pixels
in pre-defined regions of interest. In the next chapter, I will explore the new
insights taken from the developed atlas into the osteoporosis research.
Chapter 4
Application of Bone Atlas to
Understand Ageing and
Osteoporosis
Chapter 3 presented the development of a reference spatio-temporal atlas of
bone mineral density (BMD) ageing in the proximal femur. Heat-maps were
deployed to visualise the evolution of spatial BMD patterns with ageing. This
chapter presents four key contributions. First, the added value of the developed
atlas to delineate between trabecular and cortical bone architecture in the
femur is presented, for which conventional region-based analysis is insensitive.
Second, a new index called bone age is introduced to reflect the evolution
of bone microarchitecture with ageing. Bone age aims to model the actual
progression, rather than the chronological age, of each subject along the median
bone ageing trajectory. I will demonstrate the ability of bone age to serve as
a metric for estimation of the progression of osteoporosis. Third, normalising
BMD maps for bone age revealed subtle localised fracture-specific patterns
that would not be identifiable without excluding the ageing effect. A new
index called f-score is introduced to quantify these patterns. Integrating bone
age and f-score together enhanced hip fracture prediction by 3% measured as
the area under the receiver operative characteristic (ROC) curve. Finally, the
ability of the proposed pipeline to support extra explanatory variables beyond
age as the primary covariate is demonstrated by modelling the impact of body
mass index (BMI) on spatial BMD distribution.
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4.1 Introduction
Ageing is associated with an increased rate of fracture in the elderly pop-
ulation [149]. Both bone quality deterioration and other extraosseous age-
related factors such as reduced proprioceptive efficiency or impaired reflexes
also contribute to this elevated fracture risk [25]. The first factor concerning
the detrimental effects of ageing on bone strength underlies the mechanism for
osteoporosis development [110]. The details of osteoporosis progression with
ageing needs to be better understood [150, 147], for which, development of a
comprehensive model of ageing bone has been of great interest in osteoporosis
research.
Dual-energy X-ray absorptiometry (DXA) has been widely used to model
age-related changes in bone mineral density (BMD) measured at different re-
gions of interest (ROIs) in the femur [151, 152, 150, 153, 154]. Despite an
overall decline in BMD, the pattern is site-specific; the decrease in BMD mea-
sured at femoral neck, trochanter, and Ward’s triangle is almost linear while
the observed pattern at total hip is bimodal with a steeper drop at advanced
ages [151, 152, 153, 154]. Table 4.1 shows the yearly percentage BMD re-
duction for women at four ROIs commonly reported in the literature. BMD
reduction rates varied at different sites within the femur. The steepest reduc-
tion in BMD occurred in Ward’s triangle whereas the modest decrease occurred
in great trochanter. At total hip, BMD was mostly preserved before the 60th
year followed by a steep decrease afterwards.





Neck Ward’s triangle Trochanter
Total Hip
<60 >50
Warming et al. [151] 398 20-89 0.42 - - 0.24 0.37
Melton et al. [152] 351 21-93 0.50 0.88 - 0.27 0.54
Beck et al. [150] 2904 20-99 0.45 - - 0.11 0.51
Burger et al.[153] 1084 >55 0.39 0.51 0.25 - -
Aloia et al.[154] 257 20-80 0.40 0.71 0.20 - -
Due to variation in methodologies or unreported site-specific BMD change rates, all rates were recomputed
from the raw data presented in the manuscripts using linear regression analysis. For total hip BMD, data
is divided into two overlapping segments: those who aged 60 years or less in one group, and those who
aged 50 years or more in another one.
Conventional DXA analysis has facilitated our understanding of ageing
bone in the femur, but has two limitations. First, conventional DXA analysis
has limited ability to characterise local ageing patterns in spatial BMD dis-
tribution. The reported BMD reduction rates at different ROIs suggests that
averaging pixel BMD values at larger ROIs could mask more localised BMD
patterns in the femur (Table 4.1); while a steep decrease is observed consis-
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tently at Ward’s triangle throughout the adulthood age range, total hip BMD
appears to be less sensitive to ageing especially at the younger age groups.
Second, conventional DXA analysis cannot reflect age-related changes in the
trabecular microarchitecture. Several studies have suggested a relationship be-
tween bone microarchitecture and bone strength, independent of site-specific
femoral BMD values [155, 156, 150]. Therefore, quantifying the ageing effect
on trabecular architecture may further enhance our understanding of ageing
bone in the femur.
To address these limitations, other high-resolution imaging modalities in-
cluding Quantitative Computed Tomography (QCT) [157] and high resolution
peripheral QCT (HR-pQCT) [156] have been used. While these techniques pro-
vide enhanced spatial resolution comparing with DXA, access to sufficiently
large-scale datasets representing the ageing population is difficult; most stud-
ies deploying QCT or HR-pQCT were conducted on a few hundred cases (see
[156] for a review).
DXA region free analysis (RFA) with an enhanced spatial resolution of
0.5 × 0.5 mm2 allows quantification of local BMD variation across large-scale
datasets comprising thousands of subjects. In the previous chapter, a spatio-
temporal atlas of ageing bone was developed in which spatial BMD distribution
was visualised using heat-maps. In this chapter, first, the relationship between
the observed atlas-based BMD patterns and the site-specific BMD reduction
rates reported in the literature is examined. The added value of the developed
atlas to delineate between trabecular and cortical bone arrangements are pre-
sented in section 4.2. Second, to quantify the overall change in spatial BMD
distribution with ageing, a new index called bone age is introduced (section
4.3). Given that osteoporosis is a silent disease in the absence of fracture,
the feasibility of using bone age for estimation of osteoporosis progression is
discussed. Third, given that age has a dominant impact on spatial BMD distri-
bution, normalising BMD maps for bone age allowed quantifying subtle local
fracture-specific patterns in the femur. A new index called f-score is introduced
to quantify these patterns. F-score, when integrated with bone age, enhanced
hip fracture prediction by 3% measured as the area under the receiver operative
characteristic (ROC) curve (section 4.4). Fourth, the ability of the proposed
pipeline to support further explanatory variables beyond age as the primary
covariate is demonstrated by modelling the impact of body mass index (BMI)
on spatial BMD distribution. Section 4.6 concludes this chapter.
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4.2 Cortical and Trabecular BMD Variation
Fig. 4.1 shows the ultra-structure arrangements of cortical and trabecular bone
in the proximal femur. Cortical bone is mainly found in the femoral shaft and
inferior neck whereas trabecular bone with the sponge-like structure resides
inside the femoral trochanter, neck and head. The turnover of trabecular bone
is greater than cortical bone leading to higher BMD change rates inside the
femur comparing with the outer cortex (Fig. 4.2).
Figure 4.1: Ultra-structure arrangements of cortical and trabecular bone in the proximal
femur. Cortical bone (the outer highly mineralised shell) is seen at the shaft and the inferior
neck, whereas trabecular bone with the sponge-like structure resides inside the cortical shell.
(Adapted from [158]).
For most of adulthood, cortical BMD is mostly preserved with slight in-
crease at the inferior neck until the 7th decade. Following that point, cortical
BMD showed a consistent decrease with an approximate annual rate of 0.5%.
The enhanced RFA resolution allowed quantification of cortical thickness at
the femoral diaphysis. To this end, the BMD profiles at various cross-sections
perpendicular to the longitudinal axis of the femur at that given point were
analysed for peak bone mass (Fig. 4.3). The width of the femoral shaft at each
cross-section minus the distance between the two peak points was then defined
as the peak cortical thickness. Fig. 4.4 shows the average cortical thickness
variation with ageing at the femoral shaft. The average cortical thickness
decreased linearly with ageing from 6.65 mm at 20 years to 5.55 mm at 80
years.
Trabecular BMD patterns inside the femur were spatially complex (Fig.
4.2). For much of adulthood, BMD reduction was more dominant at the
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Figure 4.2: Yearly percentage BMD change in the proximal femur. Pixel BMD change rates
are normalised to the median BMD at 25 years. BMD was mostly preserved in the cortical
bone till 60th year following a consistent decrease with approximate annual rate of 0.5%.
Variation in the arrangement of trabecular architecture looks spatially complex. In the early
adulthood, BMD reduction in trabecular bone was faster at the femoral neck. In the middle
adulthood, BMD reduction accelerated throughout the femur. In the advanced adulthood,
BMD reduction was more dominant at the femoral shaft and greater trochanter.
femoral neck whereas, at advanced ages, BMD reduction was more dominant
at the femoral shaft and great trochanter. The decrease in trabecular BMD
accelerated in the mid-fifties throughout the femur which could be attributed
to menopause in women.
Observed spatial BMD patterns were consistent with the reported BMD
reduction rates at different ROIs. The sharpest decrease from high to low was
reported in the Ward’s triangle, femoral neck, and great trochanter, respec-
tively (Table 4.1). This variation in BMD reduction rates can be explained well
using the spatial BMD patterns observed in Fig. 4.2; the reddish spot associ-
ated with the greatest BMD reduction at the medial femoral neck is consistent
with accelerated BMD reduction at the Wards’ triangle. Averaging pixel BMD
values over the whole neck, however, would make the site-specific BMD change
less sensitive to ageing. Pixel BMD change at the great trochanter, visualised
with green and blue colours in Fig. 4.2, suggests slower BMD loss at this
region comparing with femoral neck. This observation is consistent with the
reported BMD reduction rate at the trochanter.

























































Figure 4.3: Proximal femoral bone density profiles at two cross-sections. (a) BMD profiles
at the femoral shaft demonstrated an M-shape graph with peak BMD at the outer cortex
and lower trabecular BMD in the middle. On each graph, the two peak BMD values in the
interior and exterior cortex are marked with asterisks. Peak cortical thickness is defined as
the width of the cross-section line minus the distance between the two peaks in the BMD
profile. (b) BMD profile at the femoral neck demonstrated only one distinct local peak BMD
at the inferior cortex where cortical bone is present (see Fig. 4.1). Ageing is associated with




















Figure 4.4: Average peak cortical thickness variation with ageing. Average peak cortical
thickness at the diaphysis was linearly decreased with ageing from 6.65 mm at 20 years to
5.55 mm at 80 years.
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4.3 Osteoporosis Progression Index
Osteoporosis is strongly related to ageing which causes gradual deterioration in
bone structure leading to elevated fracture risk in the elderly population. De-
spite the progressive nature of osteoporosis, currently the degree of progression
or the severity of disease is not estimated in clinical practice. Alternatively,
bone is categorised as either normal, osteopenia, or osteoporosis based on the
BMD measurement at the femoral neck or spine reported as T-score, i.e. the
number of standard deviation (SD) from the average for young healthy women
in the population. The world health organisation (WHO) criteria for the diag-
nosis of osteoporosis is based on the T-score cut-off point of -2.5 for osteoporosis
and -1 for osteopenia. This definition, however, is recognised as being arbitrary
and controversial [159]. Moreover, these discrete categories cannot explain the
mechanism by which osteoporosis progressively affects bone architecture in the
femur.
Given that osteoporosis is a silent disease unless a fracture occurs, os-
teoporosis progression estimation is a challenging task due to lack of clinical
symptoms. Given the close relationship between osteoporosis and ageing, one
can postulate that the normal ageing trajectories estimated for the population
also represent the disease progression trajectory. Osteoporosis is then mod-
elled as accelerated bone loss on the same trajectory attributed to the natural
ageing phenomenon. In this context, the actual progression on the bone ageing
trajectory, rather than the chronological age, defines the current osteoporosis
severity. Observe that modelling osteoporosis as accelerated normal ageing
can only be used for primary age-related/postmenopausal osteoporosis. It has
not been tested for causes of secondary osteoporosis such as primary hyper-
thyroidism or glucocorticoid treatment.
Fig. 4.5 demonstrates the bone ageing concept using a schematic graph in
a 2D space. The solid black line represents the median ageing trajectory using
BMD at two pixel coordinates. For an individual BMD map represented by a
green dot in Fig. 4.5, bone age is defined as the actual progression along the
ageing trajectory estimated by mapping the given BMD map to the closest
point on the graph (red dot in Fig. 4.5). Note that the actual bone ageing
trajectory lies on an N -dimensional space with N = 16035 is the number of
pixels in the template (Fig. 4.6).
Let a(a) denote the median bone map at age a and b denotes the bone
map for an individual subject. Both a and b are represented in the vectorised
format RN×1 where N is the number of pixels in the template. Then, the bone
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Bone Ageing Trajectory
Figure 4.5: Schematic bone ageing trajectory in a 2-dimensional space. The solid black line
represents the median ageing trajectory using BMD at two pixel coordinates. One pixel is
selected from the femoral neck, and the other one is selected from the cortex near the lesser
trochanter. For a given bone map (green dot), its bone age is estimated by mapping the given
bone map to the closest point on the trajectory. Note that the actual bone ageing trajectory
lies on an N-dimensional space where N equals the number of pixels in the template.
20 35 50 65 80 95 Bone Age
Figure 4.6: Median bone ageing trajectory. The median bone ageing trajectory is a 1D graph
in the N-dimensional space where N = 16035 is the number of pixels in the template.
age a′ is defined as the age for which a(a′) best fits the given bone map b.
Various similarity metrics could be used in practice. Here, the simple L2-norm
is deployed as the dissimilarity metric:
a′ = argmin
a
‖bT − a(a)‖L2 . (4.1)
Fig. 4.7 demonstrates the intuitive rationale behind the bone age. Fig. 4.7
shows two sample BMD maps of women aged 76 years with similar femoral neck
BMD of 0.59 g/cm2 where one sustained a follow-up hip fracture (the top row)
and the other did not (the bottom row). Despite similar age and femoral neck
BMD, the bone architecture varies between the two subjects. The one with the
interval fracture demonstrates widespread bone loss in the trochanteric region
and relatively thinner cortical thickness leading to an elevated bone age of 80
years (cf. Fig. 4.6). The bone map shown on the bottom row demonstrates
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higher densities at the bone cortex in the non-fracture subject giving a bone



































Figure 4.7: Intuitive illustration of bone age potential to differentiate between fracture and
control subjects with similar neck BMD values. The top row shows the bone map for a woman
of aged 75.8 years with femoral neck BMD of 0.5860 g/cm2 who experienced a hip fracture
following the baseline measurement. The bottom row shows the bone map for a non-fracture
subject with similar age (75.9 years) and femoral neck BMD (0.5900 g/cm2). Despite similar
age and femoral neck BMD, the spatial texture pattern varies between the two subjects. The
associated bone age was 80 and 62 years for the top and bottom rows, respectively.
The term bone age has been used for decades in medicine (by paediatri-
cians) to measure the skeletal maturity in a child, and is based on a comparison
of a wrist radiograph with atlas patterns to assess the closure of the growth
plates [160, 161]. Despite differences in methodologies for estimation of bone
age in children and adults, the underlying concept is similar; bone age repre-
sents the average age at which a specific degree of maturation/deterioration is
expected. Given this analogy, I proposed the term bone age here for assessing
the degree of bone deterioration in the adulthood, but one should observe the
difference between this technique and the bone age assessment in children in
a broader context.
Bone age is an abstract concept for modelling osteoporosis progression.
Despite its intuitive perception (see Fig. 4.7), it is difficult to validate bone
age directly using clinical criteria as osteoporosis is asymptomatic. However,
in order for bone age to usefully facilitate the management of osteoporosis,
it must satisfy the following conditions: first, it should be consistent with
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the current established diagnostic guidelines for osteoporosis, which is based
on femoral neck BMD. Second, bone age should be sufficiently precise; bone
age measured on repeated DXA measurements on the same day with patient
repositioning between scans should be similar. Third, it should demonstrate
the ability to distinguish between a young healthy population and a more
elderly cohort. Forth, a consistent increase in fracture risk should be observed
with more advanced bone ages. Fifth, it should predict fragility fractures at
least as well as the current metrics, including FRAX and conventional BMD
measurement.
To validate these properties, DXA scans selected from the MRC-Hip dataset
and the OPUS study were deployed (see section 3.3.1). The subjects in the
MRC-Hip study were followed up for a period of five years after the baseline
measurements for any major osteoporotic fractures at the hip, spine, pelvis,
upper limb or lower limb sites. The total number of fractures at these sites
was 684, of which 178 were reported at the hip. The number of control cases
who remained fracture-free was 4249 [139].
4.3.1 Consistency with Current Diagnostic Guidelines
For bone age to serve as a continuum for osteoporosis progression, it should
be consistent with currently established metrics for osteoporosis diagnosis in-
cluding neck BMD and FRAX score. Bone age was highly correlated with
neck BMD (r = −0.87; p < 0.001; Fig. 4.8). The blue and red dots represent
the fracture-free controls and the hip fracture cases, respectively. The density
of red dots increases at the bottom-right corner of the figure, consistent with
both a decrease in neck BMD and an increase in bone age.








Figure 4.8: Relationship between bone age and femoral neck BMD. Bone age is linearly
correlated with neck BMD (r = −0.86; p < 0.001). The blue and red dots represent the
fracture-free controls (n = 4249) and the hip fracture cases (n = 178), respectively. The density
of red dots increases at the bottom-right corner, consistent with both a decrease in neck BMD
and an increase in bone age.
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Fig. 4.9 shows the relationship between bone age and FRAX estimated
with BMD as a risk factor. FRAX score increased with bone ageing with an
almost exponential pattern. This pattern is consistent with the established
exponential relationship between FRAX and neck BMD.










Figure 4.9: Relationship between bone age and FRAX. The FRAX score consistently increases
with bone ageing with an exponential pattern. The blue and red dots represent the fracture-
free controls (n = 4249) and the hip fracture cases (n = 178), respectively. The density of red
dots increases with an increase in bone age and FRAX score. Note that FRAX is reported
with BMD as a risk factor.
4.3.2 Bone Ageing Precision
For bone age to be useful in clinical practice, it should be precise when mea-
sured repeatedly with a short time lapse between scans. Here, precision was
validated using 25 pairs of scans collected on the same day with patient reposi-
tioning between scan collections. The standard deviation (SD) of error was 1.4
years. No significant difference was observed between groups using a paired
t-test (p = 0.54). Fig. 4.10 shows the scatter plot of the estimated bone ages
for each subject. Using Deming regression analysis (see section 3.2.3.(B)), the
slope and the intercept were estimated as 1.00 and 0.51, respectively.






























y = 1.00x + 0.51
Figure 4.10: Bone ageing precision analysis. Twenty-five subjects were scanned two times
on the same day with patient repositioning between scans. For each subject, bone age is
estimated independently for each of the two collected scans. The SD for precision error was
1.4 years. No significant difference was observed using a paired t-test (p = 0.54).
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4.3.3 Distinction between a Young Healthy Cohort and
an Elderly Population
For bone age to serve as a useful metric to assess gradual deterioration of
bone structure with ageing, it should be able to distinguish between a young
healthy cohort with strong bones and an older cohort with excess fragility. For
this analysis, a young healthy cohort (n = 284; age<40 years) and an older
one (n = 2165; age>80 years), selected from the OPUS or MRC-hip study,
were compared against each other. Fig. 4.11 shows the receiver operative
characteristic (ROC) curve for the ability of bone age versus neck BMD to
classify between these two groups. The area under the curve (AUC) was 0.89
(95% confidence interval (CI)=0.874-0.906) and 0.94 (95% CI=0.930-0.954) for
neck BMD and bone age, respectively. The AUC for bone age was found to
be 5% higher than neck BMD alone (p < 0.001; Fig. 4.11).



















Figure 4.11: The ROC curve for ability of bone age versus neck BMD to classify between
young and old populations. The young cohort (n = 284) includes all white women aged 40
years or less selected from the OPUS dataset. The old cohort (n = 2165) includes all white
women aged 80 years or more selected from the OPUS or the MRC-Hip datasets. The AUC
for bone age and neck BMD was 0.94 (95% CI=0.930-0.954) and 0.89 (95% CI=0.874-0.906).
4.3.4 Fracture Risk and Bone Age
As bone ages, it gets weaker and thereby more likely to sustain a fragility
fracture. In line with this hypothesis, fracture risk increased consistently with
bone age (Figs. 4.12(a) and (b)). Fracture risk was computed as the number
of fracture cases divided by the number of subjects at each age band. Similar
trends were also observed with neck BMD and the FRAX score (Fig. 4.12).
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However, the increase in fracture risk the chronological age was only consistent
at the hip, and the chance of suffering from a fracture at any site was broadly
similar across age bands (Fig. 4.12(h)).




































































































































































Figure 4.12: Stratified fracture risk based on the bone age (the first row), neck BMD (the
second row), FRAX score (the third Row), and chronological age (the forth row) in the MRC-
Hip study. The first column shows the fracture risk at the hip while the second column shows
the risk for any fragility fractures occurred at the hip, spine, pelvis, lower limb, or the upper
limb. The total number of fractures was 684 out of which 178 occurred at the hip. The
number of control cases was 4249.
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4.3.5 Fracture Prediction
Fragility fractures are the result of reduced bone strength but also other ex-
traosseous factors such as the likelihood of falling. Therefore, population at-
tributable risk (PAR) attributable to low bone mass is modest (approximately
50% as reported in the study of osteoporotic fractures (SOF) [15]) due to
significant overlap in BMD between fracture and fracture-free control groups.
However, any metric that can improve on the discrimination between the frac-
ture and the control groups should, in practice, further facilitate osteoporosis
management. Fig. 4.13 shows the ROC curves for prediction of follow-up
fragility fractures in the MRC-Hip study. The AUC for hip fracture predic-
tion was 0.731 (95% CI=0.689-0.761), 0.723 (95% CI=0.690-0.754), 0.660 (95%
CI=0.619-0.694), and 0.719 (95% CI=0.682-0.755) for neck BMD, FRAX with
BMD, FRAX without BMD, and bone age, respectively. The AUC for pre-
diction of any major osteoporotic fractures was 0.632 (95% CI=0.609-0.651),
0.636 (95% CI=0.613-0.656), 0.590 (95% CI=0.569-0.613), and 0.639 (95%
CI=0.618-0.661) for neck BMD, FRAX with BMD, FRAX without BMD, and
bone age, respectively.









































(b) All Major Fragility Fractures
Figure 4.13: The ROC curve for prediction of fragility fractures. The AUC for prediction of hip
fractures (n=178) was 0.731 (95% CI=0.689-0.761), 0.723 (95% CI=0.690-0.754), 0.660 (95%
CI=0.619-0.694), and 0.719 (95% CI=0.682-0.755) for neck BMD, FRAX with BMD, FRAX
without BMD, and bone age, respectively. The AUC for prediction of any major osteoporotic
fractures (n=684) was 0.632 (95% CI=0.609-0.651), 0.636 (95% CI=0.613-0.656), 0.590 (95%
CI=0.569-0.613), and 0.639 (95% CI=0.618-0.661) for neck BMD, FRAX with BMD, FRAX
without BMD, and bone age, respectively. The number of fracture-free controls was 4249.
No statistically significant difference in the measured AUC was observed
between neck BMD, FRAX with BMD, and bone age (Fig. 4.13). Note that
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using neck BMD, the PAR for osteoporotic fractures in the MRC-Hip cohort
is relatively high (75%) in comparison to the SOF study [15]. This may be
due to the extremely old cohort recruited in the MRC-hip study; the average
age for the MRC-Hip study [139] was approximately ten years older than the
SOF study [15]. Nonetheless, the PAR between neck BMD and osteoporotic
fractures in the MRC-Hip study is already high. For comparison purposes,
the PAR between smoking and lung cancer is approximately 80% [162]. The
finding of similar performance between bone age and neck BMD in the MRC-
Hip cohort is promising. However, applying bone age to a younger cohort may
present better performance than neck BMD alone, although this is yet to be
tested.
Bone age reflects the overall evolution in trabecular architecture with age-
ing. However, it does not account for local fracture-specific patterns in the
femur. For enhanced fracture prediction, local BMD patterns could be de-
ployed as discussed in the following section.
4.4 Localised Fracture-Specific Bone Patterns
The purpose of this section is to demonstrate the ability of DXA RFA in local-
ising fracture-specific patterns in the femur and to see if these local patterns
could potentially enhance hip fracture prediction. To this end, pixel BMD val-
ues were first normalised to account for the variation in bone age by mapping
each pixel BMD to an appropriate quantile value from the developed atlas.
Fig. 4.14 shows the bone map for a woman of age 77 years who sustained
an interval hip fracture during follow up, the median atlas at the estimated
bone age of 83 years, and the quantile map for this individual. Pixel quantiles
reflect the rank of the given pixel BMD values among the population with a
similar bone age and thereby, the quantile map could be seen as a normalised
BMD map with respect to the estimated bone age.
Normalisation with respect to bone age excludes variation due this vari-
able and allows to identify fracture-specific patterns in the femur. Fig. 4.15
shows the difference in mean between hip fractures (n = 178) and fracture-
free controls (n = 4249) with the statistical significance map reported as a
FDR q-value map. The q-map shows a local pattern of bone loss oriented in
the same direction as principal tensile curves characterised in the radiography
scans using the Singh index [51]. Similar analysis on raw pixel BMD values
could not localise fracture patterns (Fig. 4.16).



























Figure 4.14: Bone-age normalised BMD map. Panel (a) shows the bone map for a woman of
age 77 years who sustained a follow-up hip fracture. Panel (b) shows the median atlas at the
estimated bone age 83 years for this subject. Panel (c) shows the normalised BMD map or
the quantile map. Pixel quantiles reflect the rank of the given pixel BMD values among the


















Figure 4.15: Localising fracture-specific patterns using bone-age normalised BMD maps.
Panel (a) shows the difference in mean quantile maps between the fracture and the fracture-
free control groups. Panel (b) shows the corresponding statistical significance map using a
two-sample t-test followed by FDR analysis. A local pattern of bone loss was observed in
the same orientation as principal tensile curves characterised in the radiography scans [51].
Panel (c) shows the trabecular arcades in the proximal femur deployed for assessing the Singh
















Figure 4.16: Localising fracture-specific patterns using raw BMD maps. Panel (a) shows the
difference in mean BMD maps between the fracture and the fracture-free control groups.
Panel (b) shows the corresponding statistical significance map using a two-sample t-test fol-
lowed by FDR analysis. Raw BMD unlike the quantiles cannot localise fracture-specific pat-
terns (cf. Fig. 4.15).
The average pixel quantile values over the region with q ≤ 1e− 6 (the red
spot on the q-map; Fig. 4.15(b)) defines a new score, named f-score, with
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power to predict fractures independent of bone age or neck BMD (see Fig.
4.17). Fig. 4.17(a),(b), and (c) show the correlation between f-score and bone
age (r = −0.4), the correlation between f-score and neck BMD (r = 0.5),
and the ROC curve for the ability of f-score versus neck BMD to identify
hip fractures. The AUC was 0.731 (95% CI=0.689-0.761) and 0.736 (95%
CI=0.694-0.769) for neck BMD and f-score, respectively. The low correlation
between f-score and either bone age or neck BMD and similar power of f-score
to neck BMD for hip fracture prediction may suggest the potential to enhance
fracture prediction by combining f-score and bone age. One way to combine
bone age and f-score is to deploy a logistic regression technique to compute
the appropriate weights between bone age and f-score. Fig. 4.18(a) shows the
ROC curve for the combination of f-score and bone age versus neck BMD.
Since logistic regression requires training to estimate appropriate weights, I
used a 5-fold cross-validation technique; each time one fold was left out for
testing and the weights were learned on the remaining data. Therefore, five
different values for AUC are computed for each division of the dataset into
5 segments. I repeated this procedure 1000 times and the distribution of the
average AUC values for each experiment are reported in Fig. 4.18(b). The new
combined score improves the AUC significantly by 3% over the conventional
neck BMD.
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Figure 4.17: The ability of f-score to predict fractures independent of bone age or neck BMD.
(a) Relationship between f-score and bone age. (b) Relationship between f-score and neck
BMD. The blue and red dots represent the fracture-free controls and the hip fracture cases,
respectively. (c) The ROC curve for classification between hip fractures (n = 178) and controls
(n = 4249). The AUC was 0.731 (95% CI=0.689-0.761) and 0.736 (95% CI=0.694-0.769) for
neck BMD and f-score, respectively. The low correlation between f-score and either bone
age or neck BMD and similar power of f-score versus neck BMD for hip fracture prediction
suggest the potential to enhance fracture prediction by combining f-score and bone age (see
Fig. 4.18).
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Figure 4.18: Ability of combined f-score and bone age versus neck BMD to predict hip frac-
tures. Logistic regression analysis was deployed to find appropriate weights to combine f-score
and bone age. (a) ROC curve for classification between hip fractures (n = 178) and controls
(n = 4249). (b) Box-plot for the estimated AUC using 1000 different iterations. A five-fold
cross-validation technique was deployed; each time one fold was left out for testing and the
combination weights were learned on the remaining data. I repeated this procedure 1000
times and the distribution of the average AUC values on all 5 folds are reported.
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4.5 BMI Impact on BMD Distribution
The purpose of this section is twofold: first, to demonstrate the ability of
the proposed framework in chapter 3 to account for new covariates of interest
(excluding the primary explanatory variable age); second, to quantify how
BMI variation would affect the spatial distribution of BMD in the proximal
femur. Fig. 4.19 visualises the spatial variation in BMD for different values
of age and BMI using heat-maps. Low BMI was associated with an overall
decrease in bone mass. High BMI resulted in increased bone mass especially
at the diaphysis and Ward’s triangle regions. The observed BMI impact on
BMD patterns were stronger at younger ages than more advanced ages (Fig.
4.19). The correlation between BMI and bone age was r = −0.33.
4.6 Discussion
In osteoporosis research, bone is commonly categorised as either normal (T-
score>-1), or osteopenic (-2.5<T-score<-1), or osteoporosic (T-score<-2.5) us-
ing BMD measurement at the femoral neck. Despite widespread use of this
definition, it is recognised as being arbitrary and controversial [159]. First, to
base the diagnosis criteria on a clear cut-off point could be misleading; the
PAR for a fragility fracture in hip was reported as 28% using T-score<-2.5
and 51% for a more relaxed threshold of T-score<-1.5 in the SOF [15]. This
means that half of the fragility fractures are attributable to normal bones. Sec-
ond, osteoporosis is an age-associated disease in which progression with ageing
forms a continuum. Classifying bone status into three discrete categories does
not precisely reflect the inherently progressive nature of the disease nor allow
estimation of osteoporosis progression rate. The ability to estimate the current
severity of the disease as well as its progression rate could facilitate the man-
agement of age-associated diseases [164]. Third, patients would be interested
to know how their bones compare with a similar person who has aged normally
rather than the relative difference from a healthy young cohort. Z-score may
potentially answer this question by comparing the subject with age- and sex-
matched cohort, but Z-score still cannot capture the underlying longitudinal
ageing effect. More to the point, Z-score accounts for the chronological age
rather than the bone age.
Given the close relationship between osteoporosis and ageing, here I as-
sumed a unique underlying mechanism for bone ageing and presented osteo-
porosis as an inextricable outcome of senescence. However, I recognised the























Figure 4.19: Spatial BMD variation with Age and BMI. The median bone maps are visualised
for 20, 35, 50, 65, 80, and 95 years of age and different BMI values of 15, 20, 25, 30, 35, 40,
and 45 kg/m2. The atlas is shown for the Hologic system at the left hip.
variation in ageing rates between subjects where osteoporosis could be seen as
an accelerated loss in BMD on the same trajectory attributable to the normal
ageing process. With this assumption, this chapter presented a technique for
estimation of osteoporosis progression based on the trabecular microarchitec-
ture in the femur. A new index, called bone age, was introduced as the age
at which the spatial BMD patterns extracted from the atlas best fit the given
individual bone map. The terminology bone age is not new; it has been used
to identify the degree of bone maturation in children. While the methodology
for estimation of bone age is different for children than adults, the underly-
ing concept is similar; bone age represents the average age at which a specific
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degree of maturation/deterioration is expected.
I demonstrated five different properties for bone age that could usefully
facilitate the management of osteoporosis. First, bone age is an intuitive met-
ric to reflect the microarchitectural arrangements of trabecular bone in the
femur that forms a continuum rather than discrete categories. Second, This
continuous scale would potentially allow computation of progression rates as
well as the current severity of the disease. The precision error (SD) for bone
age estimation was 1.4 years using 25 pairs of scans collected on the same day
with patient repositioning between them. Third, bone ageing was associated
with a consistent increase in the risk for suffering from an interval fragility
fracture. Forth, AUC for the ability of bone age versus neck BMD to dis-
criminate between a young cohort (n = 284; age<40 years) and a more older
one (n = 2165; age>80 years) was 0.94 (95% CI=0.930-0.954) and 0.89 (95%
CI=0.874-0.906), respectively. Given that the bone strength would be higher
at younger cohorts on average, this enhancement may suggest that bone age
could be potentially a better representative of bone strength than neck BMD.
Fifth, bone age demonstrated a similar power to neck BMD and FRAX with
BMD for prediction of fragility fractures in the MRC-Hip dataset.
Despite the advantages of bone age mentioned above, no improvement over
neck BMD was observed for fracture prediction in the MRC-Hip study. One
reason for that could be the extremely old population in the MRC-Hip dataset.
Using neck BMD, the PAR for fragility fractures was 38% and 75% for a T-
score below -2.5 and -1.5, respectively. This means that 75% of fractures are
attributable to osteoporotic bones with a more relaxed definition of osteo-
porosis (cf. PAR of 51% in the SOF study [15]). This is almost comparable
with PAR for smoking and lung cancer, which has been estimated to be over
80% [162]. This 25% increase in PAR for MRC-Hip versus SOF could be
attributable to the difference in age between the two studies; the MRC-Hip
cohort was on average ten years older. The high PAR of 75% makes it dif-
ficult to improve fracture prediction over neck BMD as neck BMD already
demonstrated good performance in the MRC-Hip cohort. However, given that
bone age demonstrated better performance than neck BMD in differentiating
between young and old cohorts, deploying bone age in a younger population
than the MRC-Hip cohort may potentially demonstrate better performance of
bone age versus neck BMD in hip fracture prediction.
The second reason for the limited ability of bone age over neck BMD to
improve fracture prediction is that bone age does not per se account for lo-
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calised fracture-specific patterns in the femur. Bone age accounts for age-
related changes in the arrangement of trabecular architecture in the femur,
but normalising pixel BMD for bone age revealed localised patterns of loss in
BMD oriented in the same direction as principal tensile curves characterised
on plain radiographs using the Singh index [51]. This BMD normalisation is
analogous to Z-scores with two differences: first, bone age is used rather than
chronological age; second, since pixel BMD follows a skewed normal distribu-
tion, quantile values are reported rather than the difference from the mean
expressed in SD. I introduced a new index called f-score by averaging quan-
tile values over the local regions with FDR q-value below 1e− 6. The f-score
demonstrated a similar power to neck BMD for fracture prediction indepen-
dent of bone age or neck BMD. When combining f-score and bone age, the
AUC for prediction of hip fractures was significantly increased by 3%. This
significant increase, albeit small, may suggest the potential for improving frac-
ture prediction by analysing fracture-specific BMD patterns in bone. This
potential may be fully demonstrated once these patterns are correlated with
information about the actual fracture patterns in the proximal femur. Fig.
4.20 shows six types of fractures at the subcapital neck, transcervical neck,
intertrochanter, subtrochanter, greater trochanter, or lesser trochanter. Al-
though validating this hypothesis requires a large-dataset with fracture data
at a wider age range, this is only feasible with the RFA technique and not the
conventional region-based analysis.
4.7 Conclusion
This chapter outlines several potential applications for the developed spatio-
temporal atlas that could potentially facilitate the management of osteoporosis
disease. I demonstrated how the enhanced RFA resolution could be deployed
to analyse cortical and trabecular changes in the femur, for which the con-
ventional region-based technique would be insensitive. More specifically, I
quantified the average cortical thickness in the diaphysis. A new framework
for the progression estimation of osteoporosis was proposed by introducing a
new intuitive index called bone age. To improve fracture prediction, a new in-
dex called f-score was introduced to reflect localised fracture-specific patterns.
Combining f-score and bone age together using logistic regression analysis, the
AUC for prediction of hip fractures was significantly increased by 3% over
neck BMD alone. Finally, I examined the impact of body mass index (BMI)
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Figure 4.20: Various types of fracture patterns observed in the proximal femur. DXA RFA
would allow correlation of local BMD patterns with actual fracture patterns in the femur to
enhance hip fracture prediction. The image is adapted from [165].
on the spatial distribution of BMD values in the femur to demonstrate the
ability of the proposed framework to add new covariates to the developed
spatio-temporal atlas.
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Chapter 5
Automatic Quality Control of
DXA Images
Population imaging studies have opened new opportunities for a comprehensive
characterisation of a range of diseases including osteoporosis. Despite strict
imaging protocols to ensure consistent high-quality scans, incidental artefacts
are inevitable. Detecting these artefacts using a human observer or a panel of
experts requires a considerable amount of time and expertise, making it unfea-
sible for use in large datasets. To address this challenge, methods for automatic
image quality control are needed. To date, no standard classification metric
exists for the evaluation of DXA artefacts. Here, I first propose a protocol for
manual annotation of DXA artefacts. Second, I propose an automatic quality
control framework to identify and localise DXA artefacts in large-scale clinical
datasets. I tested the proposed method on a subset of scans selected from the
MRC-Hip study (n = 1300). The sensitivity and specificity are 81.82% and
94.12%, respectively.
The content of this chapter is adapted from the following publication:
Mohsen Farzi, Jose M. Pozo, Eugene McCloskey, J. Mark Wilkinson, and Alejandro F. Frangi, “Au-
tomatic Quality Control for Population Imaging: A Generic Unsupervised Approach,” in International
Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI2016). Springer,
pp. 291–299, 2016.
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5.1 Introduction
Population imaging studies such as UK Biobank [137] provide large datasets
containing prominent imaging components in addition to demographics and
other relevant meta-information. Large imaging datasets offer new opportuni-
ties for the comprehensive characterisation of the population (see chapter 3),
but equally pose new challenges. One main challenge is the ability to control
the quality of scans automatically and accurately, given the heterogeneous na-
ture of the image acquisitions. Although strict imaging protocols are deployed
to ensure consistent high-quality scans, incidental artefacts are inevitable.
Subjective image quality assessment (IQA) using a human observer is the
simplest approach. However, this approach is prone to error. Reliable sub-
jective quality assurance of large-scale datasets would require a prohibitively
large amount of time and expertise, making it unfeasible for use in practice.
Therefore, an objective technique is preferred for automatic IQA.
Automatic IQA has been explored extensively over the last two decades
in the multimedia signal processing community [166]. However, existing algo-
rithms are not directly applicable to medical images mainly for three reasons.
Frist, IQA algorithms generally quantify image quality in relationship to hu-
man visual perception, whereas in clinical applications, the image quality is
defined based on how well the image serves for the intended purpose [167, 168].
For example, in [169, 170], the ability of a human observer to detect lesions in
an image, rather than aesthetic considerations, defines the image quality.
Second, current IQA algorithms often require information about the antic-
ipated types of distortions. This information helps to learn a set of relevant
features specific to each artefact type. This approach would be practical in the
multimedia signal processing community where a limited number of artefacts
such as blurring, noise, and JPEG compression are often of interest. On the
other hand, artefacts are much more diverse in medical imagery; they are often
specific to the imaging modality, the acquisition protocol, or the organ system
(cf. [171, 172]). Managing unknown incidental artefacts is a challenging restric-
tion of large medical imaging cohorts. To address this challenge, developing
algorithms that are non-distortion-specific or general purpose is an important
consideration.
Third, following extracting relevant quality-aware features from each scan,
current IQA algorithms often require supervision to map these features to the
subjective human scores. In multimedia signal processing, various benchmarks
such as LIVE [173] and TID2008 [174] datasets with manual quality scores
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Figure 5.1: Image representation and visual word segmentation. The input image is divided
into a set of overlapping image patches quantised to the best-matched visual words from a
learned dictionary. Each visual word is a representative patch for a cluster of similar image
patches. Visual words only account for frequent texture patterns; the abnormal key-shape
object is eliminated in the reconstructed image.
are available for training purposes. However, manual quality annotations in
large-scale medical imagery datasets are rare and their creation would require
extensive and tedious visual assessment. Therefore, development of an opinion
free algorithm without access to any reference score would be of great interest.
This chapter proposes an unsupervised, opinion free, general purpose frame-
work to detect and localise artefacts in large-scale medical imaging datasets.
In this framework, a novel patch-based image representation technique is pro-
posed to synthesise a reference image corresponding to each image in the
dataset (Fig. 5.1). To this end, first, a dictionary of visual words is learned
(section 5.2.2). Each visual word is an image patch representative that char-
acterises a cluster of similar patches. Second, an optimal coverage algorithm
is proposed to cover each image with a subset of visual words. This coverage
segments each image into a number of (possibly) overlapping image patches
paired with their corresponding visual words (section 5.2.3). Following the im-
age representation, each image is compared against the corresponding reference
image and a set of dissimilarity scores are computed. Pooling the computed
scores of all the images in the dataset, a probability distribution is then es-
tablished per each dissimilarity metric and artefacts are detected as outliers
to the estimated distributions (Fig. 5.2; section 5.2.4).
The remainder of this chapter is organised as follows. Section 5.2 presents
the new framework for automatic image quality control applicable to large-
scale clinical studies. Section 5.3 reviews various types of artefacts observed in
femoral DXA scans. Section 5.4 demonstrates the application of the proposed
technique to identify artefacts in the setting of femoral DXA scans. Section
5.5 concludes this chapter.
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Figure 5.2: Unsupervised non-distortion-specific image quality framework. The proposed
method works on image patches. In the first step, a dictionary of visual words is learned by
grouping similar image patches together using the fixed-width clustering algorithm [175]. Each
visual word is simply the centroid of each cluster. In the second step, each image is divided
into a set of patches paired with their best-matched visual words from the dictionary. A
set of dissimilarity scores is then computed per each pair. Finally, a probability distribution
is established for each dissimilarity metric over the full dataset. Artefacts are detected as
outliers of these distributions.
5.2 Unsupervised Non-Distortion-Specific Im-
age Quality Control Framework
The proposed framework relies on three main assumptions. First, artefacts
have a local nature by observing patches of an appropriate size albeit the extent
of such patches could be, in the extreme case, the full image. Second, the image
database is large enough so as to capture the statistics of the normal images and
that of the artefacts of interest. Third, the incidence of artefacts in the image
database should be small enough so that artefacts always remain outliers in the
statistical distribution of the database. Under these assumptions, I propose
an unsupervised, opinion free, non-distortion-specific framework to detect and
localise artefacts in large-scale medical imaging datasets (Fig. 5.2).
The basic idea is to build a model representing the normal characteris-
tics of the image population and detect the artefacts as deviations from this
model. Based on the assumptions above, the proposed method works on image
patches and comprises three main constituents: robust learning of a dictionary
of image patches, an optimal coverage of the images with the learned visual
words, and an assessment of the similarity between each covered patch and
the corresponding visual word. This assessment allows us to detect outliers,
identifying both images with artefacts and their locations in the image.
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5.2.1 Background
The term visual word was coined in the object recognition literature [176] and
later was deployed for image quality assessment [177]. Each visual word is
simply a quantised representative for a cluster of similar image patches. Given
a dictionary of visual words, each image is modelled as a distribution over
the visual words by normalising the histogram of occurrence counts for each
visual word. This technique is known as the bag of visual words (BOVW)
representation in the literature.
The key assumption in the BOVW representation is that the frequency
of each word in an image can discriminate between different image classes.
However, the document frequency of each word, i.e. the frequency of each
word in the whole dataset, can also play a role; the presence of words with a
low document frequency in an image might be more informative than words
that are quite common in the whole dataset. To address this issue, it is common
to weight each bin of the histogram (, i.e. frequency of words in an image)
by the inverse frequency of the words in the database in the well-known term
frequency-inverse document frequency (tf-idf) scoring technique [178].
To detect image artefacts, however, only the presence of words with low
document frequency matters rather than the frequency of each word in an
image. However, unlike text documents where words are their intrinsic com-
ponents, there is no straightforward and natural segmentation of images into
visual words (patches). Alternatively, images are first parsed into a set of
patches and, next, similar patches are clustered together. Therefore, learning
words with low document frequency would be challenging in this approach.
Here, only words with a high document frequency are learned as normal patches
and then artefact patches are detected as a deviation from this normal repre-
sentation.
5.2.2 Robust Dictionary Learning
The objective is to learn a dictionaryW = {w1, · · · , wN} with N visual words
from a large pool of patches, capturing the normal shape and appearance
variation in the image class while excluding outlier patches. An outlier patch
is expected to lie in a sparse region of the feature space, i.e. raw intensity
values here, having few or no neighbours within a typical distance r. Observe
that outlier patches detected in this step cannot be used directly to identify
image artefacts. Since images are not coregistered and patches are extracted
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from fixed locations, some proportion of outliers will be due to misalignment
not necessarily representing an image artefact.
The proposed robust dictionary learning is as follows. Each image is divided
into overlapping square patches of size k for 2D images, or cubic patches for
3D images, with an overlap of size k′ between neighbouring patches. The
fixed-width clustering algorithm is then applied as follows. All the patches
are shuffled randomly and the first patch would be the first visual word. For
all the subsequent patches, the Euclidean distance of the patch to each visual
word is computed. If a distance is less than r, then the patch is added to
the corresponding cluster and its centroid is recalculated with the average of
all members. Otherwise, the patch is added as the centroid of a new cluster.
Observe that each patch may contribute to more than one cluster. Finally,
clusters with only one member are considered as outliers and removed from
the dictionary.
5.2.3 Optimal Image Coverage
A coverage of an image I is a selection of visual words placed at different
locations in the image so that all pixels are covered at least once. Let us
consider that the image I has P pixels and each visual word can be deployed
at L locations indexed by ` ∈ [1, L], where L ≤ P depends on the stride with
which the image is swept. The binary mask m` represents the word location
` in the image, dn` denotes the word w
n placed at location ` with appropriate
zero-padding, and the binary variable zn` encodes whether d
n
` is selected to
cover the image or not. Thus, the binary vector z =
[
z11 , · · · , zNL
]
would
represent a coverage of the image if∑
n,`
zn`m` ≥ 1P×1, (5.1)
where the left-hand side is an integer vector counting how many times each
pixel is covered in the image.
The image coverage error is the defined as the L2-norm of the difference




zn` ‖dn` −m` ◦ I‖
2 . (5.2)
Here, m` ◦I denotes the component-wise product between the binary mask m`
and the image I. The optimal image coverage is defined by the minimisation
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of the coverage error subject to the constraint in Eq. 5.1.




` , the number of visual words placed at location
`. If two words, wn1 and wn2 , are used at the same location ` (zn1` = z
n2
` = 1),
then the coverage error will be always larger than using just one of them,
without any effect on the constraint. Hence, the optimal solution will place
at each location ` either one single visual word (z∗` = 1) or none (z
∗
` = 0).
Therefore, the optimisation can be split into two independent problems. First,




‖dn` −m` ◦ I‖2. (5.3)









z∗`m` ≥ 1P×1. (5.4)
Eq. 5.4 can be efficiently solved using linear integer programming packages
such as Matlab optimisation toolbox (Mathworks Inc, Cambridge, MA).
5.2.4 Artefact Detection
For a given image, a dissimilarity score is computed between each representa-
tive visual word and its corresponding image patch. Any image patch with an
associated score above an optimal threshold identifies the location of an arte-
fact in the given image. Observe that since matching of the words is local and
the best fitting locations are found after an optimal coverage without forcing
a priori known locations, images do not need to be previously registered.
(A) Dissimilarity score
The local properties of an image can be described by the set of its derivatives,
which is named as local jet [179]. For a given image I and a scale σ, the local
jet of order N at point x is defined as
JN [I](x, σ) , {Li1,··· ,in(x;σ)}Nn=0, (5.5)





i1,i2,··· ,in ∗ I
]
(x), (5.6)
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with the corresponding derivatives of the Gaussian kernel G
(σ)
i1,i2,··· ,in(x), and
ik = 1, . . . , D, for D-dimensional images. For each derivative order, a com-
plete set of independent invariants under orthogonal transformations can be
extracted [179]. For 2D images and second order, for example, this complete




i , the Lapla-
cian
∑
i Lii, the Hessian norm
∑
i,j LijLji, and the second derivative along the
gradient
∑
i,j LiLijLj. Multiresolution description can be obtained by chang-
ing the scale σ in a convenient set of scale-space representations. For each
invariant feature, the Euclidean distance between the visual word and the cor-
responding image patch is used as the dissimilarity metric.
(B) Optimum threshold
The optimum threshold for each dissimilarity score is computed as follows. For
each image in the database, the maximum score among all the representative
visual words is computed. The optimum threshold is selected as q3 + ν ∗
(q3 − q1), where ν = 1.5, and q1 and q3 are the first and third quartiles,
respectively. An image is then artefact-free only if all the representative visual
words have a dissimilarity score below the optimum threshold with respect to
all the considered features.
5.3 DXA Artefacts
In bone densitometry using DXA, various types of artefacts may mask the true
BMD measurement [171, 180, 181, 182, 37, 183]. Currently, proprietary soft-
ware packages including Hologic Apex v3.2 (Hologic Inc, Waltham, MA) and
Lunar enCORE v16 (GE Healthcare, Madison, WI) used for DXA analysis re-
quires manual interaction and so each individual scan is analysed separately by
an expert operator. Hence, artefacts are deemed to be identified online during
the analysis step almost accurately. Unlike the common perception, however,
a survey of members of the International Society for Clinical Densitometry
(ISCD) indicated that errors in DXA acquisition are not rare [180]. Therefore,
retrospective quality assessment would be a necessity in DXA analysis. For
example, Beck et al. [150] excluded 7% of scans (i.e., 1031 scans out of 14,646)
from their proposed hip structural analysis due to various DXA artefacts such
as obscured femoral neck margins, incomplete scans, osteoarthritic changes,
metal artefacts, prosthetic or calcification, and excessive anteversion.
DXA artefacts can be broadly classified into 3 categories depending on
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Figure 5.3: Various types of femoral DXA artefacts. DXA artefacts can be broadly classified
into three categories: errors due to poor calibration of the instrument prior to scan collection,
imaging artefacts during scan acquisition, and errors due to poor analysis following the scan
collection. Imaging Artefacts can be further divided into six categories.
the chronological order they may happen (Fig. 5.3). First, prior to scan
acquisition, the instrument should be calibrated against a phantom to en-
sure accurate BMD measurement. This is of great importance in multi-centre
studies or longitudinal analysis of individual patients. Second, during scan
acquisition, errors may occur due to a fault in the instrument (, e.g., scan-line
error), patient (, e.g., metal objects in clothing), or operator (, e.g., poor pa-
tient positioning). These artefacts are visible in the collected images and can
be identified retrospectively. Third, following scan collection, errors may still
happen during the analysis step, e.g. poor segmentation of bone tissue. Soft-
ware packages for DXA analysis provide some degrees of automation for bone
analysis; however, subtle errors should be identified and corrected manually
by the operator. For example, the operator should confirm whether the neck
ROI is located correctly or not in the hip scan analysis.
The aim of this study is to identify artefacts during the image acquisition
step. No standard guideline exists for classification of femoral DXA artefacts.
Lack of a standard protocol limits consistent screening for DXA artefacts as
different experts may hold different opinions of DXA artefacts. This diversity
in opinions may originate from two different perspectives: first, the relative
importance of various imaging artefacts in DXA analysis has been rarely stud-
ied in the literature and thereby, in extreme, one could be convinced that an
error is not indeed an artefact. Second, DXA scans may be deployed for vari-
ous purposes and so defining artefacts based on the intended purpose could be
ambiguous. For example, errors affecting BMD measurement at the trochanter
may not be considered as artefacts as long as neck BMD is only of interest.
Recognising these challenges, here, I propose to classify artefacts observed in
femoral DXA scans into 6 groups following visual assessment of a large number
of DXA scans, reading the literature, and consulting with radiology experts in
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the field (Fig. 5.3).
1. Incongruous objects: This category would capture any localised incon-
gruity in texture patterns that may not represent either bone or soft
tissue. Artefacts of this class are often characterised as too bright or
too dark spots in the image (Fig. 5.4(a)). Taking into account the po-
tential sources of error, this class could be further divided into three
subcategories:
• External: metal objects in or on clothing, buttons, plastic materials
in the pocket (e.g., credit card), sticking plasters.
• Internal: Surgical clips, implants, body piercing, pacemaker lead.
• Pharmaceutical: nuclear medicine (e.g., Barium examination), in-
jection of contrast media (e.g., Myelographic contrast agent).
2. Noise: This artefact is characterised either by extra granularity patterns
or a dark shadow over the pelvic region (Fig. 5.4(b)). This artefact is
often seen in obese subjects and can be attributed to inhomogeneous fat
distribution around the bone.
3. Movement: Despite leg fixation during scan acquisition, incidental move-
ments could affect the BMD measurement. This artefact is characterised
by an interruption in the continuity of bone tissue that makes the picture
looks fuzzy (Fig. 5.4(c)).
4. Scan-line: This artefact is characterised by distinct horizontal lines with
random values in the image, and is attributed to a fault in the scanner
(Fig. 5.4(d)).
5. Clinical: This class would capture any medical disorder that may affect
the BMD measurement in hip. For example, Enostosis (bone islands), hip
osteoarthritis (see Fig. 5.4(e)), Paget disease, calcific tendinitis, vascular
calcification, avascular necrosis, developmental dysplasia of the hip, etc
[171, 181].
6. Patient positioning: Since DXA is a 2D projection, inconsistency in pa-
tient positioning could result in variation in BMD measurements. DXA
manufacturers advise a standard protocol for positioning patients in the
scanner. Any deviation from this standard positioning is then defined as
artefact [37, 183]. This category can be further classified into 4 subcat-
egories:
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(a) Metal object on
clothing
(b) Noise (c) Movement
(d) Scan-line (e) Osteoarthritis (f) Rotation
Figure 5.4: Examples of various imaging artefacts in DXA. The red contour overlaid the image
shows the location of each artefact.
• Rotation: In this group, the leg is rotated from the standard posi-
tion either internally or externally. The amount of lesser trochanter
observed in the scan may reflect the rotation artefact; if rotated
externally (internally) too much (less) of lesser trochanter would be
observed. However, due to anatomical variation between subjects,
it is difficult to visually assess the presence of this artefact (see Fig.
5.4(f)).
• Coverage. In this group, the scan does not capture the intended
ROI advised by DXA manufacturers either by including more parts
than the standard or missing a few parts.
• Adduction. The limb is moved toward the mid-line of the body.
• Abduction. The limb is moved away from the mid-line of the body.
5.4 Experiments and Results
(A) Dataset
A subset of 300 hip DXA scans selected randomly from the MRC-Hip study
[139] were manually annotated for the following artefacts: incongruous object,
noise, scan-line, and movement. These annotations were used as the ground-
truth labels for evaluation of the proposed quality control framework. Another
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random selection of 1000 scans from the same study was used to learn the visual
words and to set the optimum thresholds for artefact detection.
(B) Parameter selection
The patch size and the radius r are two parameters for the proposed method.
Both parameters would be data dependent. The radius r is automatically
selected estimating a typical small distance between patches in the same image:
For each image, all pairwise distances between the patches comprising the
image are computed. Next, 1
n
-quantile of these distances are computed per
image, where n is the total number of patches extracted from each image.
Then, the parameter r is selected as the median of the computed quantiles in
the image dataset. The patch size could be estimated based on the size of the
effect that is measured. For example, in femoral DXA bones, the diameter of
the femoral stem is approximately 64 pixels. I have tested the results with
patches of size 32 and 64 with 8 pixel overlap. No differences were observed in
the sensitivity. I presented the results with patches of size 64. In summary, the
total number of 24830 patches were extracted from 1000 images. The radius
r = 3.5 is estimated for this dataset. The obtained dictionary contained 1146
visual words.
I tested invariant features up to the second order. However, the second
order features did not provide any new information. Hence, only intensity and
gradient magnitude were finally used as the features. The gradient magnitude
for each image patch or visual word is normalised to have Euclidean norm one.
Single scale analysis with σ = 0.2 was used. Optimum thresholds are derived
as 0.37 and 4.86 for the gradient magnitude and intensity, respectively.
(C) Results
Sensitivity and specificity of the method are reported on the test data based
on a priori manual annotation. The sensitivity is defined as the proportion
of images with artefacts that are detected correctly by the algorithm. The
specificity is defined as the proportion of normal images that are correctly
labelled as artefact-free.
Eleven images out of 300 were manually identified with artefacts. Nine out
of eleven are detected using the proposed algorithm. Sensitivity and speci-
ficity are 81.82% and 94.12%, respectively. Fig. 5.5 shows normal images and
artefacts. Only 2 out of 11 image artefacts are misclassified as normal. These
two scans are characterised as movement artefacts that cause subtle vertical
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displacement in the image. However, the algorithm managed to successfully
localise other types of artefacts including the existence of an external object
(key-shape object in Fig. 5.5).
Figure 5.5: Examples of successful and unsuccessful DXA artefact detection using the pro-
posed algorithm. The red square, if present in the image, shows the location of detected
artefacts.
5.5 Conclusion
This chapter presented the development of an unsupervised and non-distortion-
specific framework to address automatic quality control in large medical im-
agery datasets. Based on the assumption that artefacts constitute a small
proportion of the dataset, a dictionary-based framework based on an optimal
coverage of images was introduced to detect and localise image artefacts as
outliers to the normal image class. The method computational complexity
is linear in the number of input images, providing good scalability to large
datasets. I have tested the method on 300 femoral DXA scans and reported
good sensitivity and specificity on the dataset.
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Chapter 6
Conclusions and Future Work
6.1 Overview
Osteoporosis is an age-associated disease leading to deteriorated bone quality
with elevated fracture risk. Despite the progressive nature of osteoporosis,
currently, the degree of progression or the severity of disease is not intuitively
estimated in clinical practice. Bone status is categorised as normal, osteope-
nia, or osteoporosis based on the bone mineral density (BMD) measurement
at femoral neck or spine reported as T-score, i.e. the number of standard devi-
ation (SD) from the average for young healthy women in the population. The
world health organisation (WHO) criteria for the diagnosis of osteoporosis is
based on the T-score cut-off point of -2.5 for osteoporosis and -1 for osteope-
nia. Setting a clear cut-off point could be misleading as half of the fragility
fractures at most could be attributed to osteoporotic bones with this defini-
tion [15]. Although the population attributable risk (PAR) of 50% is still high
when compared with a PAR of 10% between hypertension and congestive heart
failure [184], the ability to provide new metrics capturing the bone strength
beyond neck BMD remains of interest in osteoporosis research. With these
limitations in mind, the overall aim of this study was to model the evolution
of spatial BMD distribution within the proximal femur as a function of age.
Quantification of age-related architectural changes in the femur would allow
the introduction of new indices capturing the gradual deterioration in bone
quality with osteoporosis progression.
In Chapter 1, I reviewed three different perspectives on bone quality as-
sessment. In the first approach, assuming fragility fractures are the important
outcome rather than the bone strength per se, other clinical risk factors to-
gether with neck BMD were deployed to improve fracture prediction. In the
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second approach, defining bone strength as the maximum stress that bone
can sustain before breaking, finite element analysis was used to model the
stress-strain relationship in bones. In the third approach, given that DXA
scans can provide much more information on bone structural properties rather
than neck BMD, various techniques were deployed to extract useful geometrical
structures or spatial BMD patterns in the setting of osteoporosis management.
In line with the third approach, an elegant framework called DXA region free
analysis (RFA) was reviewed. In DXA RFA, BMD maps are warped into a
reference template to eliminate morphological variation and so an anatomical
correspondence between pixel coordinates is established. This pixel correspon-
dence allowed application of statistical tests to quantitate localised remodelling
events. However, the initial RFA framework presented in [36] did not account
for the known multiple comparisons problem.
In Chapter 2, I reviewed various techniques to address the multiple compar-
isons problem, including the Bonferroni correction, random field theory, and
false discovery rate analysis. This chapter presented the integration of false
discovery rate analysis with DXA RFA to quantitate the magnitude and areal
size of periprosthetic BMD changes using scans acquired during two previous
randomised clinical trials.
In Chapter 3, I explored the relationship between osteoporosis and ageing,
as understanding the mechanism by which bone gets weaker with ageing might
open new perspectives to estimate osteoporosis progression over a continuum.
One main contribution of this thesis is to develop the first spatio-temporal
atlas of bone ageing in the femur using over 13,000 Caucasian women aged
20-97 years from North Western Europe. Development of a comprehensive
model for involutional bone loss is a challenging task: first, a sufficiently large
sample size is required to represent the variation in the population; second,
a deformable image warping is required to quantify spatial BMD variation at
anatomically correspondent sites. To comprise a large-scale dataset captur-
ing the whole adulthood age range, data was integrated from three previous
studies: UK Biobank (n=6,918; age range=45-80 years), OPUS (n=1,402;
age range=20-40 and 55-79 years), and MRC-Hip (n=5,018; age range=75-97
years). Since a systematic difference in BMD measurement exists between
DXA manufacturers, I also proposed and internally validated a new quantile
matching regression technique for comparative calibration between different
vendors. The new technique applies to large-scale datasets where no repeated
measurements of the same subject on different machines would be available,
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but instead relied on population-based BMD distribution data for calibration.
To quantify the BMD variation at anatomically correspondent locations, I ex-
tended the region free analysis (RFA) technique developed for peri-prosthetic
BMD analysis to a fully automatic framework applicable to the native femur.
In Chapter 4, I explored how the developed atlas usefully adds to our
understanding of bone ageing patterns in the femur. The delineation between
cortical and trabecular arrangements of bone in the femur was possible with
the enhanced RFA resolution. For example, the average cortical thickness was
linearly decreased with ageing from 6.65 mm at 20 years to 5.55 mm at 80
years. To reflect the overall effect of ageing on trabecular microarchitecture,
bone age was introduced as age at which the median bone map best fits the
given individual bone map. To find this optimised age, the `2-norm between
the bone map for the given individual and the median map from the atlas
at that age was minimised. Given ageing as the underlying mechanism for
osteoporosis, here I assumed that all individuals follow a unique bone ageing
trajectory but with different speeds. An accelerated loss in BMD is then
attributed to osteoporosis.
Promising properties demonstrated by bone age may suggest potentials for
better management of osteoporosis using the new metric. First, bone age was
highly correlated with neck BMD (r=-0.87; p<0.001) suggesting consistency
with current diagnostic guidelines. Second, bone age was precise; the standard
deviation of error estimated on 25 pairs of scans collected on the same day was
1.4 years. Third, its ability to differentiate between a young healthy population
(n = 284; age<40 years) and a more elderly cohort (n=2165; age>80 years) was
found to be 5% higher than neck BMD alone (p<0.001) measured as the area
under the curve (AUC) using receiver operating characteristic (ROC) analysis.
Fourth, the risk of sustaining a follow-up fragility fracture increased consis-
tently with bone ageing. Fifth, its ability to predict hip fractures measured
as the area under the ROC curve was similar to other metrics including neck
BMD and FRAX. When normalising BMD maps for their bone age, localised
fracture-specific patterns were observed at the superior femoral neck extended
to the trochanter with the same orientation as principal tensile curves. These
patterns could not be observed using the raw BMD maps suggesting that ex-
cluding the ageing effect may lead to the identification of new scores that can
enhance fracture prediction independent of neck BMD or bone age. In this
study, I proposed a new metric called f-score by averaging normalised pixel
BMD values over the identified localised fracture-specific regions. Integration
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of f-score and bone age significantly enhanced the AUC by 3% over neck BMD
alone.
Population imaging studies such UK Biobank study [137] have opened new
opportunities for a comprehensive characterisation of a range of diseases in-
cluding osteoporosis. However, this poses new emerging challenges in the field.
One main challenge is the ability to assess the quality of scans automatically
and accurately in large-scale datasets. In Chapter 5, I presented a novel un-
supervised, automatic, non-distortion-specific framework for quality control of
DXA scans in large-scale studies. The proposed method was tested on a subset
of scans selected from the MRC-Hip study (n = 1300). The sensitivity and
specificity were 81.82% and 94.12%, respectively. This technique is the first
step forward toward development of automatic quality control frameworks for
DXA images.
6.2 Thesis Contributions
• Integrated FDR analysis to the RFA framework to localise significant
bone remodelling events (chapter 2).
• Extended the RFA technique to a fully automatic framework applica-
ble to the native femur for quantification of spatial BMD distribution
(chapter 3).
• Developed the first spatio-temporal atlas of bone ageing in the femur
with over 13,000 Caucasian women from North Western Europe aged
between 20-97 years (chapter 3).
• Proposed a new quantile matching technique for comparative calibration
between different DXA manufacturers when multiple measurements of
the same subject on different machines are not available (chapter 3).
• Extended the notion of disease progression estimation to osteoporosis by
introducing bone age as the age at which bone microarchitecture best
fits the developed atlas (chapter 4).
• Characterised local fracture-specific patterns in the femur using enhanced
RFA resolution analysis and the introduction of a new metric called
f-score with the power to predict fractures independent of neck BMD
(chapter 4).
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• Developed the first automatic quality control framework of femoral DXA
scans (chapter 5).
6.3 Limitations
DXA RFA also has limitations. Although aggregating pixel BMD in a priori
identified regions of interest (ROIs) results in similar precision to conventional
DXA analysis, the pixel level precision in RFA is worse. This is a compromise
that offers enhanced resolution analysis. To further improve the pixel level pre-
cision, more advanced registration algorithms would be utilised to warp each
scan to the template domain. More specifically, the thin plate spline (TPS)
technique does not account for uncertainty in the selection of controlling land-
mark points. Langevin equations may be deployed to address this issue as
discussed by Marsland and Shardlow [185]. This would specifically help with
the low RFA precision at the bone margins. Another limitation of the TPS
technique is that no intensity information is utilised during the image align-
ment. Due to the random rotation of DXA scans in the population, relying
on the intensity variation for image registration could be misleading. There-
fore, the TPS was originally chosen for the registration step; however, Kuhnel
and colleagues [186] recently proposed a framework to separate deformation
from intensity changes in non-rigid registration. Application of this framework
would allow benefiting from both warp and intensity variation available in the
dataset.
Second, RFA removes potentially useful geometrical properties by aligning
all scans to a reference template. This approach, known as voxel-based anal-
ysis (VBA), has been widely used in medical imaging community to compare
between two groups (e.g., patients and controls [187]) or identifying regions
where the disease severity would correlate most with the image features [188].
In this work, RFA resulted in promising results for characterising age-related
spatial BMD variation as well as localising fracture-specific patterns in the fe-
mur. However, for a comprehensive analysis of bone structural properties, one
should explore morphological variation between scans as well. Modelling mor-
phological variation with ageing has not been addressed in the femur yet, but
this has been explored in the brain to model the severity of Alzheimer’s disease
[112]. The method proposed in [112] potentially could also be applied to the
femur, but it does not address two main challenges specific to the femoral DXA
scans. To model the ageing impact on the femoral morphology, one should first
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exclude the variation due to poor patient positioning and image magnification
in DXA scans.
Third, DXA RFA, despite enhanced spatial resolution analysis, can only
offer an approximate reflection on bone structural properties. For a detailed
analysis of micro-architectural properties, other advanced imaging techniques
including Quantitative Computed Tomography (QCT) [157] and high-resolution
peripheral QCT (HR-pQCT) [156] should be utilised in practice. While these
techniques provide enhanced spatial resolution comparing with DXA, their
application in clinical practice is unlikely in the foreseeable future [18]. On
the other hand, DXA is an inexpensive, widely available clinical tool with
extremely low radiation exposure. Given that DXA RFA can be applied retro-
spectively to the original DXA measurements, it has the potential to transform
the conventional DXA analysis in future.
6.4 Future Work
The work presented in this thesis has opened new perspectives for understand-
ing the relationship between osteoporosis and the arrangements of trabecular
microarchitecture in the proximal femur leading to weaker bones in the el-
derly population. The proposed framework in this thesis constitutes a first
step toward modelling osteoporosis progression to identify better bone-based
risk factors for prediction of fragility fractures. This study could potentially
contribute to the future research on osteoporosis as discussed below.
6.4.1 Extending the Bone Ageing Atlas
Chapter 3 presented a fully automatic pipeline to streamline the bone age-
ing analysis. The technique was deployed to generate the atlas for Cau-
casian women in the proximal femur, but the automated pipeline will facil-
itate population-specific atlas generation from other ethnic libraries, gender,
and anatomic sites.
Since osteoporosis is more prevalent among women than men, the primary
concern of this study was women. The same pipeline, however, could be de-
ployed to analyse bone density patterns in men. To construct the ageing atlas
for men, a primary challenge would be the collection of a large-scale dataset
capturing the adulthood age range. Although the ability of the proposed
pipeline for retrospective analysis of DXA scans avoids the necessity for new
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data collection, clinical studies with a focus on men are still limited. To men-
tion a few ones, Mr Os is an international multicenter study in the United
States, Hong Kong, and Sweden with men aged 69 to 80 years [189].
Although age was the primary variable of interest in this study, extending
the atlas for other covariates is possible. In chapter 4, I demonstrated how
variation due to body mass index (BMI) could be modelled using the flexibil-
ity of vector generalised additive models (VGAM) integrated into the pipeline.
Other risk factors to be included in the model could include genetic variability
between individuals, drug medications, smoking habits, alcohol consumption,
physical activity, etc. While the current framework can be extended for addi-
tional covariates, missing data could be a new emerging challenge; the more
covariates to be included, the more cases with incomplete explanatory vari-
ables. Further developments would be required to address the missing data
issue in large-scale datasets.
Among all types of fragility fractures, hip fractures are the most menacing
complication of osteoporosis with associated disability burden [190]. Therefore,
this thesis addressed the development of an ageing atlas in the proximal femur
as the first step. However, it is possible to extend the framework to other
anatomic sites including the spine. Given the different anatomy of the spine
in comparison to the femur, the automatic landmark selection step in the
proposed pipeline should be extended to account for spine scans.
6.4.2 Osteoporosis Progression Model
Although disease progression is a new concept in osteoporosis introduced in
this thesis, progression estimation has been established as a useful practice in
other age-associated diseases such as dementia [164]. In this study, the actual
progression on the median ageing trajectory in the original high-dimensional
space defined osteoporosis progression. To this end, each subject was mapped
into the ageing trajectory using a simple L2-norm. This similarity metric has
two limitations: first, it does not account for the variation in BMD distribution
around the median between pixel coordinates. To account for this variation,
other metrics such as Mahalanobis distance could be used. This is also known
as the generalised least squares minimisation problem in the literature. Sec-
ond, it does not account for the variation in uncertainty in the estimation
of the ageing trajectory at different ages. To account for this variation, a
Bayesian framework may be deployed to estimate the bone age as the age with
a maximum a posteriori probability.
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Since only baseline measurements were available in this study, the relation
between fracture incidents and the rate of osteoporosis progression has not be
analysed. Given longitudinal data measurements, computation of progression
rates may lead to a potential added value for fracture prediction beyond the
estimated baseline bone status.
6.4.3 Predicting Local Fracture Patterns
Normalising spatial BMD patterns for bone age would exclude ageing effect
allowing identification of local fracture patterns in the residual BMD map.
I have demonstrated in chapter 4 that these local patterns could enhance
fracture prediction beyond bone age or neck BMD alone. Hip fractures may
happen either at the subcapital neck, transcervical neck, intertrochanter, sub-
trochanter, greater trochanter, or lesser trochanter (Fig. 6.1). Knowing the
type of fracture, the RFA technique would allow correlating this information
with the residual BMD maps to characterise local texture patterns with added
predictive value for fracture prediction. This would lead to a more efficient
analysis of contained information in BMD maps that could further improve
the fracture risk assessment in the setting of osteoporosis disease.
Figure 6.1: Basic types of fracture patterns in the proximal femur. A single pattern or a
combination of these patterns may be observed in practice. DXA RFA would allow correlation
of local BMD patterns with actual fracture patterns in the femur to enhance hip fracture
prediction. The image is adapted from [165].
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6.5 Conclusion
In this thesis, I developed a region free analysis framework for quantification
of pixel BMD at anatomically corresponding locations in the proximal femur.
The evolution of spatial BMD distribution was modelled as a function of age.
This is, to the best of my knowledge, the first spatio-temporal atlas of BMD
ageing in the femur. Bone age was introduced to reflect the overall spatial
BMD patterns, estimating the actual progression on the median ageing tra-
jectory in the femur. Given the promising properties of bone age, I proposed
its potential to estimate osteoporosis progression as a continuum rather than
conventional discrete categories, i.e. normal, osteopenia, and osteoporosis. A
new index, called f-score, was introduced to characterise local fracture-specific
patterns. Bone age together with f-score demonstrated a statistically signifi-
cant improvement in hip fracture prediction for the elderly population. Given
access to large-scale DXA datasets, automatic quality control of DXA scans
has been identified as an emerging challenge to the community for which an
unsupervised, non-distortion-specific, opinion-free quality control framework
was proposed. The work presented in this thesis has opened new perspectives
for better understanding of localised spatial BMD patterns and their relation-
ship with osteoporosis. Future research into the relationship between these
spatial patterns and various fracture types in the femur may further enhance
hip fracture prediction in the elderly population.
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[190] L. Sànchez-Riera, N. Wilson, N. Kamalaraj, J. M. Nolla, C. Kok, Y. Li,
M. Macara, R. Norman, J. S. Chen, E. U. Smith, et al., “Osteoporosis
and fragility fractures,” Best Practice & Research Clinical Rheumatology,
vol. 24, no. 6, pp. 793–810, 2010.
